Document_And_Entity_Informatio
Document And Entity Information | 12 Months Ended |
Dec. 31, 2013 | |
Entity Information [Line Items] | ' |
Document Type | '20-F |
Amendment Flag | 'false |
Document Period End Date | 31-Dec-13 |
Document Fiscal Year Focus | '2013 |
Document Fiscal Period Focus | 'FY |
Entity Registrant Name | 'ASM INTERNATIONAL N V |
Entity Central Index Key | '0000351483 |
Trading Symbol | 'asmi |
Entity Current Reporting Status | 'Yes |
Current Fiscal Year End Date | '--12-31 |
Entity Filer Category | 'Large Accelerated Filer |
Entity Well-known Seasoned Issuer | 'Yes |
Preferred Shares [Member] | ' |
Entity Information [Line Items] | ' |
Entity Common Stock, Shares Outstanding | 0 |
Common Shares [Member] | ' |
Entity Information [Line Items] | ' |
Entity Common Stock, Shares Outstanding | 63,468,390 |
Consolidated_balance_sheets
Consolidated balance sheets (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Assets | ' | ' |
Cash and cash equivalents | € 312,437 | € 290,475 |
Accounts receivable, net | 83,016 | 304,840 |
Inventories, net | 104,467 | 403,400 |
Income taxes receivable | 1,226 | 890 |
Deferred tax assets | 3,739 | 17,967 |
Other current assets | 13,155 | 90,807 |
Total current assets | 518,040 | 1,108,379 |
Pledged cash | 0 | 20,000 |
Debt issuance costs | 276 | 735 |
Deferred tax assets | 1,320 | 5,955 |
Other intangible assets, net | 5,637 | 13,915 |
Goodwill, net | 11,421 | 51,888 |
Evaluation tools at customers | 13,332 | 16,922 |
Investments and associates | 943,954 | 278 |
Property, plant and equipment, net | 56,531 | 275,436 |
Assets held for sale | 738 | 5,998 |
Total assets | 1,551,249 | 1,499,506 |
Liabilities and shareholders’ equity | ' | ' |
Notes payable to banks | 0 | 61,675 |
Accounts payable | 44,837 | 151,761 |
Provision for warranty | 7,966 | 38,623 |
Accrued expenses and other | 38,660 | 132,060 |
Income taxes payable | 10,087 | 27,625 |
Deferred tax liabilities | 0 | 36 |
Current portion of long-term debt | 0 | 6,316 |
Total current liabilities | 101,550 | 418,096 |
Pension liabilities | 2,415 | 12,540 |
Deferred tax liabilities | 35 | 952 |
Provision for warranty | 0 | 5,298 |
Long-term debt | 0 | 12,632 |
Total liabilities | 104,000 | 449,518 |
Commitments and contingencies | ' | ' |
Common shares: | ' | ' |
Authorized 110,000,000 shares, par value €0.04, issued and outstanding 63,095,986 and 63,468,390 shares | 2,539 | 2,584 |
Preferred shares: | ' | ' |
Preferred shares | 0 | 0 |
Capital in excess of par value | 250,971 | 480,152 |
Retained earnings | 1,281,861 | 288,082 |
Accumulated other comprehensive loss | -88,122 | -28,942 |
Total shareholders’ equity | 1,447,249 | 741,876 |
Non-controlling interest | 0 | 308,112 |
Total equity | 1,447,249 | 1,049,988 |
Total liabilities and shareholders’ equity | 1,551,249 | 1,499,506 |
Financing Preferred Shares [Member] | ' | ' |
Preferred shares: | ' | ' |
Preferred shares | € 0 | € 0 |
Consolidated_balance_sheets_Pa
Consolidated balance sheets (Parenthetical) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
Common shares, authorized (in shares) | 110,000,000 | 110,000,000 |
Common shares, par value (in euro per share) | € 0.04 | € 0.04 |
Common shares, issued (in shares) | 63,468,390 | 63,095,986 |
Common shares, outstanding (in shares) | 63,468,390 | 63,095,986 |
Preferred shares, authorized (in shares) | 118,000 | 118,000 |
Preferred shares, par value (in euro per share) | € 40 | € 40 |
Preferred shares, issued (in shares) | 0 | 0 |
Financing Preferred Shares [Member] | ' | ' |
Preferred shares, authorized (in shares) | 8,000 | 8,000 |
Preferred shares, par value (in euro per share) | € 40 | € 40 |
Preferred shares, issued (in shares) | 0 | 0 |
Consolidated_statements_of_ope
Consolidated statements of operations (EUR €) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income Statement [Abstract] | ' | ' | ' |
Net sales | € 612,277 | € 1,418,067 | € 1,634,334 |
Cost of sales | -397,727 | -977,638 | -1,063,708 |
Gross profit | 214,550 | 440,429 | 570,626 |
Operating expenses: | ' | ' | ' |
Selling, general and administrative | -94,776 | -200,799 | -174,107 |
Research and development, net | -75,391 | -149,219 | -129,400 |
Amortization of other intangible assets | -696 | -1,264 | -911 |
Impairment charge property, plant and equipment and assets held for sale | -796 | 0 | -8,038 |
Restructuring expenses | -2,473 | -891 | 0 |
Total operating expenses | -174,132 | -352,173 | -312,455 |
Operating income: | ' | ' | ' |
Gain on bargain purchase | 0 | 0 | 109,279 |
Result from operations | 40,418 | 88,256 | 367,450 |
Interest income | 972 | 1,989 | 2,902 |
Interest expense | -2,943 | -12,113 | -13,497 |
Loss resulting from early extinguishment of debt | 0 | -2,209 | -824 |
Accretion interest expense convertible notes | 0 | -4,469 | -4,401 |
Revaluation conversion option | 0 | 0 | -4,378 |
Foreign currency exchange gains (losses), net | -8,158 | -3,957 | 5,604 |
Result on investments and associates | 1,030,132 | -766 | 0 |
Earnings before income taxes | 1,060,421 | 66,731 | 352,855 |
Income tax expense | -11,121 | -26,300 | -36,692 |
Net earnings | 1,049,300 | 40,431 | 316,164 |
Allocation of net earnings: | ' | ' | ' |
Shareholders of the parent | 1,051,893 | 7,149 | 186,770 |
Non-controlling interest | -€ 2,593 | € 33,282 | € 129,394 |
Share data: | ' | ' | ' |
Basic net earnings per common share (EUR) | € 16.60 | € 0.13 | € 3.38 |
Diluted net earnings per common share (EUR) | € 16.35 | € 0.13 | € 3.16 |
Weighted average number of shares used in computing per share amounts (thousand): | ' | ' | ' |
Basic (in shares) | 63,202 | 56,108 | 55,210 |
Diluted (in shares) | 64,196 | 56,767 | 64,682 |
Consolidated_statements_of_com
Consolidated statements of comprehensive income (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Statement of Comprehensive Income [Abstract] | ' | ' | ' |
Net earnings (loss) | € 1,049,300 | € 40,431 | € 316,164 |
Other comprehensive income (loss): | ' | ' | ' |
Realization deferred accumulative translation result following the sale of the 12% share of ASMPT | 23,053 | 0 | 0 |
Proportionate part in other comprehensive income (loss) ASMPT for period March 16- December 31, 2013 | 480 | 0 | 0 |
Foreign currency translation effect | -83,087 | -10,110 | 18,062 |
Unrealized gains (losses) on derivative instruments, net of tax | 0 | 0 | -13 |
Actuarial loss | -224 | -3,716 | 1,139 |
Total other comprehensive income (loss) | -59,778 | -13,826 | 19,188 |
Comprehensive income (loss) | 989,522 | 26,605 | 335,352 |
Allocation of comprehensive income (loss): | ' | ' | ' |
Common shareholders | 991,116 | -1,642 | 200,858 |
Non-controlling interest | -€ 1,594 | € 28,247 | € 134,494 |
Consolidated_statements_of_com1
Consolidated statements of comprehensive income (Parenthetical) (Asm Pacific Technology Ltd [Member]) | Jul. 25, 2013 | Mar. 15, 2013 |
Asm Pacific Technology Ltd [Member] | ' | ' |
Percentage of stake sold | 12.00% | 11.88% |
Consolidated_statements_of_tot
Consolidated statements of total equity (EUR €) | Total | Common Shares [Member] | Capital In Excess Of Par Value [Member] | Treasury Shares At Cost [Member] | Retained Earnings [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Total Shareholders' Equity [Member] | Non-Controlling Interest [Member] |
In Thousands, except Share data, unless otherwise specified | ||||||||
Beginning balance at Dec. 31, 2010 | € 647,227 | € 2,117 | € 311,841 | € 0 | € 131,741 | -€ 34,239 | € 411,460 | € 235,767 |
Beginning balance (in shares) at Dec. 31, 2010 | ' | 52,931,881 | ' | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' |
Compensation expense stock options | 1,872 | ' | 1,872 | ' | ' | ' | 1,872 | ' |
Conversion of debt into common shares (in shares) | 2,151,020 | 2,151,020 | ' | ' | ' | ' | ' | ' |
Conversion of debt into common shares | 58,525 | 86 | 58,439 | ' | ' | ' | 58,525 | ' |
Exercise stock options by issue of common shares (in shares) | ' | 294,119 | ' | ' | ' | ' | ' | ' |
Exercise stock options by issue of common shares | 4,077 | 12 | 4,065 | ' | ' | ' | 4,077 | ' |
Net earnings to common shareholders | 316,164 | ' | ' | ' | 186,770 | ' | 186,770 | 129,394 |
Dividend paid to common shareholders | -22,262 | ' | ' | ' | -22,262 | ' | -22,262 | ' |
Other comprehensive income | 19,188 | ' | ' | ' | ' | 14,088 | 14,088 | 5,100 |
Other movements in non-controlling interest: | ' | ' | ' | ' | ' | ' | ' | ' |
Dividend paid | -79,473 | ' | ' | ' | ' | ' | ' | -79,473 |
Dilution | 12,396 | ' | ' | ' | 5,266 | ' | 5,266 | 7,130 |
Ending balance at Dec. 31, 2011 | 957,714 | 2,215 | 376,217 | 0 | 301,515 | -20,151 | 659,796 | 297,918 |
Ending balance (in shares) at Dec. 31, 2011 | ' | 55,377,020 | ' | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' |
Compensation expense stock options | 3,242 | ' | 3,242 | ' | ' | ' | 3,242 | ' |
Purchase of common shares (in shares) | ' | -1,500,000 | ' | ' | ' | ' | ' | ' |
Purchase of common shares | -40,554 | ' | ' | -40,554 | ' | ' | -40,554 | ' |
Conversion of debt into common shares (in shares) | 9,074,396 | 9,074,396 | ' | ' | ' | ' | ' | ' |
Conversion of debt into common shares | 139,407 | 363 | 98,490 | 40,554 | ' | ' | 139,407 | ' |
Exercise stock options by issue of common shares (in shares) | 328,000 | 144,570 | ' | ' | ' | ' | ' | ' |
Exercise stock options by issue of common shares | 2,209 | 6 | 2,203 | ' | ' | ' | 2,209 | ' |
Net earnings to common shareholders | 40,431 | ' | ' | ' | 7,149 | ' | 7,149 | 33,282 |
Dividend paid to common shareholders | -27,519 | ' | ' | ' | -27,519 | ' | -27,519 | ' |
Other comprehensive income | -13,826 | ' | ' | ' | ' | -8,791 | -8,791 | -5,035 |
Other movements in non-controlling interest: | ' | ' | ' | ' | ' | ' | ' | ' |
Dividend paid | -27,024 | ' | ' | ' | ' | ' | ' | -27,024 |
Dilution | 15,908 | ' | ' | ' | 6,937 | ' | 6,937 | 8,971 |
Ending balance at Dec. 31, 2012 | 1,049,988 | 2,584 | 480,152 | 0 | 288,082 | -28,942 | 741,876 | 308,112 |
Ending balance (in shares) at Dec. 31, 2012 | ' | 63,095,986 | ' | ' | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' |
Compensation expense stock options | 4,440 | ' | 4,440 | ' | ' | ' | 4,440 | ' |
Reclassification | 0 | -60 | 60 | ' | ' | ' | ' | ' |
Conversion of debt into common shares (in shares) | 0 | ' | ' | ' | ' | ' | ' | ' |
Exercise stock options by issue of common shares (in shares) | ' | 125,402 | ' | ' | ' | ' | ' | ' |
Exercise stock options by issue of common shares | 1,651 | 5 | 1,646 | ' | ' | ' | 1,651 | ' |
Re-issued shares following the settlement of the Lehman treasury shares (in shares) | ' | 247,002 | ' | ' | ' | ' | ' | ' |
Re-issued shares following the settlement of the Lehman treasury shares | 4,190 | 10 | 4,180 | ' | ' | ' | 4,190 | ' |
Net earnings to common shareholders | 1,049,300 | ' | ' | ' | 1,051,893 | ' | 1,051,893 | -2,593 |
Dividend paid to common shareholders | -31,666 | ' | ' | ' | -31,666 | ' | -31,666 | ' |
Capital repayment | -269,542 | ' | -239,507 | ' | -30,035 | ' | -269,542 | ' |
Other comprehensive income | -59,778 | ' | ' | ' | ' | -60,777 | -60,777 | 999 |
Other movements in non-controlling interest: | ' | ' | ' | ' | ' | ' | ' | ' |
Dilution | 3,587 | ' | ' | ' | 3,587 | ' | 3,587 | ' |
Deconsolidation ASMPT | -304,921 | ' | ' | ' | ' | 1,597 | 1,597 | -306,518 |
Ending balance at Dec. 31, 2013 | € 1,447,249 | € 2,539 | € 250,971 | € 0 | € 1,281,861 | -€ 88,122 | € 1,447,249 | € 0 |
Ending balance (in shares) at Dec. 31, 2013 | ' | 63,468,390 | ' | ' | ' | ' | ' | ' |
Consolidated_statements_of_cas
Consolidated statements of cash flows (EUR €) | 12 Months Ended | ||
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Cash flows from operating activities: | ' | ' | ' |
Net earnings (loss) | € 1,049,300 | € 40,431 | € 316,164 |
Adjustments required to reconcile net earnings(loss) to net cash from operating activities: | ' | ' | ' |
Depreciation and amortization | 28,466 | 58,460 | 49,450 |
Impairments | 796 | 0 | 8,038 |
Gain on bargain purchase | 0 | 0 | -109,279 |
Share-based compensation | 4,703 | 23,065 | 13,452 |
Non cash result financing costs | 687 | 6,678 | 8,779 |
Result investments and associates | -1,030,132 | 766 | 0 |
Deferred income taxes | -296 | -147 | -27,691 |
Changes in assets and liabilities: | ' | ' | ' |
Accounts receivable | -8,477 | 17,905 | 67,293 |
Inventories | -20,220 | -39,920 | 8,390 |
Other current assets | 8,831 | -6,713 | -20,335 |
Accounts payable and accrued expenses | 9,963 | -32,077 | -94,601 |
Payment restructuring expenses | 0 | 0 | -3,159 |
Current income taxes | 4,924 | -25,968 | 80 |
Net cash provided by operating activities | 48,545 | 42,480 | 216,581 |
Cash flows from investing activities: | ' | ' | ' |
Capital expenditures | -17,063 | -68,162 | -89,218 |
Net purchase of intangible assets | -470 | -4,630 | -7,051 |
Acquisition of business | 0 | 0 | -994 |
Cash acquired in business combination | 0 | 0 | 43,434 |
Pledged bank deposit in business combination | 0 | 0 | -20,000 |
Disposal of 12% ASMPT share | 298,254 | 0 | 0 |
Proceeds from sale of property, plant and equipment | 3,969 | 901 | 3,794 |
Net cash used in investing activities | 284,690 | -71,891 | -70,035 |
Cash flows from financing activities: | ' | ' | ' |
Debt redemption | -40,889 | -24,726 | -23,096 |
Debt proceeds, net | 18,980 | 47,677 | 42,173 |
Proceeds from issuance of shares and exercise of stock options | 5,841 | 2,209 | 4,122 |
Dividends from associates | 10,171 | 0 | 0 |
Dividends to common shareholders of ASMI | -31,666 | -27,519 | -22,262 |
Capital repayment | -269,542 | 0 | 0 |
Dividends to minority shareholders ASMPT | 0 | -27,024 | -79,474 |
Net cash used in financing activities | -307,105 | -73,489 | -78,537 |
Foreign currency translation effect | -4,168 | 3,125 | -18,052 |
Net (decrease) increase in cash and cash equivalents | 21,962 | -99,775 | 49,956 |
Cash and cash equivalents at beginning of year | 290,475 | 390,250 | 340,294 |
Cash and cash equivalents at end of year | 312,437 | 290,475 | 390,250 |
Supplemental disclosures of cash flow information | ' | ' | ' |
Interest | 2,933 | 10,124 | 10,742 |
Income taxes | 6,493 | 52,425 | 39,929 |
Supplemental on cash investing and financing activities: | ' | ' | ' |
Subordinated debt converted | 0 | 150,000 | 32,202 |
Subordinated debt converted into number of shares (in shares) | 0 | 9,074,396 | 2,151,020 |
ASM International N.V. [Member] | ' | ' | ' |
Cash flows from operating activities: | ' | ' | ' |
Net earnings (loss) | 1,049,300 | 40,431 | 316,164 |
Adjustments required to reconcile net earnings(loss) to net cash from operating activities: | ' | ' | ' |
Depreciation and amortization | 28,466 | 58,460 | 46,973 |
Impairments | ' | ' | 8,038 |
Result investments and associates | -1,030,132 | 766 | ' |
Cash flows from investing activities: | ' | ' | ' |
Capital expenditures | ' | -68,162 | -89,218 |
Net purchase of intangible assets | ' | -4,630 | -7,051 |
Cash flows from financing activities: | ' | ' | ' |
Purchase of treasury shares | 0 | -40,554 | 0 |
Cash and cash equivalents at beginning of year | 290,475 | 390,250 | ' |
Cash and cash equivalents at end of year | 312,437 | 290,475 | 390,250 |
Asm Pacific Technology Ltd [Member] | ' | ' | ' |
Cash flows from financing activities: | ' | ' | ' |
Purchase of treasury shares | € 0 | -€ 3,552 | € 0 |
General_information_Summary_of
General information / Summary of significant accounting policies | 12 Months Ended | |
Dec. 31, 2013 | ||
Accounting Policies [Abstract] | ' | |
General information / Summary of significant accounting policies | ' | |
General information / Summary of significant accounting policies | ||
General information | ||
ASM International NV (“ASMI” or “the Company”) is a Dutch public liability company domiciled in the Netherlands with its principal operations in Europe, the United States and Asia. The Company dedicates its resources to the research, development, manufacturing, marketing and servicing of equipment and materials used to produce mainly semiconductor devices. | ||
ASMI is a leading supplier of semiconductor equipment, materials and process solutions for the wafer processing, assembly and packaging, and surface mount technology markets. Our customers include all of the top semiconductor device manufacturers in the world. Based in 14 countries, we benefit from a wider perspective and the advantages of bringing together the best brains in the world to create new breakthroughs. | ||
We pioneered important aspects of many established wafer-processing technologies used in industry, including lithography, deposition, ion implant and single-wafer epitaxy. In recent years, we brought Atomic Layer Deposition (ALD) and Plasma Enhanced Atomic Layer Deposition (PEALD) from R&D right through to mainstream production at advanced manufacturers sites. | ||
The Company’s shares are listed for trading on the NASDAQ (symbol ASMI) and the Euronext Amsterdam Stock Exchange (symbol ASM). | ||
The accompanying consolidated financial statements include the financial statements of ASM International NV headquartered in Almere, the Netherlands, and its consolidated subsidiaries (together referred to as “ASMI” or the “Company”). | ||
Basis of preparation | ||
The Company follows accounting principles generally accepted in the United States of America (“US GAAP”) and applies the going concern basis in preparing its consolidated financial statements. Historical cost is used as the measurement basis unless otherwise indicated. | ||
The accompanying consolidated financial statements are stated in euro thousand (“EUR”) unless indicated otherwise. Amounts in these financial statements are rounded to the nearest thousand euro; therefore amounts may not equal (sub) totals due to rounding. | ||
Use of estimates | ||
The preparation of financial statements in conformity with US GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, ASMI evaluates its estimates. ASMI bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. | ||
Consolidation | ||
The consolidated financial statements include the accounts of ASMI NV and all of its subsidiaries where ASMI holds a controlling interest. The non-controlling interest is disclosed separately in the consolidated financial statements. All intercompany profits, transactions and balances have been eliminated in consolidation. | ||
Subsidiaries are all entities over which ASMI has the power to govern the financial and operating policies. | ||
Subsidiaries are fully consolidated from the date on which control is transferred to ASMI and are deconsolidated from the date on which ASMI's control ceases. | ||
Loss of control | ||
Upon the loss of control, ASMI derecognizes the assets and liabilities of the subsidiary, any non-controlling interests and the other components of equity related to the subsidiary. Any surplus or deficit arising on the loss of control is recognized in profit or loss. If ASMI retains any interest in the previous subsidiary, then such interest is measured at fair value at the date that control is lost. Subsequently it is accounted for as an equity-accounted investee or as an available-for-sale financial asset depending on the level of influence retained. | ||
Segment reporting | ||
The Company organizes its activities in two operating segments, Front-end and Back-end. Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Executive Officer (“CEO”), which is the chief operating decision maker (according to ASC 280). | ||
The Back-end segment remains reported as a separate segment since the cease of control per March 15, 2013. Since that date the segment is reported as an equity method investment as the CEO reviews this information as part of his CODM package. | ||
Accordingly, the asset and profit/loss information regarding the operations that comprise the segment are disclosed. The full financial results are reviewed by the CODM, the external reporting of the segment are on an equity method investment basis. The total of all segments' financial amounts are reconciled to the corresponding amounts reported in the consolidated financial statements, eliminations are reflected in the reconciling column for amounts reported in excess of those amounts reflected in the consolidated financial statements. | ||
The Front-end segment manufactures and sells equipment used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The segment is a product driven organizational unit comprised of manufacturing, service, and sales operations in Europe, the United States of America, Japan and South East Asia. | ||
The Back-end segment manufactures and sells equipment and materials used in assembly and packaging, encompassing the processes in which silicon wafers are separated into individual circuits and subsequently assembled, packaged and tested. In January 2011 ASM Pacific Technology Ltd ("ASMPT") acquired the surface-mount technology from Siemens. The segment is organized in ASM Pacific Technology Ltd, in which the Company holds a 39.94% interest, whilst the remaining shares are listed on the Stock Exchange of Hong Kong. | ||
Foreign currency translation | ||
Items included in the financial statements of each ASMI’s entities are measured using the currency of the primary economic environment in which the entity operates (the functional currency). The consolidated financial information is presented in euro (EUR), which is the functional currency of the Company and the group’s presentation currency. | ||
In the preparation of ASMI’s consolidated financial statements, assets and liabilities of foreign subsidiaries of which the functional currency is not the euro, are translated into euros at the exchange rate in effect on the respective balance sheet dates. Income and expenses are translated into euros based on the average exchange rates for the corresponding period. Resulting translation adjustments are directly recorded in shareholders’ equity. Currency differences on intercompany loans that have the nature of a long-term investment are also accounted for directly in shareholders’ equity. | ||
Derivative financial instruments | ||
ASMI and its subsidiaries conduct business in a number of foreign countries, with certain transactions denominated in currencies other than the functional currency of the Company (euro) or one of its subsidiaries conducting the business. The purpose of the Company’s foreign currency management is to manage the effect of exchange rate fluctuations on income, expenses, cash flows and assets and liabilities denominated in selected foreign currencies, in particular denominated in US dollar. | ||
The Company may use forward exchange contracts to hedge its foreign exchange risk of anticipated sales or purchase transactions in the normal course of business, which occur within the next twelve months, for which the Company has a firm commitment from a customer or to a supplier. The terms of these contracts are consistent with the timing of the transactions being hedged. The hedges related to forecasted transactions are designated and documented at the inception of the hedge as cash flow hedges, and are evaluated for effectiveness quarterly. The effective portion of the gain or loss on these hedges is reported as a component of accumulated other comprehensive income (loss) net of taxes in shareholders’ equity, and is reclassified into earnings when the hedged transaction affects earnings. | ||
Changes in the fair value of derivatives that do not qualify for hedge treatment, as well as the ineffective portion of any hedges, are recognized in earnings. The Company records all derivatives, including forward exchange contracts, on the balance sheet at fair value in other current assets or accrued expenses and other. | ||
Substantially all amounts, which are net of taxes, included in accumulated other comprehensive loss at December 31, of any year, will be reclassified to net earnings within the next twelve months, upon completion of the underlying transactions. If the underlying transaction being hedged fails to occur, or if a portion of any derivative is ineffective, the gain or loss is immediately recognized in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. | ||
Furthermore, the Company might manage the currency exposure of certain receivables and payables using derivative instruments, such as forward exchange contracts (fair value hedges) and currency swaps, and non-derivative instruments, such as debt borrowings in foreign currencies. The gains or losses on these instruments provide an offset to the gains or losses recorded on receivables and payables denominated in foreign currencies. The derivative instruments are recorded at fair value and changes in fair value are recorded in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. Receivables and payables denominated in foreign currencies are recorded at the exchange rate at the balance sheet date and gains and losses as a result of changes in exchange rates are recorded in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. | ||
The Company does not use forward exchange contracts for trading or speculative purposes. | ||
Cash and cash equivalents | ||
Cash and cash equivalents comprise deposits held at call with banks and other short-term highly liquid investments with original maturity of three months or less. Bank overdrafts are included in notes payable to banks in current liabilities. | ||
Accounts receivable | ||
Accounts receivable are stated at nominal value less an allowance for doubtful accounts. | ||
A significant percentage of our accounts receivable is derived from sales to a limited number of large multinational semiconductor device manufacturers located throughout the world. In order to monitor potential credit losses, we perform ongoing credit evaluations of our customers’ financial condition. An allowance for doubtful accounts is maintained for potential credit losses based upon management’s assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts receivable is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration any circumstances of which we are aware regarding a customer’s inability to meet its financial obligations; and our judgments as to potential prevailing economic conditions in the industry and their potential impact on the Company’s customers. | ||
Inventories | ||
Inventories are stated at the lower of cost (first-in, first-out method) or market value. Costs include net prices paid for materials purchased, charges for freight and custom duties, production labor cost and factory overhead. Allowances are made for slow moving, obsolete or unsellable inventory. | ||
Allowances for obsolescence of inventory are determined based on the expected demand as well as the expected market value of the inventory. We regularly evaluate the value of our inventory of components and raw materials, work in progress and finished goods, based on a combination of factors including the following: forecasted sales, historical usage, product end of life cycle, estimated current and future market values, service inventory requirements and new product introductions, as well as other factors. Purchasing requirements and alternative uses for the inventory are explored within these processes to mitigate inventory exposure. We record write downs for inventory based on the above factors and take into account worldwide quantities and demand into our analysis. | ||
Evaluation tools at customers | ||
Evaluation tools at customers (“evaluation tools”) are systems generally delivered to customers under evaluation or a conditional purchase order and include substantial customization by ASMI engineers and ASMI R&D staff in the field. Evaluation tools are recorded at cost and depreciated over their useful life (5 years). The depreciation period may be shorter, depending on circumstances. The depreciation expenses are reported as Cost of sales. | ||
On final acceptance of the system the purchase consideration is recognized as revenue. The carrying value of the evaluation tool at that point in time is recognized as cost of sales. In the circumstance that the system is returned, at the end of the evaluation period, a detailed impairment review takes place, and future sales opportunities and additional costs are identified. Only when the fair value is below the carrying value of the evaluation tool an additional depreciation is recognized. The remaining carrying value is recognized as finished goods (inventory). | ||
Long-lived assets | ||
Long-lived assets include goodwill, other intangible assets and property, plant and equipment. Property, plant and equipment are carried at cost, less accumulated depreciation and any accumulated impairment losses. Capital leased assets are recorded at the present value of future lease obligations. Depreciation is calculated using the straight-line method over the estimated useful lives. Leasehold improvements are depreciated over the lesser of the estimated useful life of the leasehold improvement or the term of the underlying lease. | ||
Business combinations are accounted for under the purchase acquisition method. The Company tests its recorded goodwill and other intangible assets with indefinite lives for impairment each year on December 31 and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. | ||
Goodwill is allocated to reporting units for purposes of impairment testing and tested for impairment on a two-step approach. The implied fair value of goodwill is determined. First the recoverability is tested by comparing the carrying amount of the goodwill with the fair value being the sum of the discounted future cash flows. If the carrying amount of the goodwill at reporting unit level is higher than the fair value of the goodwill, the second step should be performed. The goodwill impairment is measured as the excess of the carrying amount of the goodwill over its fair value. | ||
Other intangible assets with finite lives are amortized over the estimated useful lives using the straight-line method. | ||
Assets held for sale | ||
A long-lived asset to be sold is classified as held for sale in the period in which all of the following criteria are met: | ||
• | Management, having the authority to approve the action, commits to a plan to sell the asset; | |
• | The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets; | |
• | An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated; | |
• | The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year; and | |
• | The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value. | |
If at any time these criteria are no longer met a long-lived asset classified as held for sale will be reclassified as held and used. | ||
If during the initial one-year period, circumstances arise that previously were considered unlikely and, as a result, a long-lived asset previously classified as held for sale is not sold by the end of that period and all of the following conditions are met: | ||
◦ | During the initial one-year period the entity initiated actions necessary to respond to the change in circumstances; | |
◦ | The asset is being actively marketed at a price that is reasonable given the change in circumstances. | |
The period required to complete the sale of a long-lived asset may be extended beyond one year. | ||
If at any time the criteria for classification as held for sale are no longer met, the entity shall cease to classify the asset as held for sale. The entity shall measure a non-current asset that ceases to be classified as held for sale at the lower of: | ||
◦ | Its carrying amount before the asset was classified as held for sale, adjusted for any depreciation that would have been recognized had the asset not been classified as held for sale; and | |
◦ | Its recoverable amount at the date of the subsequent decision not to sell. | |
A long-lived asset classified as held for sale shall be presented separately in the statement of financial position. | ||
Recoverability of long-lived assets | ||
Long-lived assets (except those not being amortized) to be held and used by the Company are reviewed by the Company for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In performing the review for recoverability, the Company estimates the future undiscounted cash flows expected to result from the use of the asset. If the undiscounted future cash flow is less than the carrying amount of the asset, the asset is deemed impaired. The amount of the impairment is measured as the difference between the carrying value and the fair value of the asset. Long-lived assets and other intangibles (except those not being amortized) to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. | ||
Business combinations | ||
ASC Topic 805 (“Business Combinations”) requires that companies record acquisitions under the purchase method of accounting. Accordingly, the purchase price is allocated to the tangible assets and liabilities and intangible assets acquired, based on their estimated fair values. The excess purchase price over the fair value is recorded as goodwill. Purchased intangibles with definite lives are amortized over their respective useful lives. When a bargain purchase incurs, which is the case when the fair value of the acquired business exceeds the purchase price, this surplus in fair value is recognized as a gain from bargain purchase. | ||
Investments and Associated companies | ||
Investments in subsidiaries and associated companies are accounted for under the equity method on a go forward basis. Dividend income from the Company’s subsidiaries and associated companies is recognized when the right to receive payment is established. | ||
Impairment of Investments and Associated companies | ||
ASMI does not separately test an investments underlying assets for impairment. However, ASMI recognizes its share of any impairment charge recorded by an investee and consider the effect, if any, of the impairment on the basis difference in the assets giving rise to the investee’s impairment charge. | ||
The ASMPT investment is accounted for under the equity method on a go forward basis. Equity method investments are tested for other than temporary impairment (“OTTI”). An investment is considered impaired if the fair value of the investment is less than its amortized cost. The determination of whether an investment is impaired is made at the individual security level in each reporting period. | ||
If the fair value of an investment is less than its cost or amortized cost at the balance sheet date, the Company determines whether the impairment is temporary or other than temporary. The Company considers the following facts and guidelines when determining whether an OTTI exists: | ||
• | Positive factors as the reasons that an OTTI does not exist must be more objectively verifiable; | |
• | With respect to measuring an OTTI, an investment's fair value as of the balance sheet date should be used to determine the new carrying value. | |
An OTTI is measured as of a balance sheet reporting date. | ||
Summarized below is a discussion of various factors (positive, negative, and otherwise) the Company considers when assessing the potential impairment of equity securities. | ||
Positive Evidence | ||
If an investment’s fair value declines below cost the Company determines whether there is adequate evidence to overcome the presumption that the decline is other-than-temporary. Such evidence may include: | ||
• | Recoveries in fair value subsequent to the balance sheet date; | |
• | The investee's financial performance and near-term prospects (as indicated by factors such as earnings trends, dividend payments, asset quality, volatility, and specific events); and | |
• | The financial condition and prospects for the investee's geographic region and industry. | |
Negative Evidence | ||
The positive factors are weighed against any negative evidence that is gathered about the security. Some of those factors and circumstances are as follows: | ||
• | A prolonged period during which the fair value of the security remains at a level substantially below cost; | |
• | The investee's deteriorating financial condition and a decrease in the quality of the investee's assets, without positive near-term; | |
• | The investee's level of earnings or the quality of its assets is below that of the investee's peers; | |
• | Severe losses sustained by the investee in the current year or in both current and prior years; | |
• | A reduction or cessation in the investee's dividend payments; | |
• | A change in the economic or technological environment in which the investee operates that is expected to adversely affect the investee's ability to achieve profitability in its operations; | |
• | Suspension of trading in the security; | |
• | A qualification in the accountant's report on the investee because of the investee's liquidity or due to problems that jeopardize the investee's ability to continue as a going concern; | |
• | The investee's announcement of adverse changes or events, such as changes in senior management, salary reductions and/or freezes, elimination of positions, sale of assets, or problems with equity investments; | |
• | Adverse conditions specifically related to the security, an industry, or a geographic area (for example, changes in the financial condition of the issuer of the security (or in the case of an asset backed debt security, in the financial condition of the underlying loan obligor), including changes in technology or the discontinuance of a segment of the business that may affect the future earnings potential of the issuer (or underlying loan obligor) of the security); | |
• | A downgrading of the investee's debt rating; | |
• | Factors, such as an order or action by a regulator, that (1) require an investee to (a) reduce or scale back operations or (b) dispose of significant assets or (2) impair the investee's ability to recover the carrying amount of assets; | |
• | Unusual changes in reserves (such as loan losses, product liability, or litigation reserves), or inventory write-downs due to changes in market conditions for products; | |
• | The investee loses a principal customer or supplier; and | |
• | Other factors that raise doubt about the investee's ability to continue as a going concern, such as negative cash flows from operations, working-capital deficiencies, or noncompliance with statutory capital requirements. | |
Revenue recognition | ||
The Company recognizes revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. | ||
Our Front-end sales frequently involve sales of complex equipment, which may include customer-specific criteria, sales to new customers or sales of equipment with new technology. For each sale, the decision whether to recognize revenue is, in addition to shipment and factory acceptance, based on: the contractual agreement with a customer; the experience with a particular customer; the technology and the number of similarly configured equipment previously delivered. Based on these criteria we may decide to defer revenue until completion of installation at the customer’s site and obtaining final acceptance from the customer. | ||
A major portion of our revenue is derived from contractual arrangements with customers that have multiple deliverables, such as equipment and installation. When a sales arrangement contains multiple elements, such as equipment and installation, ASMI allocates revenue to each element based on a selling price hierarchy. The selling price for a deliverable is based on its vendor specific objective evidence (VSOE) if available, third party evidence (TPE) if VSOE is not available, or best estimated selling price (BESP) if neither VSOE nor TPE is available. ASMI generally utilizes the BESP due to the nature of our products. The total arrangement consideration is allocated at inception of the arrangement to all deliverables on the basis of their relative selling price. The revenue relating to the undelivered elements of the arrangements is deferred at their relative selling prices until delivery of these elements. At December 31, 2011, December 31, 2012 and December 31, 2013 we have deferred revenues from installations in the amount of €6.3 million, €3.5 million and €3.9 million respectively. | ||
In general, we recognize revenue from sales of equipment upon transfer of title, which is upon shipment of the equipment, only if testing at the factory has proved that the equipment has met substantially all of the customer’s criteria and specifications. | ||
The Company recognizes revenue from installation of equipment upon completion of installation at the customer’s site. At the time of shipment, the Company defers that portion of the sales price related to the relative selling price of installation. The relative selling price of the installation process is measured based upon the per-hour amounts charged to clients parties for similar installation services. Installation is completed when testing at the customer’s site proved that the equipment has met all of the customer’s criteria and specifications. The completion of installation is signed-off by the customer (“final acceptance”). | ||
We provide training and technical support service to customers. Revenue related to such services is recognized when the service is rendered. Revenue from the sale of spare parts and materials is recognized when transfer of title took place, in general upon shipment of the goods. Freight charges billed to customers are recognized as revenue, the related costs are recognized as cost of sales. Revenues are recognized excluding the taxes levied on revenues. | ||
Cost of sales | ||
Cost of sales comprise direct costs such as labor, materials, cost of warranty, depreciation, shipping and handling costs and related overhead costs. Cost of sales also includes third party commission, depreciation expenses of evaluation tools at customers, royalty payments and costs relating to prototype and experimental products, which the Company may subsequently sell to customers. Costs of warranty include the cost of labor, material and related overhead necessary to repair a product during the warranty period. | ||
Warranty | ||
We provide maintenance on our systems during the warranty period, usually one to two years. Costs of warranty include the cost of labor, material and related overhead necessary to repair a product during the warranty period. We accrue for the estimated cost of the warranty on products shipped in a provision for warranty, upon recognition of the sale of the product. The costs are estimated based on actual historical expenses incurred and on estimated future expenses related to current sales, and are updated periodically. | ||
Research and development costs | ||
Research and development costs are expensed as incurred. Costs, which relate to prototype and experimental models and are sold to customers, are charged to cost of sales. Subsidies and other governmental credits to cover research and development costs relating to approved projects are recorded as research and development credits in the period when such project costs occur. The research and development expenses are presented net of the development credits. | ||
Share-based compensation expenses | ||
The cost relating to employee stock options (compensation expense) are recognized based upon the grant date fair value of the stock options. The fair value at grant date is estimated using a Black-Scholes option valuation model. This model requires the use of assumptions including expected stock price volatility, the estimated life of each award and the estimated dividend yield. | ||
The grant date fair value of the stock options is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of stock options that will eventually vest. The impact of the true up of the estimates is recognized in the consolidated statement of operations in the period in which the revision is determined. | ||
For further information on ASMI’s employee stock option plans reference is made to Note 20. | ||
Restructuring costs | ||
Restructuring expenses are recognized for exit or disposal activities when the liability arising from restructuring plans is incurred. Reference is made to Note 24. Distinction is made in one-time employee termination expenses, contract termination expenses and other associated expenses. For the accounting on the distinguished elements of restructuring expenses we apply to the policy as mentioned below. The expenses have been charged to “restructuring expenses”. | ||
One-time termination expenses represent the payments provided to employees that have become redundant and are terminated under the terms and conditions of a restructuring plan. A restructuring plan exists at the date the plan meets all of the following criteria and has been communicated to employees: | ||
• | Management commits to the plan; | |
• | The plan identifies the number of employees that become redundant and the expected completion date; | |
• | The plan sets out the terms and conditions of the arrangement in sufficient detail to enable employees to determine the type and amount of benefits they will receive; and | |
• | Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. | |
The timing of the recognition and measurement of a liability for one-time termination expenses depends on whether employees will be retained to render service beyond a minimum retention period. | ||
Contract termination expenses are related to the termination of an operating lease or another contract. These expenses are distinguished in: | ||
• | Expenses related to the termination of the contract before the end of its term. These expenses are recognized when the contract is terminated .The liability is measured at its fair value in accordance with the contract terms; and | |
• | Expenses related to contracts that will last for its remaining term without economic benefit to the entity. This is the case when a lease contract for premises is not terminated while the premises are not (completely) in use anymore. The liability is accrued for at the cease-use date, the date the company determined that it would no longer occupy the premises, which is conveyed to it under the contractual operating lease. The liability is measured at its fair value in accordance with the contract terms. | |
Other costs related to restructuring include costs to consolidate or close facilities and relocate employees. A liability for other expenses related to a restructuring such as transition costs is recognized and measured in the period in which the liability is incurred. The costs incurred are directly related to the restructuring activity. The definition of exit costs excludes expected future operating losses. | ||
Income taxes | ||
The Company recognizes deferred tax assets and liabilities for the estimated future tax consequences of events attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using currently enacted tax rates. The effect on deferred tax assets and liabilities of changes in tax rates is recognized in the Consolidated Statement of Operations in the period in which the enacted rate changes. Deferred tax assets are reduced through a valuation allowance at such time as, based on available evidence, it is more likely than not that the deferred tax assets will not be realized. | ||
ASC 740 prescribes a two-step approach for recognizing and measuring tax positions taken or expected to be taken in a tax return. Prior to recognizing the benefit of a tax position in the financial statements, the tax position must be more-likely-than-not of being sustained based solely on its technical merits. Once this recognition threshold has been met, tax positions are recognized at the largest amount that is more-likely-than-not to be sustained. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. | ||
Pension plans and similar commitments | ||
The Company has retirement plans covering substantially all employees. The principal plans are defined contribution plans, except for the plans of the Company’s operations in the Netherlands and Japan. The Company’s employees in the Netherlands participate in a multi-employer plan. Payment to defined contribution plans and the multi-employer plan are recognized as an expense in the Consolidated Statement of Operations as they fall due. | ||
The Company’s employees in Japan participate in a defined benefit plan. Pension costs in respect of these defined benefit plans are determined using the projected unit credit method. These costs primarily represent the increase in the actuarial present value of the obligation for pension benefits based on employee service during the year and the interest on this obligation in respect of employee service in previous years, net of the expected return on plan assets. Obligations for retirement benefit and related net periodic pension costs are determined in accordance with actuarial valuations. These valuations rely on key assumptions including discount rates, expected return on plan assets, expected salary increases, mortality rates and health care trend rates. The discount rate assumptions are determined by reference to yields on high-quality corporate bonds of appropriate duration and currency at the end of the reporting period. In case such yields are not available, discount rates are based on government bonds yields. The expected returns on plan asset assumptions are determined on a uniform methodology, considering long-term historical returns and asset allocations. Due to changing market and economic conditions, the underlying key assumptions may differ from actual development and may lead to significant changes in retirement benefit obligations. | ||
In accordance with ASC 715, “Employers’ Accounting for Defined Benefit Pension and Other Post-retirement Plans" the Company recognizes in its Consolidated Balance Sheet an asset or a liability for the plan’s overfunded status or underfunded status respectively. The unfunded status is recognized as a liability. Actuarial gains and losses are recognized in other comprehensive income when incurred. Reference is made to Note 18 and Note 19. | ||
Commitments and contingencies | ||
The Company has various contractual obligations, some of which are required to be recorded as liabilities in the Company’s consolidated financial statements, including long- and short-term debt. Others, namely operating lease commitments, purchase commitments and commitments for capital expenditure, are generally not required to be recognized as liabilities on the Company’s balance sheet but are required to be disclosed. Reference is made to Note 20. | ||
Comprehensive income | ||
Comprehensive income consists of net earnings (loss) and other comprehensive income. Other comprehensive income includes gains and losses that are not included in net earnings, but are recorded directly in Shareholders’ Equity. | ||
New accounting pronouncements | ||
In December 2011, the FASB issued ASU 2011-11: ASC 350, "Disclosures about Offsetting Assets and Liabilities". The new guidance was effective for ASMI in 2013, but did not impact on the Company's disclosure. | ||
In July 2012, the FASB issued ASU 2012-02: ASC 350,"Testing Indefinite-Lived Intangible Assets for Impairment". The new guidance was effective for ASMI in 2013. The implementation of this authoritative guidance did not impact ASMI's financial position or results. | ||
In January 2013, the FASB issued ASU 2013-01: ASC 210, "Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities". The new guidance was effective for ASMI in 2013, but did not impact on the Company's disclosure. | ||
In February 2013, the FASB issued ASU 2013-02: ASC 220, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income". The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under US GAAP to be reclassified to net income in its entirety in the same reporting period. The new guidance was effective for ASMI in 2013, and the disclosure is presented according to this guidance in Note 18. | ||
In February 2013, the FASB issued ASU 2013-04: ASC 405, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date". The new guidance will be effective for ASMI beginning January 1, 2014. We do not expect this new guidance to have material impact on our consolidated financial statements. | ||
In March 2013, the FASB issued ASU 2013-05: ASC 830, "Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity". The new guidance will be effective for ASMI beginning January 1, 2014. We applied this guidance in the financial year 2013. The cumulative translation adjustment was fully released following the sale of our 12% share in ASMPT, see Note 18. | ||
In July 2013, the FASB issued ASU 2013-11: ASC 740, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists". This amendment should be applied prospectively to all unrecognized tax benefits that exist at the effective date. retrospective application is permitted. The Company The new guidance will be effective for ASMI beginning January 1, 2014. We do not expect this new guidance to have material impact on our consolidated financial statements. |
List_of_significant_subsidiari
List of significant subsidiaries and associates | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Segment Reporting [Abstract] | ' | ||||||
List of significant subsidiaries and associates | ' | ||||||
List of significant subsidiaries and associates | |||||||
% Ownership | |||||||
December 31, | |||||||
2012 | 2013 | ||||||
Subsidiaries (consolidated) | |||||||
ASM Europe BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM United Kingdom Sales BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Germany Sales BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Pacific Holding BV 1- 3 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM France SARL | Montpellier, France | 100 | % | 100 | % | ||
ASM Belgium NV | Leuven, Belgium | 100 | % | 100 | % | ||
ASM Italia Srl | Agrate, Italy | 100 | % | 100 | % | ||
ASM Microchemistry Oy | Helsinki, Finland | 100 | % | 100 | % | ||
ASM Services and Support Ireland Ltd | Dublin, Ireland | 100 | % | 100 | % | ||
ASM Services and Support Israel Ltd | Tel Aviv, Israel | 100 | % | 100 | % | ||
ASM America, Inc | Phoenix, Arizona, United States of America | 100 | % | 100 | % | ||
ASM Japan KK | Tokyo, Japan | 100 | % | 100 | % | ||
ASM Wafer Process Equipment Ltd | Quarry Bay, Hong Kong, People’s | 100 | % | 100 | % | ||
Republic of China | |||||||
ASM China Ltd | Shanghai, People’s Republic of China | 100 | % | 100 | % | ||
ASM Wafer Process Equipment Singapore Pte Ltd | Singapore | 100 | % | 100 | % | ||
ASM Front-End Sales & Services Taiwan Co, Ltd | Hsin-Chu, Taiwan | 100 | % | 100 | % | ||
ASM Services & Support Malaysia SDN BDH | Kuala Lumpur, Malaysia | 100 | % | 100 | % | ||
ASM Front-End Manufacturing Singapore Pte Ltd | Singapore | 100 | % | 100 | % | ||
ASM Genitech Korea Ltd | Cheonan, South Korea | 100 | % | 100 | % | ||
ASM IP Holding BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Pacific Technology Ltd 2 | Kwai Chung, Hong Kong, People’s | 51.96 | % | n/a | |||
Republic of China | |||||||
Associates (non-consolidated) | |||||||
ASM Pacific Technology Ltd 2 | Kwai Chung, Hong Kong, People’s | n/a | 39.94 | % | |||
Republic of China | |||||||
1) | For these subsidiaries ASM International NV has filed statements at the Dutch Chamber of Commerce assuming joint and several liability in accordance with Article 403 of Book 2, Part 9 of the Netherlands Civil Code. | ||||||
2) | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. | ||||||
3) | Established in 2008, ASM Pacific Holding BV holds 39.94% of the shares in ASM Pacific Technology Ltd. |
Divestment
Divestment | 12 Months Ended | ||
Dec. 31, 2013 | |||
Equity Method Investments and Joint Ventures [Abstract] | ' | ||
Divestment | ' | ||
Divestment | |||
On March 13, 2013, the Company announced that it divested a controlling stake in its subsidiary ASM Pacific Technology Ltd. ("ASMPT"). The sale of the shares officially closed on March 15, 2013. The Company sold 47,424,500 ordinary shares of ASMPT at a price of HK$90 per share to institutional or other professional investors through a partial secondary share placement, representing an 11.88% stake in ASMPT. The placement generated cash proceeds for the Company of HK$4,191,980 million (approximately €413 million). | |||
The table below reconciles the cash proceeds from the divested stake in ASMPT: | |||
Gross proceeds | 420,409 | ||
Paid fees, stamp duty and other expenses | (7,213 | ) | |
Net proceeds | 413,196 | ||
Currency translation differences | 1,232 | ||
Cash balance ASMPT upon sale | (116,174 | ) | |
Net cash on disposal ASMPT | 298,254 | ||
The sale of the 11.88% stake caused ASMI to cease control of ASMPT. According to US GAAP the accounting of this sale consists of two separate transactions: | |||
• | A sale of a 51.96% subsidiary; and | ||
• | A purchase of a 40.08% associate. | ||
These transactions resulted in a substantial gain and the deconsolidation of ASMPT. This gain consisted of two elements, the realized gain on the sale of the 11.88% stake amounting to $243 million and an unrealized re-measurement gain on the remaining 40.08% of the retained interest in ASMPT approximating €1,156 million. The 'purchase' of the associate resulted in the recognition of the associate at fair value. | |||
After the initial accounting of the sale transaction and related gains, subsequent accounting under ASC 323, “Investments ”, requires that future income from ASMPT will need to be adjusted for the fair value adjustments arising the 'basis differences' as if a business combination had occurred under ASC 805, "Business Combinations", i.e. a purchase price allocation (“PPA”). | |||
The purchase of the associate has been recognized at fair value, being the value of the ASMPT shares on the day of closing of the purchase transaction. US GAAP requires that the composition of such a fair value needs to be determined through a PPA. This process took place in the remaining period of 2013. The PPA resulted in the recognition of intangible assets for customer relationship, technology, trade name and product names. For inventories and property, plant & equipment a fair value adjustment was recognized. | |||
In December 2013, 1,389,200 common shares of ASMPT were issued, for cash at par value of HK$0.10 per share, pursuant to the Employee Share Incentive Scheme of ASMPT. The shares issued under the plan in 2013 have diluted ASMI's ownership in ASMPT to 39.94% as of December 31, 2013. | |||
At each balance sheet date, the Company reviews whether there is an indication that its investments associated companies are impaired. An indication for impairment of the investments and associated companies may include a severe and other than temporary decrease in the share price of ASMPT. During the period after March 15, 2013 the ASMPT share traded for a longer period below the price at the close of sale. Considering the extent to which in the last quarter of 2013 the market price of the ASM PT shares was below cost management did a further investigation to evaluate whether this results in an impairment other than temporary. In its assessment management evaluated other factors based on its knowledge of the business and of ASM PT specifically. Such factors include the development of ASMPT’s backlog, market share and developments of the different market shares ASMPT operates in. In addition the company evaluated the financial forecast for the year 2014 as reflected in the budget. Management did not identify persuasive factors that the diminution of the value would be other-than-temporary and accordingly recorded an impairment charge, in which the value was adjusted to the share price on December 31, 2013 of HK$64.90. The impairment charge amounts to €335 million. | |||
At December 31, 2013, the book value of our equity method investment after the aforementioned impairment in ASMPT was €944 million. The historical cost basis of our 39.94% share of net assets on the books of ASMPT under US GAAP was €264 million as of December 31, 2013, resulting in a basis difference of €680 million. €162 million of this basis difference has been allocated property, plant and equipment and intangibles assets. The remaining amount was allocated to equity method goodwill. The basis difference attributed to inventory an related tax issues was recognized as expense during the year ending December 31, 2013, and totaled €40 million. Each individual, identifiable asset will periodically be reviewed for any indicators of potential impairment which, if required, would result in acceleration of basis difference amortization. We amortize the basis differences allocated to the assets on a straight-line basis, and include the impact within the results of our equity method investments. Amortization and depreciation are adjusted for related deferred tax impacts. Included in net income attributable to ASMI for 2013 was after-tax expense of €17 million, representing the depreciation and amortization of the basis differences. The market value of our 39.94% investment ASMPT at December 31, 2013 approximates €971 million. | |||
Reporting of ASMI's share in associates in the consolidated balance sheet: | |||
31-Dec-13 | |||
Associates: | |||
ASMI share (39.94%) in equity value ASMPT | 264,384 | ||
Recognized other intangible assets and fair value changes from PPA | 188,985 | ||
Goodwill | 517,761 | ||
Total value investment in ASMPT | 971,130 | ||
Deferred value related to the use of the trade name "ASM" | (27,454 | ) | |
Total value reported on line investments and associates | 943,676 | ||
Under US GAAP, the 'disposal' of the ASMPT business does not classify as discontinued operations. Reporting ASMI share in net earnings of ASMPT in the consolidated statement of operations: | |||
Year ended December 31, 2013 | |||
Result investments and associates: | |||
ASMI share net earnings March 16 - December 31, 2013 | 23,727 | ||
Realized gain on sale 11.88% ASMPT shares | 242,838 | ||
Unrealized remeasurement gain on retained 40.08% ASMPT shares | 1,155,625 | ||
Impairment loss | (335,406 | ) | |
Amortization other intangible assets and fair value changes from PPA | (56,652 | ) | |
Reported on line result investments and associates | 1,030,132 | ||
Summarized 100% earnings information for ASMPT equity method investment excluding basis adjustments: | |||
Year ended December 31, 2013 | |||
Net sales | 1,051,376 | ||
Income before income tax | 65,269 | ||
Net earnings | 53,244 | ||
Summarized 100% balance sheet information for ASMPT equity method investment excluding basis adjustments: | |||
31-Dec-13 | |||
Current assets | 749,924 | ||
Non-current assets | 254,525 | ||
Current liabilities | 308,922 | ||
Non-current liabilities | 33,287 | ||
Equity | 662,240 | ||
The ASMPT Board is responsible for ongoing monitoring of the performance of the Back-end activities. The actual results of the Back-end operating unit are discussed with the ASMPT Audit Committee, which includes the representative of ASMI. The ASMI representative reports to the ASMI Management Board and the Audit Committee of ASMI on a quarterly basis. | |||
Our share of income taxes incurred directly by the equity companies is reported in result from investments and associates and as such is not included in income taxes in our consolidated financial statements. |
Cash_And_cash_equivalents_and_
Cash And cash equivalents and pledged bank deposits | 12 Months Ended |
Dec. 31, 2013 | |
Cash and Cash Equivalents, at Carrying Value [Abstract] | ' |
Cash and cash equivalents and pledged bank deposits | ' |
Cash and cash equivalents and pledged bank deposits | |
Cash and cash equivalents include deposits with high-rated financial institutions of €312 million. Our cash and cash equivalents are predominantly denominated in US$ and partly in euro and Korean won. | |
Cash and cash equivalents have insignificant interest rate risk and deposits have a remaining maturity of three months or less at the date of acquisition. As a result of issued guarantees restrictions on usage of cash and cash equivalents for an amount of approximately €3 million exist. The carrying amount approximates their fair value. |
Accounts_receivable
Accounts receivable | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Accounts Receivable, Net, Current [Abstract] | ' | |||||
Accounts receivable | ' | |||||
Accounts receivable | ||||||
A significant percentage of our accounts receivable is derived from sales to a limited number of large multinational semiconductor device manufacturers located throughout the world. In order to monitor potential credit losses, we perform ongoing credit evaluations of our customers’ financial condition. | ||||||
The carrying amount of accounts receivable is as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Current | 223,546 | 54,614 | ||||
Overdue <30 days | 38,666 | 18,787 | ||||
Overdue 31-60 days | 13,537 | 783 | ||||
Overdue 61-120 days | 13,954 | 2,527 | ||||
Overdue >120 days | 15,137 | 6,305 | ||||
Total | 304,840 | 83,016 | ||||
In the total amount of accounts receivable for the year ended December 31, 2013, no notes receivable are included (2012: €42,588). | ||||||
An allowance for doubtful accounts receivable is maintained for potential credit losses based upon management’s assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration any circumstances of which we are aware regarding a customer’s inability to meet its financial obligations; and our judgments as to potential prevailing economic conditions in the industry and their potential impact on the Company’s customers. | ||||||
The changes in the allowance for doubtful accounts receivable are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | (7,601 | ) | (8,551 | ) | ||
Deconsolidation ASMPT | — | 6,191 | ||||
Charged to selling, general and administrative expenses | (2,825 | ) | 756 | |||
Utilization | 1,841 | 1,469 | ||||
Foreign currency translation effect | 34 | 62 | ||||
Balance at end of year | (8,551 | ) | (73 | ) | ||
The carrying amount of the accounts receivable approximates their fair value. | ||||||
Accounts receivable are stated at nominal value less an allowance for doubtful accounts. |
Inventories
Inventories | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Inventory Disclosure [Abstract] | ' | |||||
Inventories | ' | |||||
Inventories | ||||||
Inventories consist of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Components and raw materials | 180,575 | 78,579 | ||||
Work in process | 196,313 | 31,442 | ||||
Finished goods | 91,799 | 20,073 | ||||
Total inventories, gross | 468,687 | 130,094 | ||||
Allowance for obsolescence | (65,287 | ) | (25,627 | ) | ||
Total inventories, net | 403,400 | 104,467 | ||||
The changes in the allowance for obsolescence and/or lower market value are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | (58,989 | ) | (65,287 | ) | ||
Deconsolidation ASMPT | — | 39,146 | ||||
Charged to cost of sales | (10,858 | ) | (8,648 | ) | ||
Utilization | 3,569 | 6,464 | ||||
Foreign currency translation effect | 991 | 2,698 | ||||
Balance at end of year | (65,287 | ) | (25,627 | ) |
Other_intangible_assets
Other intangible assets | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | ||||||||
Other intangible assets | ' | ||||||||
Other intangible assets | |||||||||
Other intangible assets include purchased technology from third parties and software developed or purchased (including licences) for internal use. The changes in the amount of other intangible assets are as follows: | |||||||||
Software | Purchased | Total | |||||||
technology | |||||||||
and other | |||||||||
intangible | |||||||||
assets | |||||||||
At cost: | |||||||||
Balance January 1, 2012 | 18,042 | 12,212 | 30,254 | ||||||
Additions | 2,447 | 2,183 | 4,630 | ||||||
Disposals | (10 | ) | — | (10 | ) | ||||
Foreign currency translation effect | (133 | ) | (2 | ) | (135 | ) | |||
Balance December 31, 2012 | 20,346 | 14,393 | 34,739 | ||||||
Deconsolidation ASMPT | (4,931 | ) | (7,215 | ) | (12,146 | ) | |||
Additions | 437 | 33 | 470 | ||||||
Disposals | (1 | ) | — | (1 | ) | ||||
Foreign currency translation effect | (248 | ) | (169 | ) | (417 | ) | |||
Balance December 31, 2013 | 15,603 | 7,042 | 22,645 | ||||||
Accumulated amortization: | |||||||||
Balance January 1, 2012 | 10,785 | 4,693 | 15,478 | ||||||
Amortization for the year | 2,784 | 2,634 | 5,418 | ||||||
Disposals | (10 | ) | — | (10 | ) | ||||
Foreign currency translation effect | (113 | ) | 51 | (62 | ) | ||||
Balance December 31, 2012 | 13,446 | 7,378 | 20,824 | ||||||
Deconsolidation ASMPT | (3,744 | ) | (3,895 | ) | (7,639 | ) | |||
Amortization for the year | 2,118 | 2,071 | 4,189 | ||||||
Disposals | (1 | ) | — | (1 | ) | ||||
Foreign currency translation effect | (211 | ) | (154 | ) | (365 | ) | |||
Balance December 31, 2013 | 11,608 | 5,400 | 17,008 | ||||||
Other intangible assets, net: | |||||||||
31-Dec-12 | 6,900 | 7,015 | 13,915 | ||||||
31-Dec-13 | 3,995 | 1,642 | 5,637 | ||||||
Other intangible assets are amortized over their useful lives of 3 to 7 years. Estimated amortization expenses relating to other intangible assets are as follows: | |||||||||
2014 | 1,819 | ||||||||
2015 | 1,255 | ||||||||
2016 | 1,224 | ||||||||
2017 | 547 | ||||||||
2018 | 528 | ||||||||
2019 | 264 | ||||||||
5,637 | |||||||||
Goodwill
Goodwill | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||
Goodwill | ' | ||||||||
Goodwill | |||||||||
The changes in the carrying amount of goodwill are as follows: | |||||||||
Front-end | Back-end | Total | |||||||
Balance January 1, 2012 | 11,193 | 40,938 | 52,131 | ||||||
Foreign currency translation effect | 456 | (699 | ) | (243 | ) | ||||
Balance December 31, 2012 | 11,649 | 40,239 | 51,888 | ||||||
Deconsolidation ASMPT | — | (38,482 | ) | (38,482 | ) | ||||
Foreign currency translation effect | (228 | ) | (1,757 | ) | (1,985 | ) | |||
Balance December 31, 2013 | 11,421 | — | 11,421 | ||||||
The allocation of the carrying amount of goodwill is as follows: | |||||||||
December 31, | |||||||||
2012 | 2013 | ||||||||
Front-end segment: | |||||||||
ASM Microchemistry Oy | 3,560 | 3,560 | |||||||
ASM Genitech Korea Ltd | 8,089 | 7,861 | |||||||
Back-end segment: | |||||||||
ASM Pacific Technology Ltd | 40,239 | — | |||||||
Total | 51,888 | 11,421 | |||||||
We perform an annual impairment test at December 31 of each year or if events or changes in circumstances indicate that the carrying amount of goodwill exceeds its fair value. Our Front-end impairment test and the determination of the fair value is based on a discounted future cash flow approach that uses our estimates of future revenues, driven by assumed market growth and estimated costs as well as appropriate discount rates. | |||||||||
The material assumptions used for the fair value calculation of the reporting unit are: | |||||||||
• | An average discount rate of 16.0% (2012: 22.7%) representing the pre-tax weighted average cost of capital. This rate decreased compared to the rate used in 2012 as a consequence of the current situation whereby certain production lines have now passed the early phase of the product life cycle, hence reflecting a lower risk; | ||||||||
• | External market segment data, historical data and strategic plans to estimate cash flow growth per product line have been used; and | ||||||||
• | Cash flow calculations are limited to five years of cash flow; after these five years perpetuity growth rates are set based on market maturity of the products. For maturing product the perpetuity growth rates used are 1% or less and for enabling technology products the rate used is 3% or less. | ||||||||
These estimates are consistent with the plans and estimated costs we use to manage the underlying business. Based on this analysis management believes that as per December 31, 2013 the fair value of the reporting units exceeded the carrying value. |
Property_plant_and_equipment
Property, plant and equipment | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, plant and equipment | ' | ||||||||
Property, plant and equipment | |||||||||
The changes in the amount of property, plant and equipment are as follows: | |||||||||
Land, | Machinery, | Total | |||||||
buildings and | equipment, | ||||||||
leasehold | furniture | ||||||||
improvements | and | ||||||||
fixtures | |||||||||
At cost: | |||||||||
Balance January 1, 2012 | 167,874 | 454,950 | 622,824 | ||||||
Capital expenditures | 23,355 | 44,807 | 68,162 | ||||||
Retirements and sales | (278 | ) | (10,253 | ) | (10,531 | ) | |||
Reclassification | 428 | (748 | ) | (320 | ) | ||||
Foreign currency translation effect | (3,499 | ) | (13,127 | ) | (16,626 | ) | |||
Balance December 31, 2012 | 187,880 | 475,629 | 663,509 | ||||||
Capital expenditures | 1,580 | 15,483 | 17,063 | ||||||
Deconsolidation ASMPT | (145,290 | ) | (322,398 | ) | (467,688 | ) | |||
Retirements and sales | (13,792 | ) | (10,966 | ) | (24,758 | ) | |||
Reclassification from held for sale | 3,393 | — | 3,393 | ||||||
Reclassification | — | (66 | ) | (66 | ) | ||||
Foreign currency translation effect | (4,824 | ) | (15,823 | ) | (20,647 | ) | |||
Balance December 31, 2013 | 28,947 | 141,859 | 170,806 | ||||||
Accumulated depreciation: | |||||||||
Balance January 1, 2012 | 77,096 | 285,548 | 362,644 | ||||||
Depreciation for the year | 12,420 | 35,282 | 47,702 | ||||||
Retirements and sales | (81 | ) | (9,558 | ) | (9,639 | ) | |||
Reclassification | 3 | (323 | ) | (320 | ) | ||||
Foreign currency translation effect | (2,061 | ) | (10,253 | ) | (12,314 | ) | |||
Balance December 31, 2012 | 87,377 | 300,696 | 388,073 | ||||||
Depreciation for the year | 4,502 | 15,545 | 20,047 | ||||||
Deconsolidation ASMPT | (64,699 | ) | (192,581 | ) | (257,280 | ) | |||
Retirements and sales | (13,700 | ) | (7,089 | ) | (20,789 | ) | |||
Reclassification | — | (66 | ) | (66 | ) | ||||
Foreign currency translation effect | (2,751 | ) | (12,959 | ) | (15,710 | ) | |||
Balance December 31, 2013 | 10,729 | 103,546 | 114,275 | ||||||
Property, plant and equipment, net: | |||||||||
31-Dec-12 | 100,503 | 174,933 | 275,436 | ||||||
31-Dec-13 | 18,218 | 38,313 | 56,531 | ||||||
Useful lives in years: | Buildings and leasehold improvements | 25-Oct | |||||||
Machinery and equipment | 10-Feb | ||||||||
Furniture and fixtures | 10-Feb | ||||||||
As per December 31, 2013, the carrying amount includes assets under construction for land, buildings and leasehold improvements of nil (2012: €2,962), machinery, equipment, furnitures and fixtures of €11,483 (2012: €12,963). |
Assets_held_for_sale
Assets held for sale | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Assets Held-for-sale, Long Lived [Abstract] | ' | ||||||||
Assets held for sale | ' | ||||||||
Assets held for sale | |||||||||
The changes in the carrying value of assets held for sale are as follows: | |||||||||
Japan | The Netherlands | Total | |||||||
Balance January 1, 2012 | 6,585 | 277 | 6,862 | ||||||
Foreign currency translation effect | (864 | ) | — | (864 | ) | ||||
Balance December 31, 2012 | 5,721 | 277 | 5,998 | ||||||
Impairment | (796 | ) | — | (796 | ) | ||||
Reclassification to assets in use | (3,393 | ) | — | (3,393 | ) | ||||
Foreign currency translation effect | (1,071 | ) | — | (1,071 | ) | ||||
Balance December 31, 2013 | 461 | 277 | 738 | ||||||
In 2009 the decision was made to dispose certain items of property, plant and equipment. These assets represent a carrying value as per December 31, 2013 of €738. The assets held for sale are located in Japan and the Netherlands. | |||||||||
In Japan (Tama) a building that was used for research and development activities was ceased to be used in December 2009. Due to the economic circumstances and the effects of the earthquake of 2011 in Japan we think it is not reasonable to expect this building to be sold within a reasonable period of time. Therefor we ceased to classify this building as held for sale and measured it at the lower of its carrying amount before it was classified as held for sale, adjusted for any depreciation that would have been recognized had the asset not been classified as held for sale, and its recoverable amount at the date of the subsequent decision not to sell. This resulted in an impairment charge of €796 in 2013. | |||||||||
Also in Japan, a piece of land was purchased to build a research and development center is regarded as held for sale. The carrying value of €461 is below the expected selling price. The expected selling prices were determined, based on various inputs and considerations. | |||||||||
In the Netherlands the former ASMI head office located in Bilthoven has been regarded as held for sale. The carrying value of €277 is lower than the fair value less cost to sell. The expected selling prices were determined, based on various inputs and considerations. |
Evaluation_tools_at_customers
Evaluation tools at customers | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Other Inventory, Gross [Abstract] | ' | |||||
Evaluation tools at customers | ' | |||||
Evaluation tools at customers | ||||||
The changes in the amount of evaluation tools are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | 13,987 | 16,922 | ||||
Evaluation tools shipped | 11,120 | 8,329 | ||||
Depreciation | (3,798 | ) | (3,771 | ) | ||
Evaluation tools sold | (3,277 | ) | (6,221 | ) | ||
Foreign currency translation effect | (1,110 | ) | (1,927 | ) | ||
Balance at end of year | 16,922 | 13,332 | ||||
Useful lives in years: | 5 | |||||
The gross carrying amount of the evaluation tools at customers per December 31, 2013 was €18,082 (2012: €21,750), accumulated depreciation per December 31, 2013 was €4,750 (2012: €4,828). | ||||||
Evaluation tools are systems delivered to customers under evaluation agreements. Evaluation tools are recorded at cost and depreciated over their useful life (5 years). The depreciation period may be shorter, depending on circumstances. The depreciation expenses are reported as cost of sales. |
Investments_and_associates
Investments and associates | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Investments [Abstract] | ' | ||||||||||||||||||
Investments and associates | ' | ||||||||||||||||||
Investments and associates | |||||||||||||||||||
The changes in the investment and associates are as follows: | |||||||||||||||||||
Investments | Associates | Total | |||||||||||||||||
Net equity share | Other( In)tangible assets and fair value changes | Goodwill | Total associates | ||||||||||||||||
Balance January 1, 2012 | 1,044 | — | — | — | — | 1,044 | |||||||||||||
Share in income of investments and associates | (766 | ) | — | — | — | — | (766 | ) | |||||||||||
Balance December 31, 2012 | 278 | — | — | — | — | 278 | |||||||||||||
40.08% investment in ASMPT March 15, 2013 | — | 255,701 | 227,010 | 898,599 | 1,381,310 | 1,381,310 | |||||||||||||
Result investments and associates | — | 23,727 | — | — | 23,727 | 23,727 | |||||||||||||
Amortization recognized (in)tangible assets | — | — | (16,848 | ) | — | (16,848 | ) | (16,848 | ) | ||||||||||
Fair value changes related to inventories and tax losses | — | — | (39,807 | ) | — | (39,807 | ) | (39,807 | ) | ||||||||||
Impairment | — | — | — | (335,406 | ) | (335,406 | ) | (335,406 | ) | ||||||||||
Dividends | — | (10,171 | ) | — | — | (10,171 | ) | (10,171 | ) | ||||||||||
Dilution ASMPT share to 39.94% | — | 3,541 | — | — | 3,541 | 3,541 | |||||||||||||
Other changes in equity | — | 480 | — | — | 480 | 480 | |||||||||||||
Foreign currency translation effect | — | (8,894 | ) | (8,824 | ) | (45,432 | ) | (63,150 | ) | (63,150 | ) | ||||||||
Balance December 31, 2013 | 278 | 264,384 | 161,531 | 517,761 | 943,676 | 943,954 | |||||||||||||
The investment of €278 as per December 31, 2013 reflects the net equity value of the interest in Levitech BV resulting from the management buy-out in 2009 of the RTP business. ASM International NV obtained a 20% interest in Levitech BV. | |||||||||||||||||||
On March 13, 2013, the Company announced that it divested a controlling stake in its subsidiary ASM Pacific Technology Ltd ("ASMPT"). The sale of the shares officially closed on March 15, 2013. The Company sold 47,424,500 ordinary shares of ASMPT at a price of HK$90 per share to institutional or other professional investors through a partial secondary share placement, representing an 11.88% stake in ASMPT. The placement generated cash proceeds for the Company of HK$4,191,980 million (approximately €413 million). | |||||||||||||||||||
The sale of the 11.88% stake caused ASMI to cease control of ASMPT. According to US GAAP the accounting of this sale consists of two separate transactions: | |||||||||||||||||||
• | A sale of a 51.96% subsidiary; and | ||||||||||||||||||
• | A purchase of a 40.08% associate. | ||||||||||||||||||
These transactions resulted in a substantial gain and the deconsolidation of ASMPT. This gain consisted of two elements, (1) the realized gain on the sale of the 11.88% stake amounting to €242.838 million and (2) an unrealized re-measurement gain on the remaining 40.08% of the retained interest in ASMPT approximating €1,156 million. The 'purchase' of the associate resulted in the recognition of the associate at fair value. | |||||||||||||||||||
After the initial accounting of the sale transaction and related gains, subsequent accounting under ASC 323, “Investments ”, requires that future income from ASMPT will need to be adjusted for the fair value adjustments arising the 'basis differences' as if a business combination had occurred under ASC 805, "Business Combinations", i.e. a purchase price allocation (“PPA”). | |||||||||||||||||||
The purchase of the associate has been recognized at fair value, being the value of the ASMPT shares on the day of closing of the purchase transaction. US GAAP requires that the composition of such a fair value needs to be determined through a PPA. This process took place in the remaining period of 2013. The PPA resulted in the recognition of intangible assets for customer relationship, technology, trade name and product names. For inventories and property, plant & equipment a fair value adjustment was recognized. | |||||||||||||||||||
The ASMPT investment is accounted for under the equity method on a go forward basis. Equity method investments are tested for other than temporary impairment (“OTTI”). An investment is considered impaired if the fair value of the investment is less than its amortized cost. The determination of whether an investment is impaired is made at the individual security level in each reporting period . | |||||||||||||||||||
If the fair value of an investment is less than its cost or amortized cost at the balance sheet date, the Company determines whether the impairment is temporary or other than temporary. The Company considers the following facts and guidelines when determining whether an OTTI exists: | |||||||||||||||||||
• | Positive factors as the reasons that an OTTI does not exist must be more objectively verifiable; and | ||||||||||||||||||
• | With respect to measuring an OTTI, an investment's fair value as of the balance sheet date should be used to determine the new carrying value. | ||||||||||||||||||
During the period after March 15, 2013 the ASMPT share traded for a longer period below the price at the close of sale. Based on the analysis the Company performed this decrease was determined to be other than temporary. As a consequence the carrying value of our equity method investment in ASMPT was adjusted reflecting the share price on December 31, 2013 resulting in an impairment charge of €335 million. | |||||||||||||||||||
In December 2013, 1,389,200 common shares of ASMPT were issued, for cash at par value of HK$0.10 per share, pursuant to the Employee Share Incentive Scheme of ASMPT. The shares issued under the plan in 2013 have diluted ASMI's ownership in ASMPT to 39.94% as of December 31, 2013. | |||||||||||||||||||
At December 31, 2013, the book value of our equity method investment after the aforementioned impairment in ASMPT was €944 million. The historical cost basis of our 39.94% share of net assets on the books of ASMPT under US GAAP was €264 million as of December 31, 2013, resulting in a basis difference of €680 million. €162 million of this basis difference has been allocated property, plant and equipment and intangibles assets. The remaining amount was allocated to equity method goodwill. The basis difference attributed to inventory an related tax issues was recognized as expense during the year ending December 31, 2013, and totaled €40 million. Each individual, identifiable asset will periodically be reviewed for any indicators of potential impairment which, if required, would result in acceleration of basis difference amortization. We amortize the basis differences allocated to the assets on a straight-line basis, and include the impact within the results of our equity method investments. Amortization and depreciation are adjusted for related deferred tax impacts. Included in net income attributable to ASMI for 2013 was after-tax expense of €17 million, representing the depreciation and amortization of the basis differences. The market value of our 39.94% investment ASMPT at December 31, 2013 approximates €971 million. The information required under rule 4-08 is included in the segment information note 26 |
Notes_payable_to_banks
Notes payable to banks | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Notes Payable [Abstract] | ' | |||||
Notes payable to banks | ' | |||||
Notes payable to banks | ||||||
Information on notes payable to banks is as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Short-term debt outstanding: | ||||||
ASMPT | 61,675 | — | ||||
Total | 61,675 | — | ||||
Short-term debt outstanding in local currencies is as follows (in thousands): | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Hong Kong dollar | 630,686 | — | ||||
ASMI is debt free as per December 31, 2013. ASMI borrows under separate short-term lines of credit with banks. The lines contain general provisions concerning renewal and continuance at the option of the banks. | ||||||
At December 31, 2012, short-term debt bears interest at LIBOR plus a margin per annum or HIBOR plus a margin per annum, at a weighted average effective interest rate for 2012 of 1.64% per annum. | ||||||
Total short-term lines of credit amounted to €150,000 at December 31, 2013. The amount outstanding at December 31, 2013 was nil so the undrawn portion totaled €150,000. The undrawn portion represents the Company’s standby revolving credit facility of €150,000 with a consortium of banks. The facility was extended in 2013 and will be available through December 31, 2018. Once the facility is used, this usage is secured by a portion of the Company’s shareholding in ASMPT or accounts receivable. | ||||||
The credit facility of €150,000 includes two financial covenants: a minimum long-term committed capital and a total net debt/equity ratio. These financial covenants are measured twice each year, at June 30 and December 31. The minimum level of long-term committed capital for the year ended December 31, 2013 was €320 million, the long-term committed capital as per that date was €1,447 million. Long-term committed capital is defined as the consolidated total equity. The net debt/equity ratio should not exceed 2.0, whereby equity is defined as consolidated total equity. | ||||||
For the year ended December 31, 2013 net cash was €312 million and total equity €1,447 million. The Company is in compliance with these financial covenants as of June 30, 2013 and as of December 31, 2013. |
Provision_for_warranty
Provision for warranty | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Standard Product Warranty Disclosure [Abstract] | ' | |||||
Provision for warranty | ' | |||||
Provision for warranty | ||||||
The changes in the amount of provision for warranty are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | 49,512 | 43,921 | ||||
Charged to cost of sales | 26,527 | 8,491 | ||||
Deconsolidation ASMPT | — | (34,290 | ) | |||
Deductions | (31,948 | ) | (9,850 | ) | ||
Foreign currency translation effect | (170 | ) | (306 | ) | ||
Balance at end of year | 43,921 | 7,966 | ||||
Non-current portion | 5,298 | — | ||||
Current portion | 38,623 | 7,966 | ||||
Costs of warranty include the cost of labor, material and related overhead necessary to repair a product during the warranty period. The warranty period is usually one to two years. The Company accrues for the estimated cost of the warranty on its products shipped in the provision for warranty, upon recognition of the sale of the product. The costs are estimated based on actual historical expenses incurred and on estimated future expenses related to current sales, and are updated periodically. Actual warranty costs are charged against the provision for warranty. |
Accrued_expenses_and_other
Accrued expenses and other | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Payables and Accruals [Abstract] | ' | |||||
Accrued expenses and other | ' | |||||
Accrued expenses and other | ||||||
Accrued expenses and other consist of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Advance payments from customers | 29,350 | 213 | ||||
Deferred revenue | 5,938 | 7,346 | ||||
Accrual for salaries, wages and related taxes and expenses | 60,246 | 20,967 | ||||
Interest payable | 307 | — | ||||
Payables arising from acquisition of property, plant and equipment | 14,027 | — | ||||
Other | 22,192 | 10,134 | ||||
132,060 | 38,660 | |||||
Longterm_debt
Long-term debt | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Long-term Debt, Unclassified [Abstract] | ' | |||||
Long-term debt | ' | |||||
Long-term debt | ||||||
Long-term debt consists of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Term loans: | ||||||
ASMPT, LIBOR+2.5% | 18,948 | — | ||||
Current portion | 6,316 | — | ||||
Non-current portion | 12,632 | — | ||||
Long-term debt, including current portion, in local currencies is as follows (in thousands): | ||||||
December 31, | ||||||
2012 | 2013 | |||||
US dollar | 25,000 | — | ||||
Convertible_subordinated_debt
Convertible subordinated debt | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Convertible Subordinated Debt [Abstract] | ' | |||
Convertible subordinated debt | ' | |||
Convertible subordinated debt | ||||
As per 1 January 2009, ASMI applies ASC 815 “Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity’s Own Stock”. | ||||
Our convertible bonds initially due 2014, included a component that creates a financial liability to the Company and a component that grants an option to the holder of the convertible note to convert it into common shares of the Company (“conversion option”). ASC 815 requires separate recognition of these components. | ||||
For the conversion options of the convertible bonds due 2011 the accounting was different from that for the conversion option of the convertible bonds due 2014. As the convertible bonds due 2011 were denominated in US$ and the ASM International common shares in which they can be converted to are denominated in euro, these conversion options were recognized as a liability measured at fair value. The conversion option was measured at fair value through the income statement. For the conversion options of the convertible bonds due 2014 the fixed-for-fixed principle is met as both the debt instrument (the bond) and the Company’s equity shares, in which they can be converted to, are denominated in the same currency (euro). Based on this criterion the conversion option qualifies as permanent equity. | ||||
The fair value of the liability component is estimated using the prevailing market interest rate at the date of issue, for similar non-convertible debt. Subsequently, the liability is measured at amortized cost. The interest expense on the liability component is calculated by applying the market interest rate for similar non-convertible debt at the date of issue to the liability component of the instrument. The difference between this amount and the interest paid is added to the carrying amount of the convertible subordinated notes, thus creating a non-cash interest expense. For the financial year 2012 this accretion interest expense was €4,469 (2011: €4,401). | ||||
On October 8, 2012 we initiated a full redemption for all of the outstanding principle balance of our 6.50% Convertible Subordinated notes due 2014, as per November 27, 2012. This proposal for redemption resulted in a full conversion of convertible notes into 9,074,396 common shares. | ||||
The changes in the outstanding amounts of convertible subordinated debt are as follows: | ||||
6.50% | ||||
convertible | ||||
unsecured | ||||
notes, due | ||||
2014 | ||||
Liability at redemption value at date of issuance | 150,000 | |||
Conversion component at date of issuance | (23,601 | ) | ||
Liability component at date of issuance | 126,399 | |||
Balance December 31, 2011 | 135,078 | |||
Conversion of notes | (139,407 | ) | ||
Accrual of interest | 4,329 | |||
Balance December 31, 2012 | — | |||
6.50% convertible subordinated notes, due 2014 | ||||
In November 2009, ASMI issued €150.0 million in principal amount of 6.50% convertible unsecured notes due in November 2014 in a private offering. Interest on the notes is payable on February 6, May 6, August 6 and November 6 of each year. The notes are subordinated in right of payment to all of the Company’s existing and future senior indebtedness. The notes are convertible into shares of the Company’s common stock only, initially at a conversion rate of 58.5851 shares of common stock for each €1,000 principal amount of notes, subject to adjustment in certain circumstances. This is equivalent to an initial conversion price of €17.09 per share. As a result of the dividend paid on common shares during 2011 and 2012 the conversion price was adjusted to €16.85 and €16.53 respectively. On or after November 27, 2012, the Company could redeem any of the notes at a redemption price equal to 100% of the principal amount of the notes being redeemed, plus accrued and unpaid interest, if the closing price of the Company’s common shares had exceeded 130% of the conversion price for at least 20 trading days in any period of 30 consecutive trading days. | ||||
On October 8, 2012 we announced that we initiated a full redemption for all of the all outstanding 6.5% senior unsecured convertible bonds on November 27, 2012 at their principal amount, together with accrued but unpaid interest. The Notice of Redemption for the Notes was sent to all registered holders on October 8, 2012. Bondholders could exercise their right to convert their Bonds into ordinary shares ultimately on November 20, 2012. This proposal for redemption resulted in a full conversion of convertible notes into 9,074,396 common shares. | ||||
Debt issuance costs | ||||
The fees incurred for the issuance of the convertible subordinated notes are included as debt issuance costs in the Consolidated Balance Sheet and amortized by the effective interest method as interest expense during the economic life of the debts. Upon the conversion of the 6.5% convertible unsecured notes the balance of the unamortized debt issuance costs impaired, an amount of €2,209 was recognized as loss from early extinguishment of debt in the Consolidated Statement of Operations for the year 2012. |
Shareholders_equity
Shareholders' equity | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Stockholders' Equity Note [Abstract] | ' | |||||||||||
Shareholders' equity | ' | |||||||||||
Shareholders’ equity | ||||||||||||
Common shares, preferred and financing preferred shares | ||||||||||||
The authorized capital of the Company amounts to 110,000,000 shares of €0.04 par value common shares, 118,000 shares of €40 par value preferred shares and 8,000 shares of €40 par value financing preferred shares, of which 63,468,390 common shares, no preferred and no financing preferred shares were outstanding as at December 31, 2013. All common shares outstanding as per December 31, 2013 were fully paid. All shares have one vote per €0.04 par value. Treasury shares held by the Company cannot be voted on. | ||||||||||||
Financing preferred shares are designed to allow ASMI to finance equity with an instrument paying a preferred dividend, linked to EURIBOR loans and government loans, without the dilutive effects of issuing additional common shares. | ||||||||||||
Preferred and financing preferred shares are issued in registered form only and are subject to transfer restrictions. Essentially, a preferred or financing preferred shareholder must obtain the approval of the Company’s Supervisory Board to transfer shares. If the approval is denied, the Supervisory Board will provide a list of acceptable prospective buyers who are willing to purchase the shares at a cash price to be fixed by consent of the Supervisory Board and seller within two months after the approval is denied. If the transfer is approved, the shareholder must complete the transfer within three months, at which time the approval expires. | ||||||||||||
Preferred shares are entitled to a cumulative preferred dividend based on the amount paid-up on such shares. Financing preferred shares are entitled to a cumulative dividend based on the par value and share premium paid on such shares. The preferred dividend on the amount paid-up was €5 for the year 2009, since 2009 no preferred dividend was paid. | ||||||||||||
In the event preferred shares are issued, the Management Board must, within two years after such preferred shares were issued, submit to the general meeting a proposal to annul the preferred shares. | ||||||||||||
During 2008, ASMI engaged Lehman Brothers (“Lehman”). to repurchase ordinary ASMI shares on the Euronext and Nasdaq markets on behalf of ASMI. As of September 15, 2008, at the time it went into bankruptcy administration, Lehman reported that it had purchased and held on our behalf 2,552,071 shares, which were accounted for as treasury shares accordingly. ASMI filed a submission with the Lehman administrators giving notice of the shares held in custody by Lehman. At ASMI’s May 2009 Annual General Meeting, our shareholders resolved to cancel all of these treasury shares which, accordingly, was accounted for in our 2009 Annual Report as a reduction of the number of outstanding shares. Lehman was notified of the cancellation of shares at the time. | ||||||||||||
The Lehman administrators have cooperated to effect the cancellation of 2,305,069 shares through the relevant book entry systems and have agreed to cooperate similarly with respect to 25,643 shares which are currently held by a Lehman affiliate in the Unites States. This leaves 221,359 shares unaccounted for which is in line with the notification received from the Lehman administrator's in September 2010 that a shortfall in the number of shares held for the Company's account in this order of magnitude was likely to exist. | ||||||||||||
Under the terms of a settlement agreement with the Lehman administrators entered into in 2013 the Company has received a compensation in cash of US$6,251 and will receive a further €273,062 in compensation of dividends paid on the unaccounted shares. | ||||||||||||
Depending on the outcome of the Lehman bankruptcy the Company may receive further payments since the amounts received to date represent 92.2% of the principal of the Company's claims for compensation. In addition the company is entitled to the payment of interest over the principal of its claims. | ||||||||||||
The 221,359 shares unaccounted for by the Lehman administrators are and remain outstanding and have not been canceled by the resolution adopted by the AGM in 2009. As a result of the settlement agreement the Company recorded €4,190 as paid in capital to account for the compensation received. | ||||||||||||
Retained earnings | ||||||||||||
Distributions to common shareholders are limited to the extent the total amount of shareholders’ equity exceeds the amounts of nominal paid-in share capital (exclusive any share premium) and any reserves to be formed pursuant to law or the Company’s articles of association. The amounts are derived from the Statutory Financial Statements of ASM International NV. | ||||||||||||
Results on dilution of investments in subsidiaries and associates are accounted for directly in equity. For 2012 and 2013 this dilution gain was €6,937 and €3,587 respectively. | ||||||||||||
Accumulated other comprehensive loss | ||||||||||||
The changes in the amount of accumulated other comprehensive loss are as follows: | ||||||||||||
Proportionate share other comprehensive income investments | Foreign | Unrecognized | Total | |||||||||
currency | pension | |||||||||||
translation | obligations, | |||||||||||
effects | net of tax | |||||||||||
Balance January 1, 2012 | — | (20,330 | ) | 179 | (20,151 | ) | ||||||
Foreign currency translation effect on translation of foreign operations | — | (6,994 | ) | — | (6,994 | ) | ||||||
Actuarial loss | — | — | (1,797 | ) | (1,797 | ) | ||||||
Balance December 31, 2012 | — | (27,324 | ) | (1,618 | ) | (28,942 | ) | |||||
Realization deferred accumulative translation result following the sale of the 12% share of ASMPT | — | 23,053 | — | 23,053 | ||||||||
Deconsolidation ASMPT | — | — | 1,597 | 1,597 | ||||||||
Other comprehensive income investments | ||||||||||||
Foreign currency translation effect on translation of foreign operations | 480 | (84,086 | ) | — | (83,606 | ) | ||||||
Actuarial loss | — | — | (224 | ) | (224 | ) | ||||||
Balance December 31, 2013 | 480 | (88,357 | ) | (245 | ) | (88,122 | ) | |||||
Purchases of Equity Securities by the Issuer and Affiliated Purchasers | ||||||||||||
On May 16, 2013, the General Meeting of Shareholders authorized the Company, for an 18-month period, to be calculated from the date of the General Meeting, to repurchase its own shares up to the statutory maximum, at a price at least equal to the shares’ nominal value and at most a price equal to 110% of the share’s average closing price according to the listing on the Euronext Amsterdam stock exchange during the five trading days preceding the purchase date. | ||||||||||||
The maximum of shares that may yet be purchased under the program takes into account the treasury shares held by the Company (at December 31, 2013 there were no treasury shares held) and the maximum number of common shares which the Company can hold according to its Articles of Association. This maximum is 10% of the number of common shares issued. |
Employee_benefits
Employee benefits | 12 Months Ended | |||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||
Employee Benefits and Share-based Compensation [Abstract] | ' | |||||||||||||||||
Employee benefits | ' | |||||||||||||||||
Employee benefits | ||||||||||||||||||
Pension plans | ||||||||||||||||||
Front-end | ||||||||||||||||||
For the Front-end segment the Company has retirement plans covering substantially all employees. The principal plans are defined contribution plans, except for the plans of the Company’s operations in the Netherlands and Japan. | ||||||||||||||||||
Multi-employer plan | ||||||||||||||||||
The Company’s employees in the Netherlands, approximately 140 employees, participate in a multi-employer union plan, “Bedrijfstakpensioenfonds Metalektro”, (“PME”) determined in accordance with the collective bargaining agreements effective for the industry in which ASMI operates. This collective bargaining agreement has no expiration date. This multi-employer union plan covers approximately 1,300 companies and 147,000 contributing members. ASMI’s contribution to the multi-employer union plan is less than 5% of the total contribution to the plan as per the annual report for the year ended December 31, 2013. The plan monitors its risks on a global basis, not by company or employee, and is subject to regulation by Dutch governmental authorities. By law (the Dutch Pension Act), a multi-employer union plan must be monitored against specific criteria, including the coverage ratio of the plan assets to its obligations. This coverage ratio must exceed 104.3% for the total plan. Every company participating in a Dutch multi-employer union plan contributes a premium calculated as a percentage of its total pensionable salaries, with each company subject to the same percentage contribution rate. The premium can fluctuate yearly based on the coverage ratio of the multi-employer union plan. The pension rights of each employee are based upon the employee’s average salary during employment. | ||||||||||||||||||
ASMI’s net periodic pension cost for this multi-employer union plan for any period is the amount of the required contribution for that period. A contingent liability may arise from, for example, possible actuarial losses relating to other participating entities because each entity that participates in a multi-employer union plan shares in the actuarial risks of every other participating entity or any responsibility under the terms of a plan to finance any shortfall in the plan if other entities cease to participate. | ||||||||||||||||||
The coverage ratio of the multi-employer union plan increased to 103.4% as of December 31, 2013 (December 31, 2012: 93.9%). Because of the low coverage ratio PME prepared and executed a so-called “Recovery Plan” which was approved by De Nederlandsche Bank, the Dutch central bank, which is the supervisor of all pension companies in the Netherlands. Due to the low coverage ratio and according the obligation of the “Recovery Plan” the pension premium percentage is 24.1% in 2013 (2012: 24.0%). The coverage ratio is calculated by dividing the plan assets by the total sum of pension liabilities and is based on actual market interest. | ||||||||||||||||||
The Company accounts for the multi-employer plan as if it were a defined contribution plan as the manager of the plan, PME, stated that its internal administrative systems do not enable PME to provide the Company with the required Company-specific information in order to account for the plan as a defined benefit plan. The Company's net periodic pension cost for the multi-employer plan for a fiscal period is equal to the required contribution for that period. | ||||||||||||||||||
Defined benefit plan | ||||||||||||||||||
The Company’s employees in Japan participate in a defined benefit plan. The most recent actuarial valuations of plan assets and the present value of the defined benefit obligation were carried out at December 31, 2013. The present value of the defined benefit obligation and the related current service cost and passed service cost were measured using the Projected Unit Credit Method. | ||||||||||||||||||
The funded status of the plan and the amounts not yet recognized in the Consolidated Statement of Operations and the amounts recognized in the Consolidated Balance Sheet are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | (8,357 | ) | (7,604 | ) | ||||||||||||||
Fair value of plan assets | 4,794 | 5,189 | ||||||||||||||||
Funded status/(deficit) | (3,563 | ) | (2,415 | ) | ||||||||||||||
The changes in defined benefit obligations and fair value of plan assets are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 9,485 | 8,357 | ||||||||||||||||
Current service cost | 731 | 529 | ||||||||||||||||
Interest on obligation | 121 | 113 | ||||||||||||||||
Actuarial losses (gains) | (436 | ) | 660 | |||||||||||||||
Benefits paid | (423 | ) | (128 | ) | ||||||||||||||
Foreign currency translation effect | (1,121 | ) | (1,927 | ) | ||||||||||||||
Balance December 31 | 8,357 | 7,604 | ||||||||||||||||
Fair value of plan assets | ||||||||||||||||||
Balance January 1 | 4,090 | 4,794 | ||||||||||||||||
Expected return on plan assets | 144 | 142 | ||||||||||||||||
Actuarial (losses) gains | 52 | 359 | ||||||||||||||||
Company contribution | 1,544 | 1,233 | ||||||||||||||||
Benefits paid | (423 | ) | (128 | ) | ||||||||||||||
Foreign currency translation effect | (613 | ) | (1,211 | ) | ||||||||||||||
Balance December 31 | 4,794 | 5,189 | ||||||||||||||||
The net periodic benefit cost consists of the following: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Current service cost | 664 | 731 | 529 | |||||||||||||||
Interest on obligation | 107 | 121 | 113 | |||||||||||||||
Expected return on plan assets | (103 | ) | (144 | ) | (142 | ) | ||||||||||||
Amortization deferred actuarial loss | 6 | 46 | — | |||||||||||||||
Amortization of past service cost | (12 | ) | (55 | ) | (44 | ) | ||||||||||||
Net periodic pension benefit cost | 662 | 699 | 456 | |||||||||||||||
The actual return on plan assets was €196 and €501 for the years ended December 31, 2012 and 2013 respectively. | ||||||||||||||||||
The assumptions in calculating the actuarial present value of benefit obligations and net periodic benefit cost are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Discount rate for obligations | 1.25 | % | 1.55 | % | 1.5 | % | ||||||||||||
Expected return on plan assets | 3 | % | 3 | % | 3 | % | ||||||||||||
Expected rate of compensation increase | 2.93 | % | 2.93 | % | 2.93 | % | ||||||||||||
The allocation of plan assets is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Equity | 1,087 | 23 | % | 1,351 | 26 | % | ||||||||||||
Bonds | 2,957 | 62 | % | 3,019 | 59 | % | ||||||||||||
Loans | 463 | 10 | % | 453 | 9 | % | ||||||||||||
Real estate | 72 | 2 | % | 89 | 2 | % | ||||||||||||
Other | 215 | 4 | % | 215 | 4 | % | ||||||||||||
4,794 | 100 | % | 5,127 | 100 | % | |||||||||||||
The investment strategy is determined based on an asset-liability study in consultation with investment advisers and within the boundaries given by regulatory bodies for pension funds. Equity securities consist primarily of publicly traded Japanese companies and common collective funds. Publicly traded equities are valued at the closing prices reported in the active market in which the individual securities are traded (level 1). Common collective funds are valued at the published price (level 1) per share multiplied by the number of shares held as of the measurement date. | ||||||||||||||||||
Fixed income (bonds and loans) consists of corporate bonds, government securities and common collective funds. Corporate and government securities are valued by third-party pricing sources (level 2). Common collective funds are valued at the net asset value per share (level 2) multiplied by the number of shares held as of the measurement date. | ||||||||||||||||||
Real estate fund and other values are primarily reported by the fund manager and are based on valuation of the underlying investments (level 3) which include inputs such as cost, discounted cash flows, independent appraisals and market based comparable data. | ||||||||||||||||||
The plan assets do not include any of the Company’s shares. | ||||||||||||||||||
Back-end | ||||||||||||||||||
For the Back-end segment the ASMPT has retirement plans covering a substantial portion of its employees. The principal plans are defined contribution plans. | ||||||||||||||||||
The plans for employees in Hong Kong are registered under the Occupational Retirement Schemes Ordinance (“ORSO Scheme”) and a Mandatory Provident Fund Scheme (“MPF Scheme”) established under the Mandatory Provident Fund Schemes Ordinance in December 2000. The assets of the schemes are held separately from those of ASMPT in funds under the control of trustees. The ORSO Scheme is funded by monthly contributions from both employees and ASMPT at rates ranging from 5.0% to 12.5% of the employee’s basic salary, depending on the length of services with ASMPT. For members of the MPF Scheme, ASMPT contributes 5.0% of relevant payroll costs to the MPF Scheme subject only to the maximum level of payroll costs amounting to HK$25,000 per employee, which contribution is matched by the employees. | ||||||||||||||||||
The employees of ASMPT in the Peoples Republic of China, Singapore and Malaysia are members of state managed retirement benefit schemes operated by the relevant governments. ASMPT is required to contribute a certain percentage of payroll costs to these schemes to fund the benefits. The only obligation of ASMPT with respect to these schemes is to make the specified contributions. The assets of the schemes are held separately from those of ASMPT in funds under the control of trustees, and in the case of Singapore and Malaysia, by the Central Provident Fund Board of Singapore and Employee Provident Fund of Malaysia respectively. | ||||||||||||||||||
Certain ASMAS (the former SEAS) entities operate funded defined benefits pension scheme for all their qualified employees. Pension benefits provided by ASMAS Entities are currently organized primarily through defined benefit pension plans which cover virtually all German employees and certain foreign employees of ASMAS entities. Furthermore, ASMAS entities provide other post-employment benefits, which consist of transition payments and death benefits to German employees after retirement. These predominantly unfunded other post-employment benefit plans qualify as defined benefit plans. Defined benefit plans determine the entitlements of their beneficiaries. An employee’s final benefit entitlement at regular retirement age may be higher than the fixed benefits at the reporting date due to future compensation or benefit increases. The net present value of this ultimate future benefit entitlement for service already rendered is represented by the Defined Benefit Obligation (“DBO”), which is calculated with consideration of future compensation increases by actuaries. The DBO is calculated based on the projected unit credit method and reflects the net present value as of the reporting date of the accumulated pension entitlements of active employees, former employees with vested rights and of retirees and their surviving dependents with consideration of future compensation and pension increases. | ||||||||||||||||||
In the case of unfunded plans, the recognized pension liability is equal to the DBO adjusted by unrecognized past service cost. In the case of funded plans, the fair value of the plan assets is offset against the benefit obligations. The net amount, after adjusting for the effects of unrecognized past service cost, is recognized as a pension liability or prepaid pension asset. | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | (33,987 | ) | — | |||||||||||||||
Fair value of plan assets | 27,035 | — | ||||||||||||||||
Funded status/(deficit) | (6,952 | ) | — | |||||||||||||||
The changes in defined benefit obligations and fair value of plan assets are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 22,303 | 33,987 | ||||||||||||||||
Deconsolidation of ASMPT | — | (34,691 | ) | |||||||||||||||
Current service cost | 1,691 | 472 | ||||||||||||||||
Interest on obligation | 1,095 | 262 | ||||||||||||||||
Past service costs | 104 | — | ||||||||||||||||
Actuarial losses (gain) | 8,532 | — | ||||||||||||||||
Benefits paid | (55 | ) | (30 | ) | ||||||||||||||
Transfers | 85 | — | ||||||||||||||||
Contribution participants | 222 | — | ||||||||||||||||
Foreign currency translation effect | 10 | — | ||||||||||||||||
Balance December 31 | 33,987 | — | ||||||||||||||||
Fair value of plan assets | ||||||||||||||||||
Balance January 1 | 21,364 | 27,035 | ||||||||||||||||
Deconsolidation ASMPT | — | (27,820 | ) | |||||||||||||||
Expected return | 853 | 423 | ||||||||||||||||
Actuarial (losses) gains | 2,981 | — | ||||||||||||||||
Contribution participants | 222 | — | ||||||||||||||||
Contribution employer | 1,615 | 362 | ||||||||||||||||
Balance December 31 | 27,035 | — | ||||||||||||||||
The investment strategy is determined based on an asset-liability study in consultation with investment advisers and within the boundaries given by regulatory bodies for pension funds. Equity securities consist primarily of publicly traded companies and common collective funds. Publicly traded equities are valued at the closing prices reported in the active market in which the individual securities are traded (level 1). Common collective funds are valued at the published price (level 1) per share multiplied by the number of shares held as of the measurement date. | ||||||||||||||||||
Fixed income (bonds and loans) consists of corporate bonds, government securities and common collective funds. Corporate and government securities are valued by third-party pricing sources (level 2). Common collective funds are valued at the net asset value per share (level 2) multiplied by the number of shares held as of the measurement date. | ||||||||||||||||||
Real estate fund and other values are primarily reported by the fund manager and are based on valuation of the underlying investments (level 3) which include inputs such as cost, discounted cash flows, independent appraisals and market based comparable data. | ||||||||||||||||||
The plan assets do not include any of the Company’s shares. | ||||||||||||||||||
The assumptions in calculating the actuarial present value of benefit obligations and net periodic benefit cost are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Discount rate for obligations | 3.5 | % | — | % | ||||||||||||||
Expected return on plan assets | 3.5 | % | — | % | ||||||||||||||
Expected rate of compensation increase | 2.25 | % | — | % | ||||||||||||||
The allocation of plan assets is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Equity | 5,677 | 21 | % | — | — | % | ||||||||||||
Fixed income and corporate bonds | 20,817 | 77 | % | — | — | % | ||||||||||||
Cash and other assets | 541 | 2 | % | — | — | % | ||||||||||||
27,035 | 100 | % | — | — | % | |||||||||||||
The plan assets do not include any of the Company’s shares. | ||||||||||||||||||
Other post-employment benefit plans ASMPT | ||||||||||||||||||
Employees who joined ASM Assembly Systems GmbH & Co KG, a subsidiary located in Germany, on or before 30 September 1983, are entitled to transition payments and death benefits. In respect of the transition payments for the first six months after retirement, participants receive the difference between their final compensation and the retirement benefits payable under the corporate pension plan. Employees of the Group in France are entitled to retirement indemnity plans as required by the French labor laws. | ||||||||||||||||||
The reconciliation of the changes in the benefit obligation for the other post-employment benefits is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 1,414 | 1,634 | ||||||||||||||||
Current service cost | 45 | 12 | ||||||||||||||||
Interest on obligation | 69 | 12 | ||||||||||||||||
Actuarial losses / (gains) | 372 | — | ||||||||||||||||
Benefits paid | (181 | ) | (12 | ) | ||||||||||||||
Deconsolidation ASMPT | — | (1,646 | ) | |||||||||||||||
Transfers | (85 | ) | — | |||||||||||||||
Balance December 31 | 1,634 | — | ||||||||||||||||
The components of the principal pension benefit plans and the other post-employment benefit plans recognized in the consolidated statement of operations in respect of these defined benefit plans and other post-employment benefits are as follows: | ||||||||||||||||||
31-Dec-12 | 31-Dec-13 | |||||||||||||||||
Principal | Other post- | Total | Principal | Other post- | Total | |||||||||||||
defined | employment | defined | employment | |||||||||||||||
benefit | benefit | benefit | benefit | |||||||||||||||
plans | plans | plans | plans | |||||||||||||||
Current service cost | (1,691 | ) | (45 | ) | (1,736 | ) | (472 | ) | (12 | ) | (484 | ) | ||||||
Interest on obligation | (1,095 | ) | (69 | ) | (1,164 | ) | (262 | ) | (12 | ) | (274 | ) | ||||||
Past service cost | (104 | ) | — | (104 | ) | — | — | — | ||||||||||
Expected return on plan assets | 853 | — | 853 | — | — | — | ||||||||||||
Net periodic pension benefit cost | (2,037 | ) | (114 | ) | (2,151 | ) | (734 | ) | (24 | ) | (758 | ) | ||||||
Other retirement benefit obligations ASMPT | ||||||||||||||||||
The consolidated statement of financial position also includes liabilities for other retirement benefit obligations consisting of liabilities for severance payments in Italy and Austria amounting to €353 as at December 31, 2012. | ||||||||||||||||||
Retirement plan costs for ASMI consolidated | ||||||||||||||||||
ASMI expects to contribute €1,105 to the defined benefit plan in 2014. The Company expects to pay benefits for years subsequent to December 31, 2013 as follows: | ||||||||||||||||||
Front-end | ||||||||||||||||||
segment | ||||||||||||||||||
2014 | 209 | |||||||||||||||||
2015 | 313 | |||||||||||||||||
2016 | 337 | |||||||||||||||||
2017 | 493 | |||||||||||||||||
2018 | 629 | |||||||||||||||||
Aggregate for the years 2019-2023 | 2,796 | |||||||||||||||||
Total | 4,777 | |||||||||||||||||
Retirement plan costs for ASMI consolidated consist of the following: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Defined contribution plans | 15,990 | 16,952 | 5,277 | |||||||||||||||
Multi-employer plans | 1,111 | 1,420 | 1,274 | |||||||||||||||
Defined benefit plans | 1,844 | 2,779 | 988 | |||||||||||||||
Total retirement plan costs | 18,945 | 21,151 | 7,539 | |||||||||||||||
The Company does not provide for any significant post-retirement benefits other than pensions. | ||||||||||||||||||
Employee Stock Option Plan | ||||||||||||||||||
The Company has adopted various stock option plans and has entered into stock option agreements with various employees. Under these plans, employees may purchase a specific number of shares of the Company’s common stock. Options are priced at market value in euro or US dollars on the date of grant. | ||||||||||||||||||
In 2011 a new Stock Option Plan was adopted. In the new plan to limit potential dilution, the amount of outstanding (vested and non-vested) options granted to the Management Board and to other employees will not exceed 7.5% of the issued ordinary share capital of ASMI. The new Stock Option Plan 2011 consists of two sub-plans: the ASMI Stock Option Plan for employees (ESOP) and the ASMI Stock Option for members of the Management Board (MSOP). | ||||||||||||||||||
A leading principle of the option plans is that options are issued to employees and Management Board members once per annum as at 31 December of the relevant year, this includes the possible grant to newly hired employees. The number of options outstanding under the option plans or under any other plan or arrangement in aggregate may never exceed 7.5% of ASMI’s share capital. This is in accordance with the ASMI Remuneration Policy. | ||||||||||||||||||
By resolution of the AGM of May 16, 2013 the formal authority to issue options and shares was allocated to the Management Board subject to the approval of the Supervisory Board. This authority is valid for 18 months and needs to be refreshed annually by the AGM to allow the continued application of the SOPS beyond November 15, 2013. The ESOP is principally administered by the Management Board and the MSOP is principally administered by the Supervisory Board. This complies with applicable corporate governance standards. However, the Supervisory Board has no power to represent the Company. For external purposes the Management Board remains the competent body under both SOPS. The SOPS envisage that the Supervisory Board, or – in the case of the ESOP – the Management Board with the approval of the Supervisory Board, will determine the number of options to be granted to the Management Board members and to employees as of December 31 of any financial year (the Grant date). | ||||||||||||||||||
For employees and existing Management Board members the Grant Date for all options granted is December 31 of the relevant year. In each of these situations the three year Vesting Period starts at the Grant Date. The exercise price in euro of all options issued under the SOPS is determined on the basis of the market value of the ASMI shares in as at (i.e. immediately prior to) the Grant Date. | ||||||||||||||||||
The exercise period is 4 years starting at the 3rd anniversary of the vesting date. | ||||||||||||||||||
At December 31, 2013, options to purchase 2,172,455 shares have been issued under the 2011 Stock Option Plan representing 3.4% of the shares outstanding per December 31, 2013. Under previous plans no more options to purchase shares can be issued. Under the various stock option plans a total of 3,308,502 options to purchase common stock were outstanding at December 31, 2013, expiring at various dates through 2020. The number of options outstanding at December 31, 2012 and 2013 were 2,325,088 and 3,308,502 respectively. | ||||||||||||||||||
Following the sale of a 12% share of ASMPT, a capital distribution of €4.25 per common share was effectuated on July 25, 2013. As a result of this capital distribution the underlying value of ASMI option holders was diluted. The Management Board of ASMI and the Supervisory Board of ASMI decided to apply a theoretical adjustment ratio of 0.84974 to the outstanding options granted to employees including members of the Management Board as determined based on the specific rules issued and applied by NYSE Liffe. These specific rules issued by NYSE Liffe are similar to the adjustment ratio as applied to traded securities that are also not entitled to receive the capital distribution. Under these rules a theoretical adjustment ratio was determined based on the value and the effective date of the capital distribution and this ratio was applied to adjust the original number of the options and the original exercise price of the outstanding options. | ||||||||||||||||||
The following is a summary of changes in options outstanding: | ||||||||||||||||||
US dollar-plans | Euro-plans | |||||||||||||||||
Number of | Weighted | Number | Weighted | |||||||||||||||
options | average | of | average | |||||||||||||||
exercise | options | exercise | ||||||||||||||||
price in | price in € | |||||||||||||||||
US$ | ||||||||||||||||||
Balance January 1, 2011 | 686,060 | 20.4 | 759,463 | 15.74 | ||||||||||||||
Options granted | — | — | 687,114 | 22.33 | ||||||||||||||
Options forfeited | (1,080 | ) | 16.65 | — | — | |||||||||||||
Options exercised | (169,870 | ) | 19.1 | (126,620 | ) | 14.82 | ||||||||||||
Balance December 31, 2011 | 515,110 | 20.83 | 1,319,957 | 19.08 | ||||||||||||||
Options granted | — | — | 708,891 | 27.04 | ||||||||||||||
Options forfeited | (29,400 | ) | 20.63 | (44,500 | ) | 15.49 | ||||||||||||
Options exercised | (85,310 | ) | 20.42 | (59,660 | ) | 15.08 | ||||||||||||
Balance December 31, 2012 | 400,400 | 20.94 | 1,924,688 | 22.22 | ||||||||||||||
Options forfeited | (1,220 | ) | 13.65 | (25,050 | ) | 24.72 | ||||||||||||
Options exercised | (52,670 | ) | 15.97 | (23,550 | ) | 15.91 | ||||||||||||
Balance July 25, 2013 | 346,510 | 21.72 | 1,876,088 | 22.26 | ||||||||||||||
Adjustment following capital distribution | 62,145 | 18.42 | 336,446 | 18.88 | ||||||||||||||
Options granted | — | — | 776,450 | 23.73 | ||||||||||||||
Options forfeited | (2,830 | ) | 9.06 | (39,271 | ) | 20.93 | ||||||||||||
Options exercised | (17,675 | ) | 12.66 | (29,361 | ) | 10.7 | ||||||||||||
Balance December 31, 2013 | 388,150 | 18.75 | 2,920,352 | 20.22 | ||||||||||||||
The weighted average fair values of employee stock option granted in euro were €10.43 in 2011 and €12.27 in 2012 and €10.22 in 2013. | ||||||||||||||||||
The remaining contractual life of the outstanding options granted in 2013 is 7 years at December 31, 2013. | ||||||||||||||||||
The total intrinsic value of options exercised was €4,077, €2,209 and €1,651 for the years ended December 31, 2011, 2012 and 2013 respectively. In 2011, 2012 and 2013 new shares have been issued for the exercise of 294,119 options, 144,570 options and 125,402 options respectively. | ||||||||||||||||||
On December 31, 2013 options outstanding and options exercisable classified by range of exercise prices are: | ||||||||||||||||||
Options outstanding | Options exercisable | |||||||||||||||||
Range of | Number | Weighted average | Weighted | Number | Weighted | |||||||||||||
exercise | outstanding | remaining | average | exercisable | average | |||||||||||||
prices | contractual life | exercise price | exercise price | |||||||||||||||
In US$ | In years | In US$ | In US$ | |||||||||||||||
1.00-10.00 | 65,313 | 5.1 | 6.75 | 46,443 | 6.9 | |||||||||||||
10.00-15.00 | 30,265 | 3.6 | 11.57 | 21,513 | 11.83 | |||||||||||||
15.00-20.00 | 128,057 | 2.2 | 18.88 | 88,194 | 18.67 | |||||||||||||
20.00-25.00 | 114,985 | 4.4 | 22.59 | 114,985 | 22.59 | |||||||||||||
25.00-30.00 | 49,530 | 3 | 29.69 | 29,719 | 29.69 | |||||||||||||
US$1.00-30.00 | 388,150 | 3.5 | 18.75 | 300,853 | 18.95 | |||||||||||||
In € | In years | In € | In € | |||||||||||||||
1.00-10.00 | 2,715 | 0.3 | 8.32 | 803 | 8.62 | |||||||||||||
10.00-15.00 | 445,993 | 2.7 | 12.2 | 390,318 | 12.11 | |||||||||||||
15.00-20.00 | 854,171 | 4.5 | 18.61 | 112,016 | 16.51 | |||||||||||||
20.00-25.00 | 1,617,473 | 6.4 | 21.57 | 20,875 | 22.47 | |||||||||||||
€1.00-25.00 | 2,920,352 | 5.3 | 19.26 | 524,012 | 13.46 | |||||||||||||
At December 31, 2013, the aggregate intrinsic value of all options outstanding and all options exercisable is €17,702 and €8,562 respectively. | ||||||||||||||||||
The cost relating to employee stock options is measured at fair value on the grant date. The fair value was determined using the Black-Scholes option valuation model with the following weighted average assumptions: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Expected life (years) | 7 | 7 | 7 | |||||||||||||||
Risk free interest rate | 3.51 | % | 3.28 | % | 2.93 | % | ||||||||||||
Dividend yield | 0.32 | % | 0.64 | % | 0.9 | % | ||||||||||||
Expected volatility | 40.9 | % | 41.98 | % | 41.52 | % | ||||||||||||
The grant date fair value of the stock options is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of stock options that will eventually vest. The impact of the true up of the estimates is recognized in the consolidated statement of operations in the period in which the revision is determined. We recorded compensation expenses of €1,872, €3,242 and €4,440 for 2011, 2012 and 2013 respectively. | ||||||||||||||||||
Employee Share Incentive Scheme ASMPT | ||||||||||||||||||
In 1989, the shareholders of ASMPT approved a plan to issue up to 5 percent of the total issued shares of ASMPT to directors and employees. This plan was extended in 1999 for a term up to March 23, 2010. At the annual general meeting of the ASMPT held on April 24, 2009, the shareholders approved to extend the period of the Scheme for a term of a further 10 years up to March 23, 2020 and allow up to 7.5% of the issued share capital of ASMPT from time to time (excluding any shares subscribed for or purchased pursuant to the Scheme since March 23, 1990) to be subscribed for or purchased pursuant to the Scheme during such extended period and that no more than 3.5% of the issued share capital of ASMPT from time to time (excluding any shares subscribed for or purchased pursuant to the Scheme since March 23, 1990) to be subscribed for or purchased pursuant to the Scheme for the period from March 24, 2010 to March 23, 2015. | ||||||||||||||||||
The directors annually may approve an amount of supplemental compensation to the designated directors and officers, which will be used to issue or purchase ASMPT’s common shares for the designees at current market value. | ||||||||||||||||||
On March 21, 2012, the directors resolved to grant, and the Company granted, a total of 1,950,300 shares (the “2012 Incentive Shares”) in the Company to certain employees and members of the management of the Group upon expiration of the defined qualification period. The vesting period of such grant, which is the qualification period, was from March 21, 2012 to December 15, 2012. | ||||||||||||||||||
On March 28, 2012 (the “Adoption Date”), a Share Award Scheme was adopted by the Company to establish a trust to subscribe and purchase shares of the Company for the benefit of employees and members of the management of the Group under the Employee Share Incentive Scheme. The scheme is valid and effective for a period of 8 years commencing from the Adoption Date. Pursuant to the rules of the scheme, the Company has appointed a trustee, Law Debenture Trust (Asia) Limited, for purpose of administering the scheme and holding the awarded shares. As a result of such Share Award Scheme, 328,000 shares (the “2012 Awarded Share”) was allocated from the 2012 Incentive Shares as the 2012 Awarded Shares. | ||||||||||||||||||
On December 15, 2012, 1,607,400 common shares of ASMPT were issued, for cash at par value of HK$0.10 per share, pursuant to the Employee Share Incentive Scheme of ASMPT and 14,900 shares were forfeited and unallocated by ASMPT. 328,000 shares of the 2012 Awarded Shares were vested on the same date. | ||||||||||||||||||
In 2011, respectively 1,518,100 ASMPT shares were issued to certain directors and employees under the plan. The effect of this transaction on ASMI was a dilution of its ownership interest in ASMPT of 0.21% in 2012 and 0.19% in 2011. The shares issued under the plan in 2012 have diluted ASMI’s ownership in ASMPT to 51.96% as of December 31, 2012. | ||||||||||||||||||
The fair value of the 2012 Incentive shares granted was determined with reference to the market value of the shares at the grant date taking into account the expected dividends as the employees are not entitled to received dividends paid during the vesting period, while for the 2012 Awarded Shares, its fair value was determined with reference to the cost of purchase from the market included transaction costs, which is not significantly differenct from the fair value at the grant date. | ||||||||||||||||||
Total compensation expenses related to the Employee Share Incentive Scheme of respectively €11,580 in 2011 and €19,823 in 2012 were charged to the Consolidated Statement of Operations. In 2013 through date of deconsolidation ASMPT did not incur any Employee Share Incentive Scheme expenses. | ||||||||||||||||||
The fair value of the 2012 Incentive shares granted was determined with reference to the market value of the shares at the grant date. The expected dividends were taken into account as the employees are not entitled to receive dividends paid during the vesting period. For the 2012 Awarded Shares the fair value was determined with reference to the cost of purchase from the market including transaction costs, which is not significantly different from the fair value at the grant date. |
Commitments_and_contingencies
Commitments and contingencies | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||
Commitments and contingencies | ' | |||||
Commitments and contingencies | ||||||
Capital leases included in property, plant and equipment are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Machinery and equipment | 3,485 | 2,737 | ||||
Furniture and fixtures | 344 | 269 | ||||
3,829 | 3,006 | |||||
Less accumulated depreciation | (3,829 | ) | (3,006 | ) | ||
— | — | |||||
At December 31, 2013 operating leases having initial or remaining non-cancelable terms in excess of one year are as follows: | ||||||
2014 | 4,857 | |||||
2015 | 3,801 | |||||
2016 | 3,279 | |||||
2017 | 2,707 | |||||
2018 | 2,423 | |||||
Years thereafter | 3,660 | |||||
Total | 20,727 | |||||
Aggregate rental expense for operating leases was €22,335 in 2011, €24,661 in 2012 and €9,529 in 2013. At December 31, 2013 the Company had entered into purchase commitments with suppliers in the amount of €141,908 for purchases, of which €139,221 for purchases within the next 12 months. Commitments for capital expenditures at December 31, 2013 were €10,552. | ||||||
Change of Control Transaction | ||||||
Pursuant to our 1997 settlement agreement with Applied Materials, as amended and restated in 1998, if we desire to effect a change of control transaction, as defined in the settlement agreement which generally involves our operations and not our investment in ASMPT, with a competitor of Applied Materials, we must first offer the change of control transaction to Applied Materials on the same terms as we would be willing to accept from that competitor pursuant to a bona fide arm’s-length offer made by that competitor. |
Litigation_and_environmental_m
Litigation and environmental matters | 12 Months Ended |
Dec. 31, 2013 | |
Loss Contingency, Information about Litigation Matters [Abstract] | ' |
Litigation and environmental matters | ' |
Litigation and environmental matters | |
The Company is a party to various legal proceedings incidental to its business and is subject to a variety of environmental and pollution control laws and regulations. As is the case with other companies in similar industries, the Company faces exposure from actual or potential claims and legal proceedings. Although the ultimate disposition of legal proceedings cannot be predicted with certainty, it is the opinion of the Company’s management that the outcome of any claim which is pending or threatened, either individually or on a combined basis, will not have a material effect on the financial position of the Company, its cash flows and result of operations. |
Financial_instruments_and_risk
Financial instruments and risk management | 12 Months Ended | ||||||||||||||
Dec. 31, 2013 | |||||||||||||||
Summary of Derivative Instruments by Risk Exposure [Abstract] | ' | ||||||||||||||
Financial instruments and risk management | ' | ||||||||||||||
Financial instruments and risk management | |||||||||||||||
Financial Instruments | |||||||||||||||
Financial instruments include: | |||||||||||||||
Financial assets: | |||||||||||||||
December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Cash and cash equivalents | 290,475 | 312,437 | |||||||||||||
Pledged cash deposits | 20,000 | — | |||||||||||||
Accounts receivable | 304,840 | 83,016 | |||||||||||||
Derivative instruments designated in cash flow hedges | 145 | — | |||||||||||||
Financial liabilities: | |||||||||||||||
December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Notes payable to banks | 61,675 | — | |||||||||||||
Accounts payable | 151,761 | 44,837 | |||||||||||||
Current portion of long-term debt | 6,316 | — | |||||||||||||
Long-term debt | 12,632 | — | |||||||||||||
Gains or losses related to financial instruments are as follows: | |||||||||||||||
Year ended December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Interest income | 1,989 | 972 | |||||||||||||
Interest expense | (12,113 | ) | (2,943 | ) | |||||||||||
Accretion interest expense convertible notes at amortized value | (4,469 | ) | — | ||||||||||||
Loss resulting from early extinguishment of debt | (2,209 | ) | — | ||||||||||||
Losses Foreign currency exchange, net | (3,957 | ) | (8,158 | ) | |||||||||||
Addition to allowance for doubtful accounts receivable | (2,825 | ) | (377 | ) | |||||||||||
Fair value is the price that would be received to sell an asset pr paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASMI uses the following fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: | |||||||||||||||
Level 1 | |||||||||||||||
Quoted prices in active markets that are accessible at the measurement date for identical assets and liabilities. | |||||||||||||||
Level 2 | |||||||||||||||
Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. | |||||||||||||||
Level 3 | |||||||||||||||
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. | |||||||||||||||
There were no transfers between levels during the years ended December 31, 2013 and December 31, 2012. | |||||||||||||||
The following table presents the Company’s (financial) assets and liabilities that are measured at fair value on a recurring basis. | |||||||||||||||
At carrying value | At fair value | Level 2 | Level 3 | Total | |||||||||||
Level 1 | |||||||||||||||
31-Dec-12 | |||||||||||||||
Assets: | |||||||||||||||
Derivative financial instruments 1) | 145 | — | 145 | — | 145 | ||||||||||
Total | 145 | — | 145 | — | 145 | ||||||||||
31-Dec-13 | |||||||||||||||
Assets: | |||||||||||||||
Associates | 971,131 | 971,131 | — | — | 971,131 | ||||||||||
Total | 971,131 | 971,131 | — | — | 971,131 | ||||||||||
1) Derivative financial instruments consist of forward foreign exchange contracts. | |||||||||||||||
The valuation technique used to determine the fair value of forward foreign exchange contracts (used for hedging purposes) approximates the Net Present Value technique which is the estimated amount that a bank would receive or pay to terminate the forward foreign exchange contracts at the reporting date, taking into account current interest rates and current exchange rates. | |||||||||||||||
Financial Risk Factors | |||||||||||||||
ASMI is exposed to a number of risk factors: market risks (including foreign exchange risk and interest rate risk), credit risk and liquidity risk. The Company uses forward exchange contracts to hedge its foreign exchange risk. The Company does not enter into financial instrument transactions for trading or speculative purposes. | |||||||||||||||
Foreign Exchange Risk | |||||||||||||||
ASMI and its subsidiaries conduct business in a number of foreign countries, with certain transactions denominated in currencies other than the functional currency of the Company (euro) or one of its subsidiaries conducting the business. The purpose of the Company’s foreign currency management is to manage the effect of exchange rate fluctuations on revenues, costs and cash flows and assets and liabilities denominated in selected foreign currencies, in particular denominated in US dollar. | |||||||||||||||
We use forward exchange contracts to hedge foreign exchange risk of anticipated sales or purchase transactions in the normal course of business, which occur within the next twelve months, for which the Company has a firm commitment from a customer or to a supplier. The terms of these contracts are consistent with the timing of the transactions being hedged. The hedges related to forecasted transactions are designated and documented at the inception of the hedge as cash flow hedges, and are evaluated for effectiveness quarterly. The effective portion of the gain or loss on these hedges is reported as a component of accumulated other comprehensive loss in Shareholders’ Equity, and is reclassified into earnings when the hedged transaction affects earnings. | |||||||||||||||
Changes in the fair value of derivatives that do not qualify for hedge treatment, as well as the ineffective portion of any hedges, are recognized in earnings. The Company records all derivatives, including forward exchange contracts, on the balance sheet at fair value in other current assets or accrued expenses. If the underlying transaction being hedged fails to occur, or if a portion of any derivative is ineffective, the gain or loss is immediately recognized in earnings under foreign currency exchange gains (losses) in the Consolidated Statement of Operations. Hedge ineffectiveness was insignificant for the years ended December 31, 2012 and December 31, 2013. | |||||||||||||||
Furthermore, the Company might manage the currency exposure of certain receivables and payables using derivative instruments, such as forward exchange contracts (fair value hedges) and currency swaps, and non-derivative instruments, such as debt borrowings in foreign currencies. The gains or losses on these instruments provide an offset to the gains or losses recorded on receivables and payables denominated in foreign currencies. The derivative instruments are recorded at fair value and changes in fair value are recorded in earnings under foreign currency exchange gains (losses) in the Consolidated Statement of Operations. Receivables and payables denominated in foreign currencies are recorded at the exchange rate at the balance sheet date and gains and losses as a result of changes in exchange rates are recorded in earnings under foreign currency exchange gains (losses) in the Consolidated Statement of Operations. | |||||||||||||||
To the extent that exchange rate fluctuations impact the value of the Company’s investments in its foreign subsidiaries, they are not hedged. The cumulative effect of these fluctuations is separately reported in Consolidated Shareholders’ Equity. Reference is made to Note 18. | |||||||||||||||
The outstanding forward exchange contracts per December 31, 2012 were as follows, per December 31, 2013 there were no forward exchange contracts outstanding: | |||||||||||||||
Currency | Notional | Fair | Included in | ||||||||||||
amount | value | accumulated | |||||||||||||
other | |||||||||||||||
comprehensive | |||||||||||||||
income (loss) | |||||||||||||||
Euro | Euro | ||||||||||||||
31-Dec-12 | |||||||||||||||
Assets: | |||||||||||||||
Fair value hedge contracts: | |||||||||||||||
Short position | US$ | (27,100 | ) | (145 | ) | — | |||||||||
For forward exchange contracts, market values based on external quotes from banks have been used to determine the fair value. | |||||||||||||||
The following table analyzes the Company’s sensitivity to a hypothetical 10% strengthening and 10% weakening of the US dollar, Singapore dollar, Hong Kong dollar, Korean won and Japanese yen against the euro as of December 31, 2012 and December 31, 2013. This analysis includes foreign currency denominated monetary items and adjusts their translation at year end for a 10% increase and 10% decrease of the US dollar, Singapore dollar, Hong Kong dollar, Korean won or Japanese yen against the euro. A positive amount indicates an increase in equity. Recognized in equity is the revaluation effect of subsidiaries denominated in US dollar, Singapore dollar, Hong Kong dollar and Japanese yen. | |||||||||||||||
Impact on equity | |||||||||||||||
2012 | 2013 | ||||||||||||||
10% increase of US dollar versus euro | 4,564 | 4,938 | |||||||||||||
10% decrease of US dollar versus euro | (4,564 | ) | (4,938 | ) | |||||||||||
10% increase of Singapore dollar versus euro | 5,868 | 6,088 | |||||||||||||
10% decrease of Singapore dollar versus euro | (5,868 | ) | (6,088 | ) | |||||||||||
10% increase of Hong Kong dollar versus euro | 56,693 | 94,396 | |||||||||||||
10% decrease of Hong Kong dollar versus euro | (56,693 | ) | (94,396 | ) | |||||||||||
10% increase of Korean won versus euro | 3,969 | 5,840 | |||||||||||||
10% decrease of Korean won versus euro | (3,969 | ) | (5,840 | ) | |||||||||||
10% increase of Japanese yen versus euro | 5,294 | 4,561 | |||||||||||||
10% decrease of Japanese yen versus euro | (5,294 | ) | (4,561 | ) | |||||||||||
A hypothetical 10% strengthening or 10% weakening of any other currency against the euro as of December 31, 2012 and December 31, 2013 would not result in a material impact on equity. | |||||||||||||||
The following table analyzes the Company’s sensitivity to a hypothetical 10% strengthening and 10% weakening of the US dollar, Singapore dollar, Hong Kong dollar, Korean won or Japanese yen against the euro at average exchange rates for the years 2012 and 2013. A positive amount indicates an increase in net earnings. | |||||||||||||||
Impact on net earnings | |||||||||||||||
2012 | 2013 | ||||||||||||||
10% increase of US dollar versus euro | 915 | 601 | |||||||||||||
10% decrease of US dollar versus euro | (915 | ) | (601 | ) | |||||||||||
10% increase of Singapore dollar versus euro | 644 | 671 | |||||||||||||
10% decrease of Singapore dollar versus euro | (644 | ) | (671 | ) | |||||||||||
10% increase of Hong Kong dollar versus euro | 3,630 | 100,072 | |||||||||||||
10% decrease of Hong Kong dollar versus euro | (3,630 | ) | (100,072 | ) | |||||||||||
10% increase of Korean won versus euro | 1,400 | 1,962 | |||||||||||||
10% decrease of Korean won versus euro | (1,400 | ) | (1,962 | ) | |||||||||||
10% increase of Japanese yen versus euro | 923 | 485 | |||||||||||||
10% decrease of Japanese yen versus euro | (923 | ) | (485 | ) | |||||||||||
The significant possible impact on net earnings results from the realized and unrealized gain following the sale of the 12% stake in ASMPT. A hypothetical 10% strengthening or 10% weakening of any other currency against the euro at average exchange rates for the years 2012 and 2013 would not result in a material impact on net earnings. | |||||||||||||||
Interest Risk | |||||||||||||||
We are not exposed to interest rate risk through our borrowing activities. The Company does not enter into financial instrument transactions for trading or speculative purposes or to manage interest rate exposure. At December 31, 2013 the Company had no debt. | |||||||||||||||
Credit Risk | |||||||||||||||
Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and derivative instruments. These instruments contain a risk of counterparties failing to discharge their obligations. We monitor credit risk and manages credit risk exposure by type of financial instrument by assessing the creditworthiness of counterparties. We do not anticipate nonperformance by counterparties given their high creditworthiness. | |||||||||||||||
The Company’s customers are semiconductor device manufacturers located throughout the world. We perform ongoing credit evaluations of our customers' financial condition. We take additional measures to mitigate credit risk when considered appropriate by means of down payments, letters of credit. We generally do not require collateral or other security to support financial instruments with credit risk. | |||||||||||||||
Concentrations of credit risk (whether on or off-balance sheet) that arise from financial instruments exist for groups of customers or counterparties when they have similar economic characteristics that would cause their ability to meet contractual obligations to be similarly affected by changes in economic or other conditions. | |||||||||||||||
The Company derives a significant percentage of its revenue from a small number of large customers. The largest customer accounted for approximately 28.3% of net sales in 2013 (2012: 8.8%; 2011: 6.4%) and the ten largest customers accounted for approximately 85.6% of net sales in 2013 (2012: 31.6%; 2011: 27.9%). Sales to these large customers also may fluctuate significantly from time to time depending on the timing and level of purchases by these customers. Significant orders from such customers may expose the Company to a concentration of credit risk and difficulties in collecting amounts due, which could harm the Company’s financial results. At December 31, 2013 one customer accounted for 28.1% of the outstanding balance in accounts receivable (2012: 6.5%; 2011: 4.5%). | |||||||||||||||
We invest our cash and cash equivalents in short-term deposits and derivative instruments with high-rated financial institutions. We only enter into transactions with a limited number of major financial institutions that have high credit ratings and we closely monitor the creditworthiness of our counterparties. Concentration risk is mitigated by limiting the exposure to a single counterparty. | |||||||||||||||
The maximum credit exposure is equal to the carrying values of cash and cash equivalent and accounts receivable. | |||||||||||||||
Liquidity Risk | |||||||||||||||
The following table summarizes the Company’s contractual obligations as at December 31, 2013 aggregated by type of contractual obligation: | |||||||||||||||
Total | Less than | 3-Jan | 5-Mar | More than | |||||||||||
1 year | years | years | 5 years | ||||||||||||
Operating leases | 20,727 | 4,857 | 7,080 | 5,130 | 3,660 | ||||||||||
Pension liabilities | 4,777 | 209 | 650 | 1,122 | 2,796 | ||||||||||
Purchase obligations: | |||||||||||||||
Purchase commitments to suppliers | 48,982 | 48,982 | — | — | — | ||||||||||
Capital expenditure commitments | 458 | 458 | — | — | — | ||||||||||
Unrecognized tax benefits (ASC 740) | — | — | — | — | — | ||||||||||
Total contractual obligations | 74,944 | 54,506 | 7,730 | 6,252 | 6,456 | ||||||||||
Total short-term lines of credit amounted to €150,000 at December 31, 2013. The amount outstanding at December 31, 2013 was nil and the undrawn portion totaled €150,000. The standby revolving credit facility of €150,000 with a consortium of banks. The facility, available through December 20, 2018, is secured by a portion of the Company’s shareholding in ASMPT and certain accounts receivable. | |||||||||||||||
For the majority of purchase commitments, the Company has flexible delivery schedules depending on the market conditions, which allows the Company, to a certain extent, to delay delivery beyond originally planned delivery schedules. |
Research_And_development
Research And development | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Research and Development Expense [Abstract] | ' | ||||||||
Research and development | ' | ||||||||
Research and development | |||||||||
Research and Development consists of the following: | |||||||||
Year ended December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Research and development expenses | 130,153 | 150,118 | 76,427 | ||||||
Research and development grants and credits | (753 | ) | (899 | ) | (1,036 | ) | |||
Total research and development expenses | 129,400 | 149,219 | 75,391 | ||||||
The Company’s operations in the Netherlands, Germany and the United States receive research and development grants and credits from various sources. |
Restructuring_expenses
Restructuring expenses | 12 Months Ended |
Dec. 31, 2013 | |
Restructuring Charges [Abstract] | ' |
Restructuring expenses | ' |
Restructuring expenses | |
In the fourth quarter of 2012 we started a cost reduction program in our Front-end operation. We have reduced headcount in our manufacturing organization in Singapore and our product management organization in Europe and the US with approximately 100 people. Related to these actions, an amount of €0.9 million and an amount of €2.5 million in restructuring expenses was recorded in 2012 and 2013 respectively. |
Income_taxes
Income taxes | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||||||||||
Income taxes | ' | ||||||||||||||||||||
Income taxes | |||||||||||||||||||||
The components of earnings (loss) before income taxes and non-controlling interest consist of: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
The Netherlands | (3,450 | ) | (70,263 | ) | 1,018,554 | ||||||||||||||||
Other countries | 356,305 | 136,994 | 41,867 | ||||||||||||||||||
Earnings before income taxes and Non-controlling interest | 352,855 | 66,731 | 1,060,421 | ||||||||||||||||||
The income tax expense consists of: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
Current: | |||||||||||||||||||||
The Netherlands | (494 | ) | (110 | ) | (1,938 | ) | |||||||||||||||
Other countries | (64,684 | ) | (26,337 | ) | (9,479 | ) | |||||||||||||||
(65,178 | ) | (26,447 | ) | (11,417 | ) | ||||||||||||||||
Deferred: | |||||||||||||||||||||
The Netherlands | — | — | — | ||||||||||||||||||
Other countries | 28,486 | 147 | 296 | ||||||||||||||||||
Income tax expense | (36,692 | ) | (26,300 | ) | (11,121 | ) | |||||||||||||||
The provisions for income taxes as shown in the Consolidated Statements of Operations differ from the amounts computed by applying the Dutch statutory income tax rates to earnings before taxes. A reconciliation of the provisions for income taxes and the amounts that would be computed using the Dutch statutory income tax rates is set forth as follows: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
Earnings before income taxes and Non-controlling interest | 352,855 | 66,731 | 1,060,421 | ||||||||||||||||||
Dutch statutory income tax rate | 25 | % | 25 | % | 25 | % | |||||||||||||||
Income tax provision at statutory rate | (88,214 | ) | (16,683 | ) | (265,105 | ) | |||||||||||||||
Non-deductible expenses | (8,228 | ) | (6,508 | ) | (1,957 | ) | |||||||||||||||
Foreign taxes at a rate other than the Dutch statutory rate | 12,983 | (2,699 | ) | (556 | ) | ||||||||||||||||
Valuation allowance | 17,991 | (14,876 | ) | (3,960 | ) | ||||||||||||||||
Non-taxable income -1- | 30,156 | 4,887 | 260,425 | ||||||||||||||||||
Other -2- | (1,380 | ) | 9,579 | 32 | |||||||||||||||||
Income tax expense | (36,692 | ) | (26,300 | ) | (11,121 | ) | |||||||||||||||
1) | Non-taxable income for 2013 mainly consist of revenues deriving from the disposal of the 12% shareholding in ASMPT in March which are exempt under the Dutch participation exemption. | ||||||||||||||||||||
2) | Other in 2013 mainly consists of tax credits, adjustments to prior years, changes in (enacted) tax laws and revaluation of certain assets. | ||||||||||||||||||||
Included in non-taxable income for 2013 is €3,244 regarding the Company’s manufacturing operations in Singapore and other countries where income covering certain products is non-taxable or subject to concessional tax rates under tax incentive schemes granted by the local tax authority. The majority of these tax incentive schemes have terms ending by December 31, 2020. | |||||||||||||||||||||
On June 8, 2009 the Singapore Economic Development Board (“EDB”) granted a Pioneer Certificate to ASM Front-End Manufacturing Singapore Pte Ltd (“FEMS”, a principal subsidiary of the Group,) to the effect that profits arising from certain manufacturing activities by FEMS of Front-end equipment will in principle be exempted from tax for a period of 10 years effective from dates ranging between July 1, 2008, subject to fulfillment of certain criteria during the period. | |||||||||||||||||||||
On July 12, 2010, the EDB granted a Pioneer Certificate to ASM Technology Singapore Pte Limited (“ATS”), a principal subsidiary of the Group, to the effect that profits arising from certain products will be exempted from tax for a period of 10 years effective from dates ranging between June 1, 2010 and January 1, 2012 across specified products, subject to fulfillment of certain criteria during the period. EDB had also granted a 5 year Development and Expansion Incentive (DEI) to ATS to the effect that the profits arising from certain existing products shall be subject a concessionary tax rate of 5% for a period of 10 years from January 1, 2011, subject to the fulfillment of certain criteria during the period. | |||||||||||||||||||||
On the same date, the EDB also granted ATS an International Headquarters (“IHQ”) Award to the effect that certain income arising from qualifying activities conducted by ATS, excluding income from business transactions with companies or end customers in Singapore, shall be subject to concessionary tax rate of 5% for a period of 10 years from January 1, 2011, subject to fulfillment of certain criteria during the period. | |||||||||||||||||||||
In Korea a High Technology Tax Exemption has been granted to the effect that profits arising from certain equipment sales will in principle be partly exempted from tax in the period ending by 2016, subject to fulfillment of certain criteria during the period. | |||||||||||||||||||||
Since 2011 the Dutch statutory tax rate amounted to 25.0%. Taxation for other jurisdictions is calculated at the rates prevailing in the relevant jurisdictions. The Company’s deferred tax assets and liabilities have been determined in accordance with these statutory income tax rates. | |||||||||||||||||||||
Deferred income taxes developed as follows: | |||||||||||||||||||||
1-Jan-12 | Acquisitions | Reclassifications | Consolidated statement of operations | Equity | Exchange differences | 31-Dec-12 | |||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Reserves and allowances | 10,415 | — | 3,985 | 4,928 | 1,730 | (736 | ) | 20,322 | |||||||||||||
Net operating losses | 86,720 | — | — | (2,303 | ) | — | (939 | ) | 83,478 | ||||||||||||
Depreciation | 363 | — | 508 | 1,478 | — | (89 | ) | 2,260 | |||||||||||||
Other | 6,391 | — | (6,525 | ) | 1,345 | 28 | (127 | ) | 1,112 | ||||||||||||
Gross deferred tax assets | 103,889 | — | (2,032 | ) | 5,448 | 1,758 | (1,891 | ) | 107,172 | ||||||||||||
Less: valuation allowance | (76,467 | ) | — | (180 | ) | (6,442 | ) | — | (161 | ) | (83,250 | ) | |||||||||
Net deferred tax assets | 27,422 | — | (2,212 | ) | (994 | ) | 1,758 | (2,052 | ) | 23,922 | |||||||||||
Deferred tax liabilities | (4,381 | ) | — | 2,212 | 1,142 | — | 39 | (988 | ) | ||||||||||||
Net deferred income taxes | 23,041 | — | — | 148 | 1,758 | (2,013 | ) | 22,934 | |||||||||||||
1-Jan-13 | Deconsolidation ASMPT | Change income tax rate | Consolidated statement of operations | Equity | Exchange differences | 31-Dec-13 | |||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Reserves and allowances | 20,322 | (15,199 | ) | (258 | ) | (814 | ) | 255 | (1,152 | ) | 3,154 | ||||||||||
Net operating losses | 83,478 | (11,905 | ) | — | (1,664 | ) | — | 49 | 69,958 | ||||||||||||
Depreciation | 2,260 | (2,121 | ) | (88 | ) | 1,603 | — | (319 | ) | 1,335 | |||||||||||
Other | 1,112 | (194 | ) | (38 | ) | (146 | ) | — | (164 | ) | 570 | ||||||||||
Gross deferred tax assets | 107,172 | (29,419 | ) | (384 | ) | (1,021 | ) | 255 | (1,586 | ) | 75,017 | ||||||||||
Less: valuation allowance | (83,250 | ) | 11,675 | — | 1,664 | — | (47 | ) | (69,958 | ) | |||||||||||
Net deferred tax assets | 23,922 | (17,744 | ) | (384 | ) | 643 | 255 | (1,633 | ) | 5,059 | |||||||||||
Deferred tax liabilities | (988 | ) | 921 | — | 37 | — | (5 | ) | (35 | ) | |||||||||||
Net deferred income taxes | 22,934 | (16,823 | ) | (384 | ) | 680 | 255 | (1,638 | ) | 5,024 | |||||||||||
Deferred tax assets and liabilities are classified in the consolidated balance sheet as follows: | |||||||||||||||||||||
December 31, | |||||||||||||||||||||
2012 | 2013 | ||||||||||||||||||||
Deferred tax assets—current | 17,967 | 3,739 | |||||||||||||||||||
Deferred tax assets—non-current | 5,955 | 1,320 | |||||||||||||||||||
Deferred tax liabilities—current | (36 | ) | — | ||||||||||||||||||
Deferred tax liabilities—non-current | (952 | ) | (35 | ) | |||||||||||||||||
22,934 | 5,024 | ||||||||||||||||||||
Based on tax filings, ASMI and its individual subsidiaries have net operating losses available at December 31, 2013 of €272,610 for tax return purposes to reduce future income taxes, mainly in Europe. The Company believes that realization of its net deferred tax assets is dependent on the ability of the Company to generate taxable income in the future. Given the volatile nature of the semiconductor equipment industry, past experience, and the tax jurisdictions where the Company has net operating losses, the Company believes that there is currently insufficient evidence to substantiate recognition of substantially all net deferred tax assets with respect to net operating losses. Accordingly, a valuation allowance of €83,250 in 2012 and €69,958 in 2013 has been recorded. | |||||||||||||||||||||
The amounts and expiration dates of net operating losses for tax purposes are as follows: | |||||||||||||||||||||
Expiration year | Total of net operating losses for tax purposes | Net operating losses for which deferred tax assets are recognized | |||||||||||||||||||
2014 | 37,607 | — | |||||||||||||||||||
2015-2016 | — | — | |||||||||||||||||||
2017 | 47,429 | — | |||||||||||||||||||
2018 | 44,664 | — | |||||||||||||||||||
2019 | 35,905 | — | |||||||||||||||||||
2020 | 4 | — | |||||||||||||||||||
2021 | 60,198 | — | |||||||||||||||||||
2022 | 28,556 | — | |||||||||||||||||||
2023-2028 | — | — | |||||||||||||||||||
2029 | 14,343 | — | |||||||||||||||||||
2030 | 3,779 | — | |||||||||||||||||||
Unlimited | 125 | — | |||||||||||||||||||
Total | 272,610 | — | |||||||||||||||||||
The Company has not provided for deferred foreign withholding taxes, if any, on undistributed earnings of its foreign subsidiaries. At December 31, 2013 the undistributed earnings of subsidiaries, subject to withholding taxes, were approximately €26,734. These earnings could become subject to foreign (withholding) taxes if they were remitted as dividends and / or if the Company should sell its interest in the subsidiaries. | |||||||||||||||||||||
Consistent with the provisions of ASC 740, as of December 31, 2013, ASMI has no liability of unrecognized tax benefits. A reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits is as follows: | |||||||||||||||||||||
Balance January 1, 2011 | 20,057 | ||||||||||||||||||||
Gross increases - tax positions in current year | 950 | ||||||||||||||||||||
Foreign currency translation effect | 742 | ||||||||||||||||||||
Balance December 31, 2011 | 21,749 | ||||||||||||||||||||
Gross increases - tax positions in current year | 1,157 | ||||||||||||||||||||
Foreign currency translation effect | (395 | ) | |||||||||||||||||||
Balance December 31, 2012 | 22,511 | ||||||||||||||||||||
Deconsolidation ASMPT | (22,325 | ) | |||||||||||||||||||
Gross increases - tax positions in current year | — | ||||||||||||||||||||
Foreign currency translation effect | (186 | ) | |||||||||||||||||||
Balance December 31, 2013 | — | ||||||||||||||||||||
Unrecognized tax benefits mainly relate to transfer pricing positions, tax credits (US$20.9 million) and tax deductible costs. The Company estimates that no interest and penalties are related to these unrecognized tax benefits. In the year ended December 31, 2013, no settlement with tax authorities and no reduction as a result of a lapse of statute of limitations occurred. | |||||||||||||||||||||
Unrecognized tax benefits would, if recognized, impact the Company’s effective tax rate. The Company provided for an amount of zero reflecting managements best estimate to mitigate possible impact in case of an unfavorable outcome. The unrecognized tax benefits are classified in the consolidated balance sheet under “accrued expenses and other” and are covered with purchased tax certificates which are classified in the consolidated balance sheet under “other current assets”. | |||||||||||||||||||||
A summary of open tax years by major jurisdiction is as follows: | |||||||||||||||||||||
Jurisdiction | |||||||||||||||||||||
Japan | 2009-2013 | ||||||||||||||||||||
The Netherlands | 2009-2013 | ||||||||||||||||||||
Singapore | 2008-2013 | ||||||||||||||||||||
United States of America | 1997-2013 | ||||||||||||||||||||
South Korea | 2008-2013 | ||||||||||||||||||||
The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws. The Company’s estimate for the potential outcome of any unrecognized tax benefits is highly judgmental. Settlement of unrecognized tax benefits in a manner inconsistent with the Company’s expectations could have a material impact on the Company’s financial position, net earnings and cash flows. The Company is subject to tax audits in its major tax jurisdictions, local tax authorities may challenge the positions taken by the Company. |
Disclosures_about_segments_and
Disclosures about segments and related information | 12 Months Ended | |||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||
Disclosures about segments and related information | ' | |||||||||||||||||
Disclosures about segments and related information | ||||||||||||||||||
The Company organizes its activities in two operating segments, Front-end and Back-end. Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Executive Officer (“CEO”), which is the chief operating decision maker (according to ASC 280). | ||||||||||||||||||
The Front-end segment manufactures and sells equipment used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The segment is a product driven organizational unit comprised of manufacturing, service, and sales operations in Europe, the United States of America, Japan and South East Asia. | ||||||||||||||||||
The Back-end segment manufactures and sells equipment and materials used in assembly and packaging, encompassing the processes in which silicon wafers are separated into individual circuits and subsequently assembled, packaged and tested. The segment is organized in ASM Pacific Technology Ltd, in which the Company holds a substantial share of 39.94% interest, whilst the remaining shares are listed on the Stock Exchange of Hong Kong. The segment’s main operations are located in Hong Kong, the People’s Republic of China, Singapore, Malaysia and Germany. | ||||||||||||||||||
The Back-end segment remains reported as a separate segment since the cease of control per March 15, 2013. Since that date the segment is reported as an equity method investment as the CEO reviews this information as part of his CODM package. | ||||||||||||||||||
Accordingly, the asset and profit/loss information regarding the operations that comprise the segment are disclosed. The full financial results are reviewed by the CODM, the external reporting of the segment are on an equity method investment basis. The total of all segments' financial amounts are reconciled to the corresponding amounts reported in the consolidated financial statements, eliminations are reflected in the reconciling column for amounts reported in excess of those amounts reflected in the consolidated financial statements. | ||||||||||||||||||
Year ended December 31, 2011 | ||||||||||||||||||
Front-end | Back-end | Total | ||||||||||||||||
Net sales to unaffiliated customers | 456,065 | 1,178,270 | 1,634,334 | |||||||||||||||
Gross profit | 172,318 | 398,308 | 570,626 | |||||||||||||||
Result from operations | 62,581 | 304,869 | 367,450 | |||||||||||||||
Interest income | 976 | 1,925 | 2,902 | |||||||||||||||
Interest expense | (13,142 | ) | (354 | ) | (13,497 | ) | ||||||||||||
Loss resulting from early extinguishment of debt | (824 | ) | — | (824 | ) | |||||||||||||
Accretion interest expense convertible notes | (4,401 | ) | — | (4,401 | ) | |||||||||||||
Revaluation conversion option | (4,378 | ) | — | (4,378 | ) | |||||||||||||
Foreign currency exchange gains (losses), net | 8,296 | (2,692 | ) | 5,604 | ||||||||||||||
Income tax expense | (4,581 | ) | (32,111 | ) | (36,692 | ) | ||||||||||||
Net earnings (loss) | 44,527 | 271,637 | 316,164 | |||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 186,770 | |||||||||||||||||
Non-controlling interest | 129,394 | |||||||||||||||||
Capital expenditures | 16,369 | 72,849 | 89,218 | |||||||||||||||
Net purchase of other intangibles | 6,141 | 910 | 7,051 | |||||||||||||||
Depreciation and amortization | 14,335 | 32,638 | 46,973 | |||||||||||||||
Impairment of property, plant and equipment | — | (8,038 | ) | (8,038 | ) | |||||||||||||
Cash and cash equivalents | 228,114 | 162,136 | 390,250 | |||||||||||||||
Capitalized goodwill | 11,193 | 40,939 | 52,131 | |||||||||||||||
Other intangible assets | 9,643 | 5,133 | 14,776 | |||||||||||||||
Other identifiable assets | 336,090 | 788,973 | 1,125,063 | |||||||||||||||
Total assets | 585,040 | 997,181 | 1,582,221 | |||||||||||||||
Total debt | 162,464 | 32,946 | 195,409 | |||||||||||||||
Headcount in full-time equivalents -1- | 1,631 | 14,563 | 16,194 | |||||||||||||||
___________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
Year ended December 31, 2012 | ||||||||||||||||||
Front-end | Back-end | Total | ||||||||||||||||
Net sales to unaffiliated customers | 370,409 | 1,047,658 | 1,418,067 | |||||||||||||||
Gross profit | 124,531 | 315,898 | 440,429 | |||||||||||||||
Result from operations | 539 | 87,717 | 88,256 | |||||||||||||||
Interest income | 1,015 | 974 | 1,989 | |||||||||||||||
Interest expense | (11,381 | ) | (732 | ) | (12,113 | ) | ||||||||||||
Loss resulting from early extinguishment of debt | (2,209 | ) | — | (2,209 | ) | |||||||||||||
Accretion interest expense convertible notes | (4,329 | ) | (140 | ) | (4,469 | ) | ||||||||||||
Foreign currency exchange gains (losses), net | (3,050 | ) | (907 | ) | (3,957 | ) | ||||||||||||
Result on investments | (766 | ) | — | (766 | ) | |||||||||||||
Income tax expense | (8,965 | ) | (17,335 | ) | (26,300 | ) | ||||||||||||
Net earnings (loss) | (29,146 | ) | 69,577 | 40,431 | ||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 7,149 | |||||||||||||||||
Non-controlling interest | 33,282 | |||||||||||||||||
Capital expenditures | 21,973 | 46,189 | 68,162 | |||||||||||||||
Net purchase of other intangibles | 2,042 | 2,588 | 4,630 | |||||||||||||||
Depreciation and amortization | 18,838 | 39,622 | 58,460 | |||||||||||||||
Cash and cash equivalents | 145,061 | 145,414 | 290,475 | |||||||||||||||
Capitalized goodwill | 11,649 | 40,239 | 51,888 | |||||||||||||||
Other intangible assets | 9,049 | 4,866 | 13,915 | |||||||||||||||
Other identifiable assets | 334,399 | 808,829 | 1,143,228 | |||||||||||||||
Total assets | 500,158 | 999,348 | 1,499,506 | |||||||||||||||
Total debt | — | 80,623 | 80,623 | |||||||||||||||
Headcount in full-time equivalents -1- | 1,636 | 15,768 | 17,404 | |||||||||||||||
__________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
Year ended December 31, 2013 | ||||||||||||||||||
Front-end | Back-end 100% | Elimination non consolidated | Total | |||||||||||||||
Net sales to unaffiliated customers | 451,992 | 1,051,376 | (891,091 | ) | 612,277 | |||||||||||||
Gross profit | 176,160 | 307,618 | (269,228 | ) | 214,550 | |||||||||||||
Result from operations | 44,704 | 66,352 | (70,638 | ) | 40,418 | |||||||||||||
Interest income | 904 | 272 | (204 | ) | 972 | |||||||||||||
Interest expense | (2,553 | ) | (2,082 | ) | 1,693 | (2,942 | ) | |||||||||||
Foreign currency exchange gains (losses), net | (9,005 | ) | 847 | — | (8,158 | ) | ||||||||||||
Result from investments | — | — | 1,030,132 | 1,030,132 | ||||||||||||||
Income tax expense | (9,484 | ) | (11,308 | ) | 9,671 | (11,121 | ) | |||||||||||
Net earnings (loss) | 24,565 | 54,081 | 970,654 | 1,049,300 | ||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 1,051,893 | |||||||||||||||||
Non-controlling interest | (2,593 | ) | ||||||||||||||||
Capital expenditures and purchase of intangible assets | 11,072 | 34,003 | (27,542 | ) | 17,533 | |||||||||||||
Depreciation and amortization | 19,415 | 41,066 | (32,015 | ) | 28,466 | |||||||||||||
Cash and cash equivalents | 312,437 | 149,313 | (149,313 | ) | 312,437 | |||||||||||||
Capitalized goodwill | 11,421 | — | — | 11,421 | ||||||||||||||
Other intangible assets | 5,637 | 902 | (902 | ) | 5,637 | |||||||||||||
Investments and associates | 278 | — | 943,676 | 943,954 | ||||||||||||||
Other identifiable assets | 277,800 | 599,709 | (599,709 | ) | 277,800 | |||||||||||||
Total assets | 607,573 | 749,924 | 193,752 | 1,551,249 | ||||||||||||||
Total debt | — | 65,105 | (65,105 | ) | — | |||||||||||||
Headcount in full-time equivalents -1- | 1,503 | 14,400 | (14,400 | ) | 1,503 | |||||||||||||
__________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
There are no inter-segment transactions, other than charges for management services, which are based on actual cost. The accounting policies used to measure the net earnings and total assets in each segment are identical to those used in the Consolidated Financial Statements. The measurement methods used to determine reported segment earnings are consistently applied for all periods presented. There were no asymmetrical allocations to segments. | ||||||||||||||||||
Geographical information is summarized as follows: | ||||||||||||||||||
Europe | United | Japan | Southeast | Corporate | Consolidated | |||||||||||||
States of | Asia | |||||||||||||||||
America | ||||||||||||||||||
Year ended December 31, 2011 | ||||||||||||||||||
Net sales to unaffiliated customers | 338,065 | 185,943 | 96,697 | 1,013,629 | — | 1,634,334 | ||||||||||||
Long-lived assets | 16,021 | 13,110 | 18,273 | 212,605 | 171 | 260,180 | ||||||||||||
Total assets | 406,586 | 131,498 | 120,717 | 733,571 | 189,849 | 1,582,221 | ||||||||||||
Capital expenditures | 7,425 | 8,429 | 1,559 | 71,720 | 85 | 89,218 | ||||||||||||
Purchase of intangible assets | 29 | 779 | 635 | 1,378 | 4,230 | 7,051 | ||||||||||||
Year ended December 31, 2012 | ||||||||||||||||||
Net sales to unaffiliated customers | 255,795 | 197,566 | 59,385 | 905,321 | — | 1,418,067 | ||||||||||||
Long-lived assets | 17,587 | 22,567 | 17,313 | 217,849 | 120 | 275,436 | ||||||||||||
Total assets | 473,561 | 128,484 | 71,838 | 717,986 | 107,637 | 1,499,506 | ||||||||||||
Capital expenditures | 7,098 | 12,837 | 4,947 | 43,280 | — | 68,162 | ||||||||||||
Purchase of intangible assets | 1,732 | 437 | 72 | 997 | 1,392 | 4,630 | ||||||||||||
Year ended December 31, 2013 | ||||||||||||||||||
Net sales to unaffiliated customers | 97,777 | 147,036 | 36,623 | 330,841 | — | 612,277 | ||||||||||||
Long-lived assets | 2,871 | 24,429 | 15,112 | 14,075 | 44 | 56,531 | ||||||||||||
Total assets | 60,709 | 105,952 | 62,252 | 1,112,919 | 209,417 | 1,551,249 | ||||||||||||
Capital expenditures | 3,693 | 8,179 | 1,128 | 4,063 | — | 17,063 | ||||||||||||
Purchase of intangible assets | 108 | — | — | 124 | 238 | 470 | ||||||||||||
Long-lived assets for the years ended December 31, 2011, 2012 and 2013 consist of the Company’s property, plant and equipment. |
Selected_operating_expenses_an
Selected operating expenses and additional information | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Compensation Related Costs [Abstract] | ' | ||||||||
Selected operating expenses and additional information | ' | ||||||||
Selected operating expenses and additional information | |||||||||
Personnel expenses for employees were as follows: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Wages and salaries | 318,944 | 353,437 | 136,936 | ||||||
Social security | 42,622 | 47,124 | 16,049 | ||||||
Pension expenses | 18,945 | 21,151 | 7,539 | ||||||
380,511 | 421,712 | 160,524 | |||||||
The average number of employees, exclusive of temporary workers, by geographic area during the year was as follows: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
The Netherlands | 167 | 178 | 156 | ||||||
Other European countries | 993 | 1,057 | 448 | ||||||
United States of America | 468 | 594 | 556 | ||||||
Southeast Asia | 15,716 | 15,300 | 5,050 | ||||||
Japan | 181 | 203 | 181 | ||||||
17,525 | 17,332 | 6,391 | |||||||
The average number of employees for the year 2013 includes the weighted average of the ASMPT employees for the period January 1 - March 15. |
Earnings_per_share
Earnings per share | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Earnings per share | ' | ||||||||
Earnings per share | |||||||||
Basic net earnings per common share is computed by dividing net earnings by the weighted average ordinary shares outstanding for that period. Diluted net earnings per ordinary share reflects the potential dilution that could occur if stock options under the ASMI Option Plan were exercised and if convertible notes were converted, unless potential dilution would have an anti-dilutive effect. | |||||||||
The following represents a reconciliation of net earnings and weighted average number of shares outstanding (in thousands) for purposes of calculating basic and diluted net earnings per share: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Net earnings used for purpose of computing basic earnings per common share | 186,770 | 7,149 | 1,049,300 | ||||||
After-tax equivalent of interest expense on convertible subordinated notes | 17,670 | — | — | ||||||
Net earnings used for purposes of computing diluted net earnings per common share | 204,440 | 7,149 | 1,049,300 | ||||||
Basic weighted average number of shares outstanding during the year used for purpose of computing basic earnings per share (thousands) | 55,210 | 56,108 | 63,202 | ||||||
Dilutive effect of stock options | 570 | 659 | 994 | ||||||
Dilutive effect of convertible subordinated notes | 8,902 | — | — | ||||||
Dilutive weighted average number of shares outstanding | 64,682 | 56,767 | 64,196 | ||||||
Net earnings per share: | |||||||||
Basic net earnings from continuing operations | 3.38 | 0.13 | 16.6 | ||||||
Diluted net earnings from continuing operations | 3.16 | 0.13 | 16.35 | ||||||
For the year ended December 31, 2012, the effect of 8,231,432 conversion rights was anti-dilutive. | |||||||||
For the year ended December 31, 2011, 81,500 option rights were not in the money and therefore not implicated in the dilutive effect of stock options. | |||||||||
During 2008, ASMI engaged Lehman Brothers (“Lehman”). to repurchase ordinary ASMI shares on the Euronext and Nasdaq markets on behalf of ASMI. As of September 15, 2008, at the time it went into bankruptcy administration, Lehman reported that it had purchased and held on our behalf 2,552,071 shares, which were accounted for as treasury shares accordingly. ASMI filed a submission with the Lehman administrators giving notice of the shares held in custody by Lehman. At ASMI’s May 2009 Annual General Meeting, our shareholders resolved to cancel all of these treasury shares which, accordingly, was accounted for in our 2009 Annual Report as a reduction of the number of outstanding shares. Lehman was notified of the cancellation of shares at the time. | |||||||||
The Lehman administrators have cooperated to effect the cancellation of 2,305,069 shares through the relevant book entry systems and have agreed to cooperate similarly with respect to 25,643 shares which are currently held by a Lehman affiliate in the Unites States. This leaves 221,359 shares unaccounted for which is in line with the notification received from the Lehman administrator's in September 2010 that a shortfall in the number of shares held for the Company's account in this order of magnitude was likely to exist. | |||||||||
Under the terms of a settlement agreement with the Lehman administrators entered into in 2013 the Company has received a compensation in cash of US$6,251 and will receive a further €273,062 in compensation of dividends paid on the unaccounted shares. | |||||||||
Depending on the outcome of the Lehman bankruptcy the Company may receive further payments since the amounts received to date represent 92.2% of the principal of the Company's claims for compensation. In addition the Company is entitled to the payment of interest over the principal of its claims. | |||||||||
The 221,359 shares unaccounted for by the Lehman administrators are and remain outstanding and have not been canceled by the resolution adopted by the AGM in 2009. As a result of the settlement agreement the Company recorded €4,190 as paid in capital to account for the compensation received. |
Board_remuneration
Board remuneration | 12 Months Ended | ||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||
Board Remuneration [Abstract] | ' | ||||||||||||||||||||||
Board remuneration | ' | ||||||||||||||||||||||
Board remuneration | |||||||||||||||||||||||
The remuneration of members of the Management Board has been determined by the Supervisory Board. | |||||||||||||||||||||||
During 2013, the Company considered the members of the Management Board and the Supervisory Board to be the key management personnel. | |||||||||||||||||||||||
The following table sets forth as to all current and former members of the Management Board of the Company, information concerning all remuneration from the Company (including its subsidiaries) for services in all capacities: | |||||||||||||||||||||||
Base | Bonuses | Pensions | Share based payment expenses -1- | Other | Total | ||||||||||||||||||
compensation | |||||||||||||||||||||||
Management Board: | |||||||||||||||||||||||
C.D. del Prado | |||||||||||||||||||||||
2013 2) | 520 | 527 | 92 | 506 | 60 | 1,705 | |||||||||||||||||
2012 2) | 510 | 177 | 76 | 398 | 59 | 1,220 | |||||||||||||||||
2011 | 500 | 339 | 69 | 182 | 56 | 1,146 | |||||||||||||||||
P.A.M. van Bommel | |||||||||||||||||||||||
2013 2) | 375 | 391 | 79 | 418 | 45 | 1,308 | |||||||||||||||||
2012 2) | 367 | 144 | 88 | 325 | 59 | 983 | |||||||||||||||||
2011 | 360 | 233 | 54 | 141 | 46 | 834 | |||||||||||||||||
1. | These amounts represent the vesting expenses related to the financial year. | ||||||||||||||||||||||
2. | A one-time crisis levy of 16% as imposed by the Dutch government amounts to €145 (2012: €175 ) in total. This crisis tax levy is payable by the employer and is charged over income of employees exceeding a €150 threshold for both years. These expenses do not form part of the remuneration costs mentioned. | ||||||||||||||||||||||
Bonus | |||||||||||||||||||||||
Each year, a variable cash incentive can be earned, based on achievement of specific challenging targets. These targets are for 75% based on company financial targets and for 25% based on non-financial targets. The on-target bonus percentage for the members of the Management Board is 75%, with a maximum pay-out of 125% of base salary. | |||||||||||||||||||||||
Stock options | |||||||||||||||||||||||
The members of the Management Board are eligible to receive stock options under the ASM International NV 2011 Stock Option Plan for members of the Management Board (“plan”) in order to focus on the long term interest of the company. Stock options vest in three years subject to continued employment and expire after seven years. | |||||||||||||||||||||||
Pension benefit | |||||||||||||||||||||||
The members of the Management Board are offered participation of the pension plan of the industry wide pension fund (“Bedrijfstakpensioenfonds Metalektro”) for the base salary up to the predetermined ceiling. For the base salary above the ceiling, the members of the Management Board are offered participation of a defined contribution plan, insured by Nationale Nederlanden. | |||||||||||||||||||||||
Other compensation | |||||||||||||||||||||||
Other compensation is covering compensation relative to use of a (company) car, a representation and expense allowance, social security premium and premium for health and disability insurance. | |||||||||||||||||||||||
The following table shows the outstanding options to purchase ASM International NV common shares held by members of the Management Board, and changes in such holdings during 2013: | |||||||||||||||||||||||
Year | Outstanding January 1, 2013 | Granted | Exercised | Adjustments following the capital distribution -6- | Outstanding December 31, 2013 | Exercise | End date | ||||||||||||||||
of | in 2013 | in 2013 -7- | price | ||||||||||||||||||||
grant | |||||||||||||||||||||||
C.D. del Prado 1,5 | 2003 | 20,000 | — | (20,000 | ) | — | — | US$ | 11.35 | Feb 1, 2013 | |||||||||||||
C.D. del Prado 2 | 2007 | 19,645 | — | — | 3,523 | 23,168 | € | 16.51 | May 23, 2015 | ||||||||||||||
C.D. del Prado 2 | 2008 | 125,000 | — | — | 22,416 | 147,416 | € | 10.78 | Mar 31, 2016 | ||||||||||||||
C.D. del Prado 3 | 2009 | 50,000 | — | — | 8,967 | 58,967 | € | 12.79 | Dec 31, 2017 | ||||||||||||||
C.D. del Prado 4 | 2011 | 75,000 | — | — | 13,450 | 88,450 | € | 18.93 | Dec 31, 2018 | ||||||||||||||
C.D. del Prado 4 | 2012 | 60,000 | — | 10,760 | 70,760 | € | 22.93 | Dec 31, 2019 | |||||||||||||||
C.D. del Prado 4 | 2013 | — | 75,000 | — | 75,000 | € | 23.73 | Dec 31, 2020 | |||||||||||||||
P.A.M. van Bommel 3 | 2010 | 25,000 | — | — | 4,483 | 29,483 | € | 13.8 | Jun 7, 2018 | ||||||||||||||
P.A.M. van Bommel 4 | 2011 | 53,000 | — | — | 9,504 | 62,504 | € | 18.93 | Dec 31, 2018 | ||||||||||||||
P.A.M. van Bommel 4 | 2012 | 40,000 | — | — | 7,173 | 47,173 | € | 22.93 | Dec 31, 2019 | ||||||||||||||
P.A.M. van Bommel 4 | 2013 | — | 53,000 | — | 53,000 | € | 23.73 | Dec 31, 2020 | |||||||||||||||
467,645 | 128,000 | (20,000 | ) | 80,276 | 655,921 | ||||||||||||||||||
1 | These options are granted for a term of ten years, and became exercisable in equal parts over a five year period. | ||||||||||||||||||||||
2 | These options are conditional. A percentage, not exceeding 150%, of the options which have been granted conditionally will become unconditional after three years, based on the total return of the Company's shares for the three years after the options are granted compared to the average total return of the shares of a relevant number of companies which are similar to the Company during the same three-year period. The options are granted for a term of eight years | ||||||||||||||||||||||
3 | These options are granted for a term of eight years and become exercisable after a three years vesting period. | ||||||||||||||||||||||
4 | These options are granted for a term of seven years and become exercisable after a three years vesting period. | ||||||||||||||||||||||
5 | These options have been exercised on January 25, 2013 at a share price of €29.04. | ||||||||||||||||||||||
6 | Following the sale of a 12% share of ASMPT, a capital distribution of €4.25 per common share was effectuated on July 25, 2013. As a result of this capital distribution the underlying value of ASMI option holders was diluted. The Management Board of ASMI and the Supervisory Board of ASMI decided to apply a theoretical adjustment ratio of 0.84974 to the outstanding options granted to employees including members of the Management Board as determined based on the specific rules issued and applied by NYSE Liffe. These specific rules issued by NYSE Liffe are similar to the adjustment ratio as applied to traded securities that are also not entitled to receive the capital distribution. Under these rules a theoretical adjustment ratio was determined based on the value and the effective date of the capital distribution and this ratio was applied to adjust the original number of the options and the original exercise price of the outstanding options. | ||||||||||||||||||||||
7 | These options were exercised in January 2013 at a share price of US$38.87. | ||||||||||||||||||||||
The fair value per option of options granted to current and former members of the Management Board was €10.43 in 2011, €12.27 in 2012 and €10.22 in 2013. | |||||||||||||||||||||||
In 2013, 20,000 options to purchase ASM International NV common shares were exercised and as a result 20,000 new shares were issued for the exercise of these options. | |||||||||||||||||||||||
The following table sets forth as to all current and former members of the Supervisory Board of the Company information concerning all remuneration (base compensation, no bonuses or pensions were paid) from the Company (including its subsidiaries) for services in all capacities: | |||||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||||
Supervisory Board: | |||||||||||||||||||||||
J.C. Lobbezoo | 53 | 53 | 61 | ||||||||||||||||||||
G.J. Kramer -1- | 68 | 68 | 25 | ||||||||||||||||||||
J.M.R. Danneels | 50 | 50 | 50 | ||||||||||||||||||||
H.W. Kreutzer | 50 | 50 | 51 | ||||||||||||||||||||
M.C.J. van Pernis | 50 | 50 | 51 | ||||||||||||||||||||
U.H.R. Schumacher | 50 | 50 | 50 | ||||||||||||||||||||
321 | 321 | 288 | |||||||||||||||||||||
1) Mr Kramer resigned from the Supervisory Board on May 16, 2013. | |||||||||||||||||||||||
The remuneration of members of the Supervisory Board has been determined by the General Meeting of Shareholders. | |||||||||||||||||||||||
No stock options have been granted to members of the Supervisory Board. |
Share_ownership_and_related_pa
Share ownership and related party transactions | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Related Party Transactions [Abstract] | ' | |||||||||||
Share ownership and related party transactions | ' | |||||||||||
Share ownership and related party transactions | ||||||||||||
The ownership or controlling interest of outstanding common shares of ASM International NV by members of the Management Board and Supervisory Board or members of their immediate family are as follows: | ||||||||||||
31-Dec-12 | 31-Dec-13 | |||||||||||
Shares | Percentage of | Shares | Percentage of | |||||||||
owned | Common shares | owned | Common shares | |||||||||
outstanding | outstanding | |||||||||||
A.H. del Prado | 9,204,284 | 14.59 | % | 9,204,284 | 14.5 | % | ||||||
C.D. del Prado (member of the Management Board) | 132,945 | 0.21 | % | 132,945 | 0.21 | % | ||||||
Stichting Administratiekantoor ASMI | 2,142,039 | 3.39 | % | 2,142,039 | 3.37 | % | ||||||
Stichting Administratiekantoor ASMI is a trust controlled by Mr A.H. del Prado. The number of shares owned by Stichting Administratiekantoor ASMI includes 713,000 common shares which are beneficially owned by Mr C.D. del Prado. | ||||||||||||
The Company has a related party relationship with its subsidiaries, equity accounted investees and members of the Supervisory Board and the Management Board. Related party transactions are conducted on an at arm’s length basis with terms comparable to transactions with third parties. For transactions with the Supervisory Board and the Management Board see note 29 “Board Remuneration”. | ||||||||||||
The Group has no significant transactions or outstanding balances with its equity-accounted investees other than its equity-interest holdings. |
General_information_Summary_of1
General information / Summary of significant accounting policies (Policy) | 12 Months Ended | |
Dec. 31, 2013 | ||
Accounting Policies [Abstract] | ' | |
Basis Of Preparation | ' | |
Basis of preparation | ||
The Company follows accounting principles generally accepted in the United States of America (“US GAAP”) and applies the going concern basis in preparing its consolidated financial statements. Historical cost is used as the measurement basis unless otherwise indicated. | ||
The accompanying consolidated financial statements are stated in euro thousand (“EUR”) unless indicated otherwise. Amounts in these financial statements are rounded to the nearest thousand euro; therefore amounts may not equal (sub) totals due to rounding. | ||
Use Of Estimates | ' | |
Use of estimates | ||
The preparation of financial statements in conformity with US GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, ASMI evaluates its estimates. ASMI bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. | ||
Consolidation | ' | |
Consolidation | ||
The consolidated financial statements include the accounts of ASMI NV and all of its subsidiaries where ASMI holds a controlling interest. The non-controlling interest is disclosed separately in the consolidated financial statements. All intercompany profits, transactions and balances have been eliminated in consolidation. | ||
Subsidiaries are all entities over which ASMI has the power to govern the financial and operating policies. | ||
Subsidiaries are fully consolidated from the date on which control is transferred to ASMI and are deconsolidated from the date on which ASMI's control ceases. | ||
Loss of Control | ' | |
Loss of control | ||
Upon the loss of control, ASMI derecognizes the assets and liabilities of the subsidiary, any non-controlling interests and the other components of equity related to the subsidiary. Any surplus or deficit arising on the loss of control is recognized in profit or loss. If ASMI retains any interest in the previous subsidiary, then such interest is measured at fair value at the date that control is lost. Subsequently it is accounted for as an equity-accounted investee or as an available-for-sale financial asset depending on the level of influence retained. | ||
Segment Reporting | ' | |
Segment reporting | ||
The Company organizes its activities in two operating segments, Front-end and Back-end. Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Executive Officer (“CEO”), which is the chief operating decision maker (according to ASC 280). | ||
The Back-end segment remains reported as a separate segment since the cease of control per March 15, 2013. Since that date the segment is reported as an equity method investment as the CEO reviews this information as part of his CODM package. | ||
Accordingly, the asset and profit/loss information regarding the operations that comprise the segment are disclosed. The full financial results are reviewed by the CODM, the external reporting of the segment are on an equity method investment basis. The total of all segments' financial amounts are reconciled to the corresponding amounts reported in the consolidated financial statements, eliminations are reflected in the reconciling column for amounts reported in excess of those amounts reflected in the consolidated financial statements. | ||
The Front-end segment manufactures and sells equipment used in wafer processing, encompassing the fabrication steps in which silicon wafers are layered with semiconductor devices. The segment is a product driven organizational unit comprised of manufacturing, service, and sales operations in Europe, the United States of America, Japan and South East Asia. | ||
The Back-end segment manufactures and sells equipment and materials used in assembly and packaging, encompassing the processes in which silicon wafers are separated into individual circuits and subsequently assembled, packaged and tested. In January 2011 ASM Pacific Technology Ltd ("ASMPT") acquired the surface-mount technology from Siemens. The segment is organized in ASM Pacific Technology Ltd, in which the Company holds a 39.94% interest, whilst the remaining shares are listed on the Stock Exchange of Hong Kong. | ||
Foreign Currency Translation | ' | |
Foreign currency translation | ||
Items included in the financial statements of each ASMI’s entities are measured using the currency of the primary economic environment in which the entity operates (the functional currency). The consolidated financial information is presented in euro (EUR), which is the functional currency of the Company and the group’s presentation currency. | ||
In the preparation of ASMI’s consolidated financial statements, assets and liabilities of foreign subsidiaries of which the functional currency is not the euro, are translated into euros at the exchange rate in effect on the respective balance sheet dates. Income and expenses are translated into euros based on the average exchange rates for the corresponding period. Resulting translation adjustments are directly recorded in shareholders’ equity. Currency differences on intercompany loans that have the nature of a long-term investment are also accounted for directly in shareholders’ equity. | ||
Derivative Financial Instruments | ' | |
Derivative financial instruments | ||
ASMI and its subsidiaries conduct business in a number of foreign countries, with certain transactions denominated in currencies other than the functional currency of the Company (euro) or one of its subsidiaries conducting the business. The purpose of the Company’s foreign currency management is to manage the effect of exchange rate fluctuations on income, expenses, cash flows and assets and liabilities denominated in selected foreign currencies, in particular denominated in US dollar. | ||
The Company may use forward exchange contracts to hedge its foreign exchange risk of anticipated sales or purchase transactions in the normal course of business, which occur within the next twelve months, for which the Company has a firm commitment from a customer or to a supplier. The terms of these contracts are consistent with the timing of the transactions being hedged. The hedges related to forecasted transactions are designated and documented at the inception of the hedge as cash flow hedges, and are evaluated for effectiveness quarterly. The effective portion of the gain or loss on these hedges is reported as a component of accumulated other comprehensive income (loss) net of taxes in shareholders’ equity, and is reclassified into earnings when the hedged transaction affects earnings. | ||
Changes in the fair value of derivatives that do not qualify for hedge treatment, as well as the ineffective portion of any hedges, are recognized in earnings. The Company records all derivatives, including forward exchange contracts, on the balance sheet at fair value in other current assets or accrued expenses and other. | ||
Substantially all amounts, which are net of taxes, included in accumulated other comprehensive loss at December 31, of any year, will be reclassified to net earnings within the next twelve months, upon completion of the underlying transactions. If the underlying transaction being hedged fails to occur, or if a portion of any derivative is ineffective, the gain or loss is immediately recognized in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. | ||
Furthermore, the Company might manage the currency exposure of certain receivables and payables using derivative instruments, such as forward exchange contracts (fair value hedges) and currency swaps, and non-derivative instruments, such as debt borrowings in foreign currencies. The gains or losses on these instruments provide an offset to the gains or losses recorded on receivables and payables denominated in foreign currencies. The derivative instruments are recorded at fair value and changes in fair value are recorded in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. Receivables and payables denominated in foreign currencies are recorded at the exchange rate at the balance sheet date and gains and losses as a result of changes in exchange rates are recorded in earnings under foreign currency exchange gains (losses) in the consolidated statement of operations. | ||
The Company does not use forward exchange contracts for trading or speculative purposes. | ||
Cash And Cash Equivalents | ' | |
Cash and cash equivalents | ||
Cash and cash equivalents comprise deposits held at call with banks and other short-term highly liquid investments with original maturity of three months or less. Bank overdrafts are included in notes payable to banks in current liabilities. | ||
Accounts Receivable | ' | |
Accounts receivable | ||
Accounts receivable are stated at nominal value less an allowance for doubtful accounts. | ||
A significant percentage of our accounts receivable is derived from sales to a limited number of large multinational semiconductor device manufacturers located throughout the world. In order to monitor potential credit losses, we perform ongoing credit evaluations of our customers’ financial condition. An allowance for doubtful accounts is maintained for potential credit losses based upon management’s assessment of the expected collectability of all accounts receivable. The allowance for doubtful accounts receivable is reviewed periodically to assess the adequacy of the allowance. In making this assessment, management takes into consideration any circumstances of which we are aware regarding a customer’s inability to meet its financial obligations; and our judgments as to potential prevailing economic conditions in the industry and their potential impact on the Company’s customers. | ||
Inventories | ' | |
Inventories | ||
Inventories are stated at the lower of cost (first-in, first-out method) or market value. Costs include net prices paid for materials purchased, charges for freight and custom duties, production labor cost and factory overhead. Allowances are made for slow moving, obsolete or unsellable inventory. | ||
Allowances for obsolescence of inventory are determined based on the expected demand as well as the expected market value of the inventory. We regularly evaluate the value of our inventory of components and raw materials, work in progress and finished goods, based on a combination of factors including the following: forecasted sales, historical usage, product end of life cycle, estimated current and future market values, service inventory requirements and new product introductions, as well as other factors. Purchasing requirements and alternative uses for the inventory are explored within these processes to mitigate inventory exposure. We record write downs for inventory based on the above factors and take into account worldwide quantities and demand into our analysis. | ||
Evaluation Tools At Customers | ' | |
Evaluation tools at customers | ||
Evaluation tools at customers (“evaluation tools”) are systems generally delivered to customers under evaluation or a conditional purchase order and include substantial customization by ASMI engineers and ASMI R&D staff in the field. Evaluation tools are recorded at cost and depreciated over their useful life (5 years). The depreciation period may be shorter, depending on circumstances. The depreciation expenses are reported as Cost of sales. | ||
On final acceptance of the system the purchase consideration is recognized as revenue. The carrying value of the evaluation tool at that point in time is recognized as cost of sales. In the circumstance that the system is returned, at the end of the evaluation period, a detailed impairment review takes place, and future sales opportunities and additional costs are identified. Only when the fair value is below the carrying value of the evaluation tool an additional depreciation is recognized. The remaining carrying value is recognized as finished goods (inventory). | ||
Long-Lived Assets | ' | |
Long-lived assets | ||
Long-lived assets include goodwill, other intangible assets and property, plant and equipment. Property, plant and equipment are carried at cost, less accumulated depreciation and any accumulated impairment losses. Capital leased assets are recorded at the present value of future lease obligations. Depreciation is calculated using the straight-line method over the estimated useful lives. Leasehold improvements are depreciated over the lesser of the estimated useful life of the leasehold improvement or the term of the underlying lease. | ||
Business combinations are accounted for under the purchase acquisition method. The Company tests its recorded goodwill and other intangible assets with indefinite lives for impairment each year on December 31 and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. | ||
Goodwill is allocated to reporting units for purposes of impairment testing and tested for impairment on a two-step approach. The implied fair value of goodwill is determined. First the recoverability is tested by comparing the carrying amount of the goodwill with the fair value being the sum of the discounted future cash flows. If the carrying amount of the goodwill at reporting unit level is higher than the fair value of the goodwill, the second step should be performed. The goodwill impairment is measured as the excess of the carrying amount of the goodwill over its fair value. | ||
Other intangible assets with finite lives are amortized over the estimated useful lives using the straight-line method. | ||
Asset Held for Sale / Recoverability Of Long-Lived Assets | ' | |
Assets held for sale | ||
A long-lived asset to be sold is classified as held for sale in the period in which all of the following criteria are met: | ||
• | Management, having the authority to approve the action, commits to a plan to sell the asset; | |
• | The asset is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets; | |
• | An active program to locate a buyer and other actions required to complete the plan to sell the asset have been initiated; | |
• | The sale of the asset is probable, and transfer of the asset is expected to qualify for recognition as a completed sale, within one year; and | |
• | The asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value. | |
If at any time these criteria are no longer met a long-lived asset classified as held for sale will be reclassified as held and used. | ||
If during the initial one-year period, circumstances arise that previously were considered unlikely and, as a result, a long-lived asset previously classified as held for sale is not sold by the end of that period and all of the following conditions are met: | ||
◦ | During the initial one-year period the entity initiated actions necessary to respond to the change in circumstances; | |
◦ | The asset is being actively marketed at a price that is reasonable given the change in circumstances. | |
The period required to complete the sale of a long-lived asset may be extended beyond one year. | ||
If at any time the criteria for classification as held for sale are no longer met, the entity shall cease to classify the asset as held for sale. The entity shall measure a non-current asset that ceases to be classified as held for sale at the lower of: | ||
◦ | Its carrying amount before the asset was classified as held for sale, adjusted for any depreciation that would have been recognized had the asset not been classified as held for sale; and | |
◦ | Its recoverable amount at the date of the subsequent decision not to sell. | |
A long-lived asset classified as held for sale shall be presented separately in the statement of financial position. | ||
Recoverability of long-lived assets | ||
Long-lived assets (except those not being amortized) to be held and used by the Company are reviewed by the Company for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In performing the review for recoverability, the Company estimates the future undiscounted cash flows expected to result from the use of the asset. If the undiscounted future cash flow is less than the carrying amount of the asset, the asset is deemed impaired. The amount of the impairment is measured as the difference between the carrying value and the fair value of the asset. Long-lived assets and other intangibles (except those not being amortized) to be disposed of are reported at the lower of carrying amount or fair value less cost to sell. | ||
Business Combinations | ' | |
Business combinations | ||
ASC Topic 805 (“Business Combinations”) requires that companies record acquisitions under the purchase method of accounting. Accordingly, the purchase price is allocated to the tangible assets and liabilities and intangible assets acquired, based on their estimated fair values. The excess purchase price over the fair value is recorded as goodwill. Purchased intangibles with definite lives are amortized over their respective useful lives. When a bargain purchase incurs, which is the case when the fair value of the acquired business exceeds the purchase price, this surplus in fair value is recognized as a gain from bargain purchase. | ||
Investments and Associated Companies | ' | |
Investments and Associated companies | ||
Investments in subsidiaries and associated companies are accounted for under the equity method on a go forward basis. Dividend income from the Company’s subsidiaries and associated companies is recognized when the right to receive payment is established. | ||
Impairment of Investments and Associated companies | ||
ASMI does not separately test an investments underlying assets for impairment. However, ASMI recognizes its share of any impairment charge recorded by an investee and consider the effect, if any, of the impairment on the basis difference in the assets giving rise to the investee’s impairment charge. | ||
The ASMPT investment is accounted for under the equity method on a go forward basis. Equity method investments are tested for other than temporary impairment (“OTTI”). An investment is considered impaired if the fair value of the investment is less than its amortized cost. The determination of whether an investment is impaired is made at the individual security level in each reporting period. | ||
If the fair value of an investment is less than its cost or amortized cost at the balance sheet date, the Company determines whether the impairment is temporary or other than temporary. The Company considers the following facts and guidelines when determining whether an OTTI exists: | ||
• | Positive factors as the reasons that an OTTI does not exist must be more objectively verifiable; | |
• | With respect to measuring an OTTI, an investment's fair value as of the balance sheet date should be used to determine the new carrying value. | |
An OTTI is measured as of a balance sheet reporting date. | ||
Summarized below is a discussion of various factors (positive, negative, and otherwise) the Company considers when assessing the potential impairment of equity securities. | ||
Positive Evidence | ||
If an investment’s fair value declines below cost the Company determines whether there is adequate evidence to overcome the presumption that the decline is other-than-temporary. Such evidence may include: | ||
• | Recoveries in fair value subsequent to the balance sheet date; | |
• | The investee's financial performance and near-term prospects (as indicated by factors such as earnings trends, dividend payments, asset quality, volatility, and specific events); and | |
• | The financial condition and prospects for the investee's geographic region and industry. | |
Negative Evidence | ||
The positive factors are weighed against any negative evidence that is gathered about the security. Some of those factors and circumstances are as follows: | ||
• | A prolonged period during which the fair value of the security remains at a level substantially below cost; | |
• | The investee's deteriorating financial condition and a decrease in the quality of the investee's assets, without positive near-term; | |
• | The investee's level of earnings or the quality of its assets is below that of the investee's peers; | |
• | Severe losses sustained by the investee in the current year or in both current and prior years; | |
• | A reduction or cessation in the investee's dividend payments; | |
• | A change in the economic or technological environment in which the investee operates that is expected to adversely affect the investee's ability to achieve profitability in its operations; | |
• | Suspension of trading in the security; | |
• | A qualification in the accountant's report on the investee because of the investee's liquidity or due to problems that jeopardize the investee's ability to continue as a going concern; | |
• | The investee's announcement of adverse changes or events, such as changes in senior management, salary reductions and/or freezes, elimination of positions, sale of assets, or problems with equity investments; | |
• | Adverse conditions specifically related to the security, an industry, or a geographic area (for example, changes in the financial condition of the issuer of the security (or in the case of an asset backed debt security, in the financial condition of the underlying loan obligor), including changes in technology or the discontinuance of a segment of the business that may affect the future earnings potential of the issuer (or underlying loan obligor) of the security); | |
• | A downgrading of the investee's debt rating; | |
• | Factors, such as an order or action by a regulator, that (1) require an investee to (a) reduce or scale back operations or (b) dispose of significant assets or (2) impair the investee's ability to recover the carrying amount of assets; | |
• | Unusual changes in reserves (such as loan losses, product liability, or litigation reserves), or inventory write-downs due to changes in market conditions for products; | |
• | The investee loses a principal customer or supplier; and | |
• | Other factors that raise doubt about the investee's ability to continue as a going concern, such as negative cash flows from operations, working-capital deficiencies, or noncompliance with statutory capital requirements. | |
Revenue Recognition | ' | |
Revenue recognition | ||
The Company recognizes revenue when all four revenue recognition criteria have been met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to buyer is fixed or determinable; and collectability is reasonably assured. | ||
Our Front-end sales frequently involve sales of complex equipment, which may include customer-specific criteria, sales to new customers or sales of equipment with new technology. For each sale, the decision whether to recognize revenue is, in addition to shipment and factory acceptance, based on: the contractual agreement with a customer; the experience with a particular customer; the technology and the number of similarly configured equipment previously delivered. Based on these criteria we may decide to defer revenue until completion of installation at the customer’s site and obtaining final acceptance from the customer. | ||
A major portion of our revenue is derived from contractual arrangements with customers that have multiple deliverables, such as equipment and installation. When a sales arrangement contains multiple elements, such as equipment and installation, ASMI allocates revenue to each element based on a selling price hierarchy. The selling price for a deliverable is based on its vendor specific objective evidence (VSOE) if available, third party evidence (TPE) if VSOE is not available, or best estimated selling price (BESP) if neither VSOE nor TPE is available. ASMI generally utilizes the BESP due to the nature of our products. The total arrangement consideration is allocated at inception of the arrangement to all deliverables on the basis of their relative selling price. The revenue relating to the undelivered elements of the arrangements is deferred at their relative selling prices until delivery of these elements. At December 31, 2011, December 31, 2012 and December 31, 2013 we have deferred revenues from installations in the amount of €6.3 million, €3.5 million and €3.9 million respectively. | ||
In general, we recognize revenue from sales of equipment upon transfer of title, which is upon shipment of the equipment, only if testing at the factory has proved that the equipment has met substantially all of the customer’s criteria and specifications. | ||
The Company recognizes revenue from installation of equipment upon completion of installation at the customer’s site. At the time of shipment, the Company defers that portion of the sales price related to the relative selling price of installation. The relative selling price of the installation process is measured based upon the per-hour amounts charged to clients parties for similar installation services. Installation is completed when testing at the customer’s site proved that the equipment has met all of the customer’s criteria and specifications. The completion of installation is signed-off by the customer (“final acceptance”). | ||
We provide training and technical support service to customers. Revenue related to such services is recognized when the service is rendered. Revenue from the sale of spare parts and materials is recognized when transfer of title took place, in general upon shipment of the goods. Freight charges billed to customers are recognized as revenue, the related costs are recognized as cost of sales. Revenues are recognized excluding the taxes levied on revenues. | ||
Cost Of Sales | ' | |
Cost of sales | ||
Cost of sales comprise direct costs such as labor, materials, cost of warranty, depreciation, shipping and handling costs and related overhead costs. Cost of sales also includes third party commission, depreciation expenses of evaluation tools at customers, royalty payments and costs relating to prototype and experimental products, which the Company may subsequently sell to customers. Costs of warranty include the cost of labor, material and related overhead necessary to repair a product during the warranty period. | ||
Warranty | ' | |
Warranty | ||
We provide maintenance on our systems during the warranty period, usually one to two years. Costs of warranty include the cost of labor, material and related overhead necessary to repair a product during the warranty period. We accrue for the estimated cost of the warranty on products shipped in a provision for warranty, upon recognition of the sale of the product. The costs are estimated based on actual historical expenses incurred and on estimated future expenses related to current sales, and are updated periodically. | ||
Research And Development Costs | ' | |
Research and development costs | ||
Research and development costs are expensed as incurred. Costs, which relate to prototype and experimental models and are sold to customers, are charged to cost of sales. Subsidies and other governmental credits to cover research and development costs relating to approved projects are recorded as research and development credits in the period when such project costs occur. The research and development expenses are presented net of the development credits. | ||
Share-Based Compensation Expenses | ' | |
Share-based compensation expenses | ||
The cost relating to employee stock options (compensation expense) are recognized based upon the grant date fair value of the stock options. The fair value at grant date is estimated using a Black-Scholes option valuation model. This model requires the use of assumptions including expected stock price volatility, the estimated life of each award and the estimated dividend yield. | ||
The grant date fair value of the stock options is expensed on a straight-line basis over the vesting period, based on the Company’s estimate of stock options that will eventually vest. The impact of the true up of the estimates is recognized in the consolidated statement of operations in the period in which the revision is determined. | ||
Restructuring Costs | ' | |
Restructuring costs | ||
Restructuring expenses are recognized for exit or disposal activities when the liability arising from restructuring plans is incurred. Reference is made to Note 24. Distinction is made in one-time employee termination expenses, contract termination expenses and other associated expenses. For the accounting on the distinguished elements of restructuring expenses we apply to the policy as mentioned below. The expenses have been charged to “restructuring expenses”. | ||
One-time termination expenses represent the payments provided to employees that have become redundant and are terminated under the terms and conditions of a restructuring plan. A restructuring plan exists at the date the plan meets all of the following criteria and has been communicated to employees: | ||
• | Management commits to the plan; | |
• | The plan identifies the number of employees that become redundant and the expected completion date; | |
• | The plan sets out the terms and conditions of the arrangement in sufficient detail to enable employees to determine the type and amount of benefits they will receive; and | |
• | Actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. | |
The timing of the recognition and measurement of a liability for one-time termination expenses depends on whether employees will be retained to render service beyond a minimum retention period. | ||
Contract termination expenses are related to the termination of an operating lease or another contract. These expenses are distinguished in: | ||
• | Expenses related to the termination of the contract before the end of its term. These expenses are recognized when the contract is terminated .The liability is measured at its fair value in accordance with the contract terms; and | |
• | Expenses related to contracts that will last for its remaining term without economic benefit to the entity. This is the case when a lease contract for premises is not terminated while the premises are not (completely) in use anymore. The liability is accrued for at the cease-use date, the date the company determined that it would no longer occupy the premises, which is conveyed to it under the contractual operating lease. The liability is measured at its fair value in accordance with the contract terms. | |
Other costs related to restructuring include costs to consolidate or close facilities and relocate employees. A liability for other expenses related to a restructuring such as transition costs is recognized and measured in the period in which the liability is incurred. The costs incurred are directly related to the restructuring activity. The definition of exit costs excludes expected future operating losses. | ||
Income Taxes | ' | |
Income taxes | ||
The Company recognizes deferred tax assets and liabilities for the estimated future tax consequences of events attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using currently enacted tax rates. The effect on deferred tax assets and liabilities of changes in tax rates is recognized in the Consolidated Statement of Operations in the period in which the enacted rate changes. Deferred tax assets are reduced through a valuation allowance at such time as, based on available evidence, it is more likely than not that the deferred tax assets will not be realized. | ||
ASC 740 prescribes a two-step approach for recognizing and measuring tax positions taken or expected to be taken in a tax return. Prior to recognizing the benefit of a tax position in the financial statements, the tax position must be more-likely-than-not of being sustained based solely on its technical merits. Once this recognition threshold has been met, tax positions are recognized at the largest amount that is more-likely-than-not to be sustained. ASC 740 also provides guidance on derecognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. | ||
Pension Plans And Similar Commitments | ' | |
Pension plans and similar commitments | ||
The Company has retirement plans covering substantially all employees. The principal plans are defined contribution plans, except for the plans of the Company’s operations in the Netherlands and Japan. The Company’s employees in the Netherlands participate in a multi-employer plan. Payment to defined contribution plans and the multi-employer plan are recognized as an expense in the Consolidated Statement of Operations as they fall due. | ||
The Company’s employees in Japan participate in a defined benefit plan. Pension costs in respect of these defined benefit plans are determined using the projected unit credit method. These costs primarily represent the increase in the actuarial present value of the obligation for pension benefits based on employee service during the year and the interest on this obligation in respect of employee service in previous years, net of the expected return on plan assets. Obligations for retirement benefit and related net periodic pension costs are determined in accordance with actuarial valuations. These valuations rely on key assumptions including discount rates, expected return on plan assets, expected salary increases, mortality rates and health care trend rates. The discount rate assumptions are determined by reference to yields on high-quality corporate bonds of appropriate duration and currency at the end of the reporting period. In case such yields are not available, discount rates are based on government bonds yields. The expected returns on plan asset assumptions are determined on a uniform methodology, considering long-term historical returns and asset allocations. Due to changing market and economic conditions, the underlying key assumptions may differ from actual development and may lead to significant changes in retirement benefit obligations. | ||
In accordance with ASC 715, “Employers’ Accounting for Defined Benefit Pension and Other Post-retirement Plans" the Company recognizes in its Consolidated Balance Sheet an asset or a liability for the plan’s overfunded status or underfunded status respectively. The unfunded status is recognized as a liability. Actuarial gains and losses are recognized in other comprehensive income when incurred. | ||
Commitments And Contingencies | ' | |
Commitments and contingencies | ||
The Company has various contractual obligations, some of which are required to be recorded as liabilities in the Company’s consolidated financial statements, including long- and short-term debt. Others, namely operating lease commitments, purchase commitments and commitments for capital expenditure, are generally not required to be recognized as liabilities on the Company’s balance sheet but are required to be disclosed. | ||
Comprehensive Income | ' | |
Comprehensive income | ||
Comprehensive income consists of net earnings (loss) and other comprehensive income. Other comprehensive income includes gains and losses that are not included in net earnings, but are recorded directly in Shareholders’ Equity. | ||
New Accounting Pronouncements | ' | |
New accounting pronouncements | ||
In December 2011, the FASB issued ASU 2011-11: ASC 350, "Disclosures about Offsetting Assets and Liabilities". The new guidance was effective for ASMI in 2013, but did not impact on the Company's disclosure. | ||
In July 2012, the FASB issued ASU 2012-02: ASC 350,"Testing Indefinite-Lived Intangible Assets for Impairment". The new guidance was effective for ASMI in 2013. The implementation of this authoritative guidance did not impact ASMI's financial position or results. | ||
In January 2013, the FASB issued ASU 2013-01: ASC 210, "Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities". The new guidance was effective for ASMI in 2013, but did not impact on the Company's disclosure. | ||
In February 2013, the FASB issued ASU 2013-02: ASC 220, "Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income". The amendments do not change the current requirements for reporting net income or other comprehensive income in financial statements. However, the amendments require an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income but only if the amount reclassified is required under US GAAP to be reclassified to net income in its entirety in the same reporting period. The new guidance was effective for ASMI in 2013, and the disclosure is presented according to this guidance in Note 18. | ||
In February 2013, the FASB issued ASU 2013-04: ASC 405, "Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date". The new guidance will be effective for ASMI beginning January 1, 2014. We do not expect this new guidance to have material impact on our consolidated financial statements. | ||
In March 2013, the FASB issued ASU 2013-05: ASC 830, "Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity". The new guidance will be effective for ASMI beginning January 1, 2014. We applied this guidance in the financial year 2013. The cumulative translation adjustment was fully released following the sale of our 12% share in ASMPT, see Note 18. | ||
In July 2013, the FASB issued ASU 2013-11: ASC 740, "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists". This amendment should be applied prospectively to all unrecognized tax benefits that exist at the effective date. retrospective application is permitted. The Company The new guidance will be effective for ASMI beginning January 1, 2014. We do not expect this new guidance to have material impact on our consolidated financial statements. |
List_of_significant_subsidiari1
List of significant subsidiaries and associates (Tables) | 12 Months Ended | ||||||
Dec. 31, 2013 | |||||||
Segment Reporting [Abstract] | ' | ||||||
List of Significant Subsidiaries | ' | ||||||
% Ownership | |||||||
December 31, | |||||||
2012 | 2013 | ||||||
Subsidiaries (consolidated) | |||||||
ASM Europe BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM United Kingdom Sales BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Germany Sales BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Pacific Holding BV 1- 3 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM France SARL | Montpellier, France | 100 | % | 100 | % | ||
ASM Belgium NV | Leuven, Belgium | 100 | % | 100 | % | ||
ASM Italia Srl | Agrate, Italy | 100 | % | 100 | % | ||
ASM Microchemistry Oy | Helsinki, Finland | 100 | % | 100 | % | ||
ASM Services and Support Ireland Ltd | Dublin, Ireland | 100 | % | 100 | % | ||
ASM Services and Support Israel Ltd | Tel Aviv, Israel | 100 | % | 100 | % | ||
ASM America, Inc | Phoenix, Arizona, United States of America | 100 | % | 100 | % | ||
ASM Japan KK | Tokyo, Japan | 100 | % | 100 | % | ||
ASM Wafer Process Equipment Ltd | Quarry Bay, Hong Kong, People’s | 100 | % | 100 | % | ||
Republic of China | |||||||
ASM China Ltd | Shanghai, People’s Republic of China | 100 | % | 100 | % | ||
ASM Wafer Process Equipment Singapore Pte Ltd | Singapore | 100 | % | 100 | % | ||
ASM Front-End Sales & Services Taiwan Co, Ltd | Hsin-Chu, Taiwan | 100 | % | 100 | % | ||
ASM Services & Support Malaysia SDN BDH | Kuala Lumpur, Malaysia | 100 | % | 100 | % | ||
ASM Front-End Manufacturing Singapore Pte Ltd | Singapore | 100 | % | 100 | % | ||
ASM Genitech Korea Ltd | Cheonan, South Korea | 100 | % | 100 | % | ||
ASM IP Holding BV 1 | Almere, the Netherlands | 100 | % | 100 | % | ||
ASM Pacific Technology Ltd 2 | Kwai Chung, Hong Kong, People’s | 51.96 | % | n/a | |||
Republic of China | |||||||
Associates (non-consolidated) | |||||||
ASM Pacific Technology Ltd 2 | Kwai Chung, Hong Kong, People’s | n/a | 39.94 | % | |||
Republic of China | |||||||
1) | For these subsidiaries ASM International NV has filed statements at the Dutch Chamber of Commerce assuming joint and several liability in accordance with Article 403 of Book 2, Part 9 of the Netherlands Civil Code. | ||||||
2) | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. | ||||||
3) | Established in 2008, ASM Pacific Holding BV holds 39.94% of the shares in ASM Pacific Technology Ltd. |
Divestment_Tables
Divestment (Tables) | 12 Months Ended | ||
Dec. 31, 2013 | |||
Equity Method Investments and Joint Ventures [Abstract] | ' | ||
Reconciliation of Cash Proceeds from Disposition of Stock in Subsidiary | ' | ||
The table below reconciles the cash proceeds from the divested stake in ASMPT: | |||
Gross proceeds | 420,409 | ||
Paid fees, stamp duty and other expenses | (7,213 | ) | |
Net proceeds | 413,196 | ||
Currency translation differences | 1,232 | ||
Cash balance ASMPT upon sale | (116,174 | ) | |
Net cash on disposal ASMPT | 298,254 | ||
Equity Method Investments | ' | ||
Reporting ASMI share in net earnings of ASMPT in the consolidated statement of operations: | |||
Year ended December 31, 2013 | |||
Result investments and associates: | |||
ASMI share net earnings March 16 - December 31, 2013 | 23,727 | ||
Realized gain on sale 11.88% ASMPT shares | 242,838 | ||
Unrealized remeasurement gain on retained 40.08% ASMPT shares | 1,155,625 | ||
Impairment loss | (335,406 | ) | |
Amortization other intangible assets and fair value changes from PPA | (56,652 | ) | |
Reported on line result investments and associates | 1,030,132 | ||
Reporting of ASMI's share in associates in the consolidated balance sheet: | |||
31-Dec-13 | |||
Associates: | |||
ASMI share (39.94%) in equity value ASMPT | 264,384 | ||
Recognized other intangible assets and fair value changes from PPA | 188,985 | ||
Goodwill | 517,761 | ||
Total value investment in ASMPT | 971,130 | ||
Deferred value related to the use of the trade name "ASM" | (27,454 | ) | |
Total value reported on line investments and associates | 943,676 | ||
Summarized 100% earnings information for ASMPT equity method investment excluding basis adjustments: | |||
Year ended December 31, 2013 | |||
Net sales | 1,051,376 | ||
Income before income tax | 65,269 | ||
Net earnings | 53,244 | ||
Summarized 100% balance sheet information for ASMPT equity method investment excluding basis adjustments: | |||
31-Dec-13 | |||
Current assets | 749,924 | ||
Non-current assets | 254,525 | ||
Current liabilities | 308,922 | ||
Non-current liabilities | 33,287 | ||
Equity | 662,240 | ||
Accounts_receivable_Tables
Accounts receivable (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Accounts Receivable, Net, Current [Abstract] | ' | |||||
Schedule of Carrying Amount Of Accounts Receivable | ' | |||||
The carrying amount of accounts receivable is as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Current | 223,546 | 54,614 | ||||
Overdue <30 days | 38,666 | 18,787 | ||||
Overdue 31-60 days | 13,537 | 783 | ||||
Overdue 61-120 days | 13,954 | 2,527 | ||||
Overdue >120 days | 15,137 | 6,305 | ||||
Total | 304,840 | 83,016 | ||||
Schedule of Changes In Allowance For Doubtful Accounts Receivable | ' | |||||
The changes in the allowance for doubtful accounts receivable are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | (7,601 | ) | (8,551 | ) | ||
Deconsolidation ASMPT | — | 6,191 | ||||
Charged to selling, general and administrative expenses | (2,825 | ) | 756 | |||
Utilization | 1,841 | 1,469 | ||||
Foreign currency translation effect | 34 | 62 | ||||
Balance at end of year | (8,551 | ) | (73 | ) |
Inventories_Tables
Inventories (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Inventory Disclosure [Abstract] | ' | |||||
Schedule of Inventories | ' | |||||
Inventories consist of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Components and raw materials | 180,575 | 78,579 | ||||
Work in process | 196,313 | 31,442 | ||||
Finished goods | 91,799 | 20,073 | ||||
Total inventories, gross | 468,687 | 130,094 | ||||
Allowance for obsolescence | (65,287 | ) | (25,627 | ) | ||
Total inventories, net | 403,400 | 104,467 | ||||
Schedule of Changes In Allowance For Obsolescence | ' | |||||
The changes in the allowance for obsolescence and/or lower market value are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | (58,989 | ) | (65,287 | ) | ||
Deconsolidation ASMPT | — | 39,146 | ||||
Charged to cost of sales | (10,858 | ) | (8,648 | ) | ||
Utilization | 3,569 | 6,464 | ||||
Foreign currency translation effect | 991 | 2,698 | ||||
Balance at end of year | (65,287 | ) | (25,627 | ) |
Other_intangible_assets_Tables
Other intangible assets (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' | ||||||||
Schedule of Change In The Amount Of Intangible Assets | ' | ||||||||
The changes in the amount of other intangible assets are as follows: | |||||||||
Software | Purchased | Total | |||||||
technology | |||||||||
and other | |||||||||
intangible | |||||||||
assets | |||||||||
At cost: | |||||||||
Balance January 1, 2012 | 18,042 | 12,212 | 30,254 | ||||||
Additions | 2,447 | 2,183 | 4,630 | ||||||
Disposals | (10 | ) | — | (10 | ) | ||||
Foreign currency translation effect | (133 | ) | (2 | ) | (135 | ) | |||
Balance December 31, 2012 | 20,346 | 14,393 | 34,739 | ||||||
Deconsolidation ASMPT | (4,931 | ) | (7,215 | ) | (12,146 | ) | |||
Additions | 437 | 33 | 470 | ||||||
Disposals | (1 | ) | — | (1 | ) | ||||
Foreign currency translation effect | (248 | ) | (169 | ) | (417 | ) | |||
Balance December 31, 2013 | 15,603 | 7,042 | 22,645 | ||||||
Accumulated amortization: | |||||||||
Balance January 1, 2012 | 10,785 | 4,693 | 15,478 | ||||||
Amortization for the year | 2,784 | 2,634 | 5,418 | ||||||
Disposals | (10 | ) | — | (10 | ) | ||||
Foreign currency translation effect | (113 | ) | 51 | (62 | ) | ||||
Balance December 31, 2012 | 13,446 | 7,378 | 20,824 | ||||||
Deconsolidation ASMPT | (3,744 | ) | (3,895 | ) | (7,639 | ) | |||
Amortization for the year | 2,118 | 2,071 | 4,189 | ||||||
Disposals | (1 | ) | — | (1 | ) | ||||
Foreign currency translation effect | (211 | ) | (154 | ) | (365 | ) | |||
Balance December 31, 2013 | 11,608 | 5,400 | 17,008 | ||||||
Other intangible assets, net: | |||||||||
31-Dec-12 | 6,900 | 7,015 | 13,915 | ||||||
31-Dec-13 | 3,995 | 1,642 | 5,637 | ||||||
Schedule of Estimated Amortization Expenses | ' | ||||||||
Estimated amortization expenses relating to other intangible assets are as follows: | |||||||||
2014 | 1,819 | ||||||||
2015 | 1,255 | ||||||||
2016 | 1,224 | ||||||||
2017 | 547 | ||||||||
2018 | 528 | ||||||||
2019 | 264 | ||||||||
5,637 | |||||||||
Goodwill_Tables
Goodwill (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ||||||||
Schedule of Changes in the Carrying Amount of Goodwill | ' | ||||||||
The changes in the carrying amount of goodwill are as follows: | |||||||||
Front-end | Back-end | Total | |||||||
Balance January 1, 2012 | 11,193 | 40,938 | 52,131 | ||||||
Foreign currency translation effect | 456 | (699 | ) | (243 | ) | ||||
Balance December 31, 2012 | 11,649 | 40,239 | 51,888 | ||||||
Deconsolidation ASMPT | — | (38,482 | ) | (38,482 | ) | ||||
Foreign currency translation effect | (228 | ) | (1,757 | ) | (1,985 | ) | |||
Balance December 31, 2013 | 11,421 | — | 11,421 | ||||||
Schedule of Allocation of the Carrying Amount of Goodwill | ' | ||||||||
The allocation of the carrying amount of goodwill is as follows: | |||||||||
December 31, | |||||||||
2012 | 2013 | ||||||||
Front-end segment: | |||||||||
ASM Microchemistry Oy | 3,560 | 3,560 | |||||||
ASM Genitech Korea Ltd | 8,089 | 7,861 | |||||||
Back-end segment: | |||||||||
ASM Pacific Technology Ltd | 40,239 | — | |||||||
Total | 51,888 | 11,421 | |||||||
Property_plant_and_equipment_T
Property, plant and equipment (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Schedule of Changes in the Amount of Property, Plant And Equipment | ' | ||||||||
The changes in the amount of property, plant and equipment are as follows: | |||||||||
Land, | Machinery, | Total | |||||||
buildings and | equipment, | ||||||||
leasehold | furniture | ||||||||
improvements | and | ||||||||
fixtures | |||||||||
At cost: | |||||||||
Balance January 1, 2012 | 167,874 | 454,950 | 622,824 | ||||||
Capital expenditures | 23,355 | 44,807 | 68,162 | ||||||
Retirements and sales | (278 | ) | (10,253 | ) | (10,531 | ) | |||
Reclassification | 428 | (748 | ) | (320 | ) | ||||
Foreign currency translation effect | (3,499 | ) | (13,127 | ) | (16,626 | ) | |||
Balance December 31, 2012 | 187,880 | 475,629 | 663,509 | ||||||
Capital expenditures | 1,580 | 15,483 | 17,063 | ||||||
Deconsolidation ASMPT | (145,290 | ) | (322,398 | ) | (467,688 | ) | |||
Retirements and sales | (13,792 | ) | (10,966 | ) | (24,758 | ) | |||
Reclassification from held for sale | 3,393 | — | 3,393 | ||||||
Reclassification | — | (66 | ) | (66 | ) | ||||
Foreign currency translation effect | (4,824 | ) | (15,823 | ) | (20,647 | ) | |||
Balance December 31, 2013 | 28,947 | 141,859 | 170,806 | ||||||
Accumulated depreciation: | |||||||||
Balance January 1, 2012 | 77,096 | 285,548 | 362,644 | ||||||
Depreciation for the year | 12,420 | 35,282 | 47,702 | ||||||
Retirements and sales | (81 | ) | (9,558 | ) | (9,639 | ) | |||
Reclassification | 3 | (323 | ) | (320 | ) | ||||
Foreign currency translation effect | (2,061 | ) | (10,253 | ) | (12,314 | ) | |||
Balance December 31, 2012 | 87,377 | 300,696 | 388,073 | ||||||
Depreciation for the year | 4,502 | 15,545 | 20,047 | ||||||
Deconsolidation ASMPT | (64,699 | ) | (192,581 | ) | (257,280 | ) | |||
Retirements and sales | (13,700 | ) | (7,089 | ) | (20,789 | ) | |||
Reclassification | — | (66 | ) | (66 | ) | ||||
Foreign currency translation effect | (2,751 | ) | (12,959 | ) | (15,710 | ) | |||
Balance December 31, 2013 | 10,729 | 103,546 | 114,275 | ||||||
Property, plant and equipment, net: | |||||||||
31-Dec-12 | 100,503 | 174,933 | 275,436 | ||||||
31-Dec-13 | 18,218 | 38,313 | 56,531 | ||||||
Useful lives in years: | Buildings and leasehold improvements | 25-Oct | |||||||
Machinery and equipment | 10-Feb | ||||||||
Furniture and fixtures | 10-Feb |
Assets_held_for_sale_Tables
Assets held for sale (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Assets Held-for-sale, Long Lived [Abstract] | ' | ||||||||
Schedule of Changes in the Carrying Value of Assets Held For Sale | ' | ||||||||
The changes in the carrying value of assets held for sale are as follows: | |||||||||
Japan | The Netherlands | Total | |||||||
Balance January 1, 2012 | 6,585 | 277 | 6,862 | ||||||
Foreign currency translation effect | (864 | ) | — | (864 | ) | ||||
Balance December 31, 2012 | 5,721 | 277 | 5,998 | ||||||
Impairment | (796 | ) | — | (796 | ) | ||||
Reclassification to assets in use | (3,393 | ) | — | (3,393 | ) | ||||
Foreign currency translation effect | (1,071 | ) | — | (1,071 | ) | ||||
Balance December 31, 2013 | 461 | 277 | 738 | ||||||
Evaluation_tools_at_customers_
Evaluation tools at customers (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Other Inventory, Gross [Abstract] | ' | |||||
Schedule of changes in the Amount of Evaluation Tools | ' | |||||
The changes in the amount of evaluation tools are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | 13,987 | 16,922 | ||||
Evaluation tools shipped | 11,120 | 8,329 | ||||
Depreciation | (3,798 | ) | (3,771 | ) | ||
Evaluation tools sold | (3,277 | ) | (6,221 | ) | ||
Foreign currency translation effect | (1,110 | ) | (1,927 | ) | ||
Balance at end of year | 16,922 | 13,332 | ||||
Useful lives in years: | 5 |
Investments_and_associates_Tab
Investments and associates (Tables) | 12 Months Ended | ||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||
Investments [Abstract] | ' | ||||||||||||||||||
Schedule of Changes in Investment | ' | ||||||||||||||||||
The changes in the investment and associates are as follows: | |||||||||||||||||||
Investments | Associates | Total | |||||||||||||||||
Net equity share | Other( In)tangible assets and fair value changes | Goodwill | Total associates | ||||||||||||||||
Balance January 1, 2012 | 1,044 | — | — | — | — | 1,044 | |||||||||||||
Share in income of investments and associates | (766 | ) | — | — | — | — | (766 | ) | |||||||||||
Balance December 31, 2012 | 278 | — | — | — | — | 278 | |||||||||||||
40.08% investment in ASMPT March 15, 2013 | — | 255,701 | 227,010 | 898,599 | 1,381,310 | 1,381,310 | |||||||||||||
Result investments and associates | — | 23,727 | — | — | 23,727 | 23,727 | |||||||||||||
Amortization recognized (in)tangible assets | — | — | (16,848 | ) | — | (16,848 | ) | (16,848 | ) | ||||||||||
Fair value changes related to inventories and tax losses | — | — | (39,807 | ) | — | (39,807 | ) | (39,807 | ) | ||||||||||
Impairment | — | — | — | (335,406 | ) | (335,406 | ) | (335,406 | ) | ||||||||||
Dividends | — | (10,171 | ) | — | — | (10,171 | ) | (10,171 | ) | ||||||||||
Dilution ASMPT share to 39.94% | — | 3,541 | — | — | 3,541 | 3,541 | |||||||||||||
Other changes in equity | — | 480 | — | — | 480 | 480 | |||||||||||||
Foreign currency translation effect | — | (8,894 | ) | (8,824 | ) | (45,432 | ) | (63,150 | ) | (63,150 | ) | ||||||||
Balance December 31, 2013 | 278 | 264,384 | 161,531 | 517,761 | 943,676 | 943,954 | |||||||||||||
Notes_payable_to_banks_Tables
Notes payable to banks (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | |||||
Schedule Of Information On Notes Payable | ' | |||||
Information on notes payable to banks is as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Short-term debt outstanding: | ||||||
ASMPT | 61,675 | — | ||||
Total | 61,675 | — | ||||
Local Currencies [Member] | ' | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | |||||
Schedule Of Information On Notes Payable | ' | |||||
Short-term debt outstanding in local currencies is as follows (in thousands): | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Hong Kong dollar | 630,686 | — | ||||
Provision_for_warranty_Tables
Provision for warranty (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Standard Product Warranty Disclosure [Abstract] | ' | |||||
Schedule of Changes in the Amount of Provision for Warranty | ' | |||||
The changes in the amount of provision for warranty are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Balance at beginning of year | 49,512 | 43,921 | ||||
Charged to cost of sales | 26,527 | 8,491 | ||||
Deconsolidation ASMPT | — | (34,290 | ) | |||
Deductions | (31,948 | ) | (9,850 | ) | ||
Foreign currency translation effect | (170 | ) | (306 | ) | ||
Balance at end of year | 43,921 | 7,966 | ||||
Non-current portion | 5,298 | — | ||||
Current portion | 38,623 | 7,966 | ||||
Accrued_expenses_and_other_Tab
Accrued expenses and other (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Payables and Accruals [Abstract] | ' | |||||
Schedule of Accrued Expenses and Other | ' | |||||
Accrued expenses and other consist of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Advance payments from customers | 29,350 | 213 | ||||
Deferred revenue | 5,938 | 7,346 | ||||
Accrual for salaries, wages and related taxes and expenses | 60,246 | 20,967 | ||||
Interest payable | 307 | — | ||||
Payables arising from acquisition of property, plant and equipment | 14,027 | — | ||||
Other | 22,192 | 10,134 | ||||
132,060 | 38,660 | |||||
Longterm_debt_Tables
Long-term debt (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Long-term Debt, Unclassified [Abstract] | ' | |||||
Schedule Of Long-Term Debt | ' | |||||
Long-term debt consists of the following: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Term loans: | ||||||
ASMPT, LIBOR+2.5% | 18,948 | — | ||||
Current portion | 6,316 | — | ||||
Non-current portion | 12,632 | — | ||||
Schedule Of Long-Term Debt, Including Current Portion, In Local Currencies | ' | |||||
Long-term debt, including current portion, in local currencies is as follows (in thousands): | ||||||
December 31, | ||||||
2012 | 2013 | |||||
US dollar | 25,000 | — | ||||
Convertible_subordinated_debt_
Convertible subordinated debt (Tables) | 12 Months Ended | |||
Dec. 31, 2013 | ||||
Convertible Subordinated Debt [Abstract] | ' | |||
Schedule Of Changes In Outstanding Amounts Of Convertible Subordinated Debt | ' | |||
The changes in the outstanding amounts of convertible subordinated debt are as follows: | ||||
6.50% | ||||
convertible | ||||
unsecured | ||||
notes, due | ||||
2014 | ||||
Liability at redemption value at date of issuance | 150,000 | |||
Conversion component at date of issuance | (23,601 | ) | ||
Liability component at date of issuance | 126,399 | |||
Balance December 31, 2011 | 135,078 | |||
Conversion of notes | (139,407 | ) | ||
Accrual of interest | 4,329 | |||
Balance December 31, 2012 | — | |||
Shareholders_equity_Tables
Shareholders' equity (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Stockholders' Equity Note [Abstract] | ' | |||||||||||
Schedule Of Changes In The Amount Of Accumulated Other Comprehensive Loss | ' | |||||||||||
The changes in the amount of accumulated other comprehensive loss are as follows: | ||||||||||||
Proportionate share other comprehensive income investments | Foreign | Unrecognized | Total | |||||||||
currency | pension | |||||||||||
translation | obligations, | |||||||||||
effects | net of tax | |||||||||||
Balance January 1, 2012 | — | (20,330 | ) | 179 | (20,151 | ) | ||||||
Foreign currency translation effect on translation of foreign operations | — | (6,994 | ) | — | (6,994 | ) | ||||||
Actuarial loss | — | — | (1,797 | ) | (1,797 | ) | ||||||
Balance December 31, 2012 | — | (27,324 | ) | (1,618 | ) | (28,942 | ) | |||||
Realization deferred accumulative translation result following the sale of the 12% share of ASMPT | — | 23,053 | — | 23,053 | ||||||||
Deconsolidation ASMPT | — | — | 1,597 | 1,597 | ||||||||
Other comprehensive income investments | ||||||||||||
Foreign currency translation effect on translation of foreign operations | 480 | (84,086 | ) | — | (83,606 | ) | ||||||
Actuarial loss | — | — | (224 | ) | (224 | ) | ||||||
Balance December 31, 2013 | 480 | (88,357 | ) | (245 | ) | (88,122 | ) | |||||
Employee_benefits_Tables
Employee benefits (Tables) | 12 Months Ended | |||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||
Front-End [Member] | ' | |||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | |||||||||||||||||
Schedule Of The Funded Status Of The Plan | ' | |||||||||||||||||
The funded status of the plan and the amounts not yet recognized in the Consolidated Statement of Operations and the amounts recognized in the Consolidated Balance Sheet are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | (8,357 | ) | (7,604 | ) | ||||||||||||||
Fair value of plan assets | 4,794 | 5,189 | ||||||||||||||||
Funded status/(deficit) | (3,563 | ) | (2,415 | ) | ||||||||||||||
Schedule Of Changes In Defined Benefit Obligations And Fair Value Of Plan Assets | ' | |||||||||||||||||
The changes in defined benefit obligations and fair value of plan assets are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 9,485 | 8,357 | ||||||||||||||||
Current service cost | 731 | 529 | ||||||||||||||||
Interest on obligation | 121 | 113 | ||||||||||||||||
Actuarial losses (gains) | (436 | ) | 660 | |||||||||||||||
Benefits paid | (423 | ) | (128 | ) | ||||||||||||||
Foreign currency translation effect | (1,121 | ) | (1,927 | ) | ||||||||||||||
Balance December 31 | 8,357 | 7,604 | ||||||||||||||||
Fair value of plan assets | ||||||||||||||||||
Balance January 1 | 4,090 | 4,794 | ||||||||||||||||
Expected return on plan assets | 144 | 142 | ||||||||||||||||
Actuarial (losses) gains | 52 | 359 | ||||||||||||||||
Company contribution | 1,544 | 1,233 | ||||||||||||||||
Benefits paid | (423 | ) | (128 | ) | ||||||||||||||
Foreign currency translation effect | (613 | ) | (1,211 | ) | ||||||||||||||
Balance December 31 | 4,794 | 5,189 | ||||||||||||||||
Schedule Of Net Periodic Benefit Cost | ' | |||||||||||||||||
The net periodic benefit cost consists of the following: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Current service cost | 664 | 731 | 529 | |||||||||||||||
Interest on obligation | 107 | 121 | 113 | |||||||||||||||
Expected return on plan assets | (103 | ) | (144 | ) | (142 | ) | ||||||||||||
Amortization deferred actuarial loss | 6 | 46 | — | |||||||||||||||
Amortization of past service cost | (12 | ) | (55 | ) | (44 | ) | ||||||||||||
Net periodic pension benefit cost | 662 | 699 | 456 | |||||||||||||||
Schedule Of Actuarial Present Value Of Benefit Obligations And Net Periodic Benefit Cost | ' | |||||||||||||||||
The assumptions in calculating the actuarial present value of benefit obligations and net periodic benefit cost are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Discount rate for obligations | 1.25 | % | 1.55 | % | 1.5 | % | ||||||||||||
Expected return on plan assets | 3 | % | 3 | % | 3 | % | ||||||||||||
Expected rate of compensation increase | 2.93 | % | 2.93 | % | 2.93 | % | ||||||||||||
Schedule Of Allocation Of Plan Assets | ' | |||||||||||||||||
The allocation of plan assets is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Equity | 1,087 | 23 | % | 1,351 | 26 | % | ||||||||||||
Bonds | 2,957 | 62 | % | 3,019 | 59 | % | ||||||||||||
Loans | 463 | 10 | % | 453 | 9 | % | ||||||||||||
Real estate | 72 | 2 | % | 89 | 2 | % | ||||||||||||
Other | 215 | 4 | % | 215 | 4 | % | ||||||||||||
4,794 | 100 | % | 5,127 | 100 | % | |||||||||||||
Back-End [Member] | ' | |||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | |||||||||||||||||
Schedule Of The Funded Status Of The Plan | ' | |||||||||||||||||
In the case of unfunded plans, the recognized pension liability is equal to the DBO adjusted by unrecognized past service cost. In the case of funded plans, the fair value of the plan assets is offset against the benefit obligations. The net amount, after adjusting for the effects of unrecognized past service cost, is recognized as a pension liability or prepaid pension asset. | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | (33,987 | ) | — | |||||||||||||||
Fair value of plan assets | 27,035 | — | ||||||||||||||||
Funded status/(deficit) | (6,952 | ) | — | |||||||||||||||
Schedule Of Changes In Defined Benefit Obligations And Fair Value Of Plan Assets | ' | |||||||||||||||||
The changes in defined benefit obligations and fair value of plan assets are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 22,303 | 33,987 | ||||||||||||||||
Deconsolidation of ASMPT | — | (34,691 | ) | |||||||||||||||
Current service cost | 1,691 | 472 | ||||||||||||||||
Interest on obligation | 1,095 | 262 | ||||||||||||||||
Past service costs | 104 | — | ||||||||||||||||
Actuarial losses (gain) | 8,532 | — | ||||||||||||||||
Benefits paid | (55 | ) | (30 | ) | ||||||||||||||
Transfers | 85 | — | ||||||||||||||||
Contribution participants | 222 | — | ||||||||||||||||
Foreign currency translation effect | 10 | — | ||||||||||||||||
Balance December 31 | 33,987 | — | ||||||||||||||||
Fair value of plan assets | ||||||||||||||||||
Balance January 1 | 21,364 | 27,035 | ||||||||||||||||
Deconsolidation ASMPT | — | (27,820 | ) | |||||||||||||||
Expected return | 853 | 423 | ||||||||||||||||
Actuarial (losses) gains | 2,981 | — | ||||||||||||||||
Contribution participants | 222 | — | ||||||||||||||||
Contribution employer | 1,615 | 362 | ||||||||||||||||
Balance December 31 | 27,035 | — | ||||||||||||||||
Schedule Of Actuarial Present Value Of Benefit Obligations And Net Periodic Benefit Cost | ' | |||||||||||||||||
The assumptions in calculating the actuarial present value of benefit obligations and net periodic benefit cost are as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Discount rate for obligations | 3.5 | % | — | % | ||||||||||||||
Expected return on plan assets | 3.5 | % | — | % | ||||||||||||||
Expected rate of compensation increase | 2.25 | % | — | % | ||||||||||||||
Schedule Of Allocation Of Plan Assets | ' | |||||||||||||||||
The allocation of plan assets is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Equity | 5,677 | 21 | % | — | — | % | ||||||||||||
Fixed income and corporate bonds | 20,817 | 77 | % | — | — | % | ||||||||||||
Cash and other assets | 541 | 2 | % | — | — | % | ||||||||||||
27,035 | 100 | % | — | — | % | |||||||||||||
Other Post-Employment Benefit Plans ASMPT [Member] | ' | |||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | |||||||||||||||||
Schedule Of Changes In Defined Benefit Obligations And Fair Value Of Plan Assets | ' | |||||||||||||||||
The reconciliation of the changes in the benefit obligation for the other post-employment benefits is as follows: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2012 | 2013 | |||||||||||||||||
Defined benefit obligations | ||||||||||||||||||
Balance January 1 | 1,414 | 1,634 | ||||||||||||||||
Current service cost | 45 | 12 | ||||||||||||||||
Interest on obligation | 69 | 12 | ||||||||||||||||
Actuarial losses / (gains) | 372 | — | ||||||||||||||||
Benefits paid | (181 | ) | (12 | ) | ||||||||||||||
Deconsolidation ASMPT | — | (1,646 | ) | |||||||||||||||
Transfers | (85 | ) | — | |||||||||||||||
Balance December 31 | 1,634 | — | ||||||||||||||||
Schedule Of Net Periodic Benefit Cost | ' | |||||||||||||||||
The components of the principal pension benefit plans and the other post-employment benefit plans recognized in the consolidated statement of operations in respect of these defined benefit plans and other post-employment benefits are as follows: | ||||||||||||||||||
31-Dec-12 | 31-Dec-13 | |||||||||||||||||
Principal | Other post- | Total | Principal | Other post- | Total | |||||||||||||
defined | employment | defined | employment | |||||||||||||||
benefit | benefit | benefit | benefit | |||||||||||||||
plans | plans | plans | plans | |||||||||||||||
Current service cost | (1,691 | ) | (45 | ) | (1,736 | ) | (472 | ) | (12 | ) | (484 | ) | ||||||
Interest on obligation | (1,095 | ) | (69 | ) | (1,164 | ) | (262 | ) | (12 | ) | (274 | ) | ||||||
Past service cost | (104 | ) | — | (104 | ) | — | — | — | ||||||||||
Expected return on plan assets | 853 | — | 853 | — | — | — | ||||||||||||
Net periodic pension benefit cost | (2,037 | ) | (114 | ) | (2,151 | ) | (734 | ) | (24 | ) | (758 | ) | ||||||
Other Retirement Benefit Obligations ASMPT [Member] | ' | |||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | |||||||||||||||||
Schedule Of Expected To Pay Benefits For Subsequent Years | ' | |||||||||||||||||
The Company expects to pay benefits for years subsequent to December 31, 2013 as follows: | ||||||||||||||||||
Front-end | ||||||||||||||||||
segment | ||||||||||||||||||
2014 | 209 | |||||||||||||||||
2015 | 313 | |||||||||||||||||
2016 | 337 | |||||||||||||||||
2017 | 493 | |||||||||||||||||
2018 | 629 | |||||||||||||||||
Aggregate for the years 2019-2023 | 2,796 | |||||||||||||||||
Total | 4,777 | |||||||||||||||||
Schedule Of Retirement Plan Costs | ' | |||||||||||||||||
Retirement plan costs for ASMI consolidated consist of the following: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Defined contribution plans | 15,990 | 16,952 | 5,277 | |||||||||||||||
Multi-employer plans | 1,111 | 1,420 | 1,274 | |||||||||||||||
Defined benefit plans | 1,844 | 2,779 | 988 | |||||||||||||||
Total retirement plan costs | 18,945 | 21,151 | 7,539 | |||||||||||||||
Employee Stock Option Plan [Member] | ' | |||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | |||||||||||||||||
Schedule of Changes in Options Outstanding | ' | |||||||||||||||||
The following is a summary of changes in options outstanding: | ||||||||||||||||||
US dollar-plans | Euro-plans | |||||||||||||||||
Number of | Weighted | Number | Weighted | |||||||||||||||
options | average | of | average | |||||||||||||||
exercise | options | exercise | ||||||||||||||||
price in | price in € | |||||||||||||||||
US$ | ||||||||||||||||||
Balance January 1, 2011 | 686,060 | 20.4 | 759,463 | 15.74 | ||||||||||||||
Options granted | — | — | 687,114 | 22.33 | ||||||||||||||
Options forfeited | (1,080 | ) | 16.65 | — | — | |||||||||||||
Options exercised | (169,870 | ) | 19.1 | (126,620 | ) | 14.82 | ||||||||||||
Balance December 31, 2011 | 515,110 | 20.83 | 1,319,957 | 19.08 | ||||||||||||||
Options granted | — | — | 708,891 | 27.04 | ||||||||||||||
Options forfeited | (29,400 | ) | 20.63 | (44,500 | ) | 15.49 | ||||||||||||
Options exercised | (85,310 | ) | 20.42 | (59,660 | ) | 15.08 | ||||||||||||
Balance December 31, 2012 | 400,400 | 20.94 | 1,924,688 | 22.22 | ||||||||||||||
Options forfeited | (1,220 | ) | 13.65 | (25,050 | ) | 24.72 | ||||||||||||
Options exercised | (52,670 | ) | 15.97 | (23,550 | ) | 15.91 | ||||||||||||
Balance July 25, 2013 | 346,510 | 21.72 | 1,876,088 | 22.26 | ||||||||||||||
Adjustment following capital distribution | 62,145 | 18.42 | 336,446 | 18.88 | ||||||||||||||
Options granted | — | — | 776,450 | 23.73 | ||||||||||||||
Options forfeited | (2,830 | ) | 9.06 | (39,271 | ) | 20.93 | ||||||||||||
Options exercised | (17,675 | ) | 12.66 | (29,361 | ) | 10.7 | ||||||||||||
Balance December 31, 2013 | 388,150 | 18.75 | 2,920,352 | 20.22 | ||||||||||||||
Schedule Of Options Outstanding And Options Exercisable Classified By Range Of Exercise Prices | ' | |||||||||||||||||
On December 31, 2013 options outstanding and options exercisable classified by range of exercise prices are: | ||||||||||||||||||
Options outstanding | Options exercisable | |||||||||||||||||
Range of | Number | Weighted average | Weighted | Number | Weighted | |||||||||||||
exercise | outstanding | remaining | average | exercisable | average | |||||||||||||
prices | contractual life | exercise price | exercise price | |||||||||||||||
In US$ | In years | In US$ | In US$ | |||||||||||||||
1.00-10.00 | 65,313 | 5.1 | 6.75 | 46,443 | 6.9 | |||||||||||||
10.00-15.00 | 30,265 | 3.6 | 11.57 | 21,513 | 11.83 | |||||||||||||
15.00-20.00 | 128,057 | 2.2 | 18.88 | 88,194 | 18.67 | |||||||||||||
20.00-25.00 | 114,985 | 4.4 | 22.59 | 114,985 | 22.59 | |||||||||||||
25.00-30.00 | 49,530 | 3 | 29.69 | 29,719 | 29.69 | |||||||||||||
US$1.00-30.00 | 388,150 | 3.5 | 18.75 | 300,853 | 18.95 | |||||||||||||
In € | In years | In € | In € | |||||||||||||||
1.00-10.00 | 2,715 | 0.3 | 8.32 | 803 | 8.62 | |||||||||||||
10.00-15.00 | 445,993 | 2.7 | 12.2 | 390,318 | 12.11 | |||||||||||||
15.00-20.00 | 854,171 | 4.5 | 18.61 | 112,016 | 16.51 | |||||||||||||
20.00-25.00 | 1,617,473 | 6.4 | 21.57 | 20,875 | 22.47 | |||||||||||||
€1.00-25.00 | 2,920,352 | 5.3 | 19.26 | 524,012 | 13.46 | |||||||||||||
Schedule Of Black-Scholes Weighted Average Assumptions | ' | |||||||||||||||||
The cost relating to employee stock options is measured at fair value on the grant date. The fair value was determined using the Black-Scholes option valuation model with the following weighted average assumptions: | ||||||||||||||||||
December 31, | ||||||||||||||||||
2011 | 2012 | 2013 | ||||||||||||||||
Expected life (years) | 7 | 7 | 7 | |||||||||||||||
Risk free interest rate | 3.51 | % | 3.28 | % | 2.93 | % | ||||||||||||
Dividend yield | 0.32 | % | 0.64 | % | 0.9 | % | ||||||||||||
Expected volatility | 40.9 | % | 41.98 | % | 41.52 | % |
Commitments_and_contingencies_
Commitments and contingencies (Tables) | 12 Months Ended | |||||
Dec. 31, 2013 | ||||||
Commitments and Contingencies Disclosure [Abstract] | ' | |||||
Schedule of Capital Leases Included in Property, Plant and Equipment | ' | |||||
Capital leases included in property, plant and equipment are as follows: | ||||||
December 31, | ||||||
2012 | 2013 | |||||
Machinery and equipment | 3,485 | 2,737 | ||||
Furniture and fixtures | 344 | 269 | ||||
3,829 | 3,006 | |||||
Less accumulated depreciation | (3,829 | ) | (3,006 | ) | ||
— | — | |||||
Schedule of Future Minimum Rental Payments for Operating Leases | ' | |||||
At December 31, 2013 operating leases having initial or remaining non-cancelable terms in excess of one year are as follows: | ||||||
2014 | 4,857 | |||||
2015 | 3,801 | |||||
2016 | 3,279 | |||||
2017 | 2,707 | |||||
2018 | 2,423 | |||||
Years thereafter | 3,660 | |||||
Total | 20,727 | |||||
Financial_instruments_and_risk1
Financial instruments and risk management (Tables) | 12 Months Ended | ||||||||||||||
Dec. 31, 2013 | |||||||||||||||
Summary of Derivative Instruments by Risk Exposure [Abstract] | ' | ||||||||||||||
Schedule of Financial Instruments | ' | ||||||||||||||
Financial assets: | |||||||||||||||
December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Cash and cash equivalents | 290,475 | 312,437 | |||||||||||||
Pledged cash deposits | 20,000 | — | |||||||||||||
Accounts receivable | 304,840 | 83,016 | |||||||||||||
Derivative instruments designated in cash flow hedges | 145 | — | |||||||||||||
Financial liabilities: | |||||||||||||||
December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Notes payable to banks | 61,675 | — | |||||||||||||
Accounts payable | 151,761 | 44,837 | |||||||||||||
Current portion of long-term debt | 6,316 | — | |||||||||||||
Long-term debt | 12,632 | — | |||||||||||||
Schedule of Gains or Losses Related to Financial Instruments | ' | ||||||||||||||
Gains or losses related to financial instruments are as follows: | |||||||||||||||
Year ended December 31, | |||||||||||||||
2012 | 2013 | ||||||||||||||
Interest income | 1,989 | 972 | |||||||||||||
Interest expense | (12,113 | ) | (2,943 | ) | |||||||||||
Accretion interest expense convertible notes at amortized value | (4,469 | ) | — | ||||||||||||
Loss resulting from early extinguishment of debt | (2,209 | ) | — | ||||||||||||
Losses Foreign currency exchange, net | (3,957 | ) | (8,158 | ) | |||||||||||
Addition to allowance for doubtful accounts receivable | (2,825 | ) | (377 | ) | |||||||||||
Schedule of Financial Assets and Financial Liabilities That are Measured at Fair Value on a Recurring Basis | ' | ||||||||||||||
The following table presents the Company’s (financial) assets and liabilities that are measured at fair value on a recurring basis. | |||||||||||||||
At carrying value | At fair value | Level 2 | Level 3 | Total | |||||||||||
Level 1 | |||||||||||||||
31-Dec-12 | |||||||||||||||
Assets: | |||||||||||||||
Derivative financial instruments 1) | 145 | — | 145 | — | 145 | ||||||||||
Total | 145 | — | 145 | — | 145 | ||||||||||
31-Dec-13 | |||||||||||||||
Assets: | |||||||||||||||
Associates | 971,131 | 971,131 | — | — | 971,131 | ||||||||||
Total | 971,131 | 971,131 | — | — | 971,131 | ||||||||||
1) Derivative financial instruments consist of forward foreign exchange contracts. | |||||||||||||||
Schedule of Outstanding Forward Exchange Contracts | ' | ||||||||||||||
The outstanding forward exchange contracts per December 31, 2012 were as follows, per December 31, 2013 there were no forward exchange contracts outstanding: | |||||||||||||||
Currency | Notional | Fair | Included in | ||||||||||||
amount | value | accumulated | |||||||||||||
other | |||||||||||||||
comprehensive | |||||||||||||||
income (loss) | |||||||||||||||
Euro | Euro | ||||||||||||||
31-Dec-12 | |||||||||||||||
Assets: | |||||||||||||||
Fair value hedge contracts: | |||||||||||||||
Short position | US$ | (27,100 | ) | (145 | ) | — | |||||||||
Schedule of Company's Price Sensitivity Impact on Equity | ' | ||||||||||||||
The following table analyzes the Company’s sensitivity to a hypothetical 10% strengthening and 10% weakening of the US dollar, Singapore dollar, Hong Kong dollar, Korean won and Japanese yen against the euro as of December 31, 2012 and December 31, 2013. This analysis includes foreign currency denominated monetary items and adjusts their translation at year end for a 10% increase and 10% decrease of the US dollar, Singapore dollar, Hong Kong dollar, Korean won or Japanese yen against the euro. A positive amount indicates an increase in equity. Recognized in equity is the revaluation effect of subsidiaries denominated in US dollar, Singapore dollar, Hong Kong dollar and Japanese yen. | |||||||||||||||
Impact on equity | |||||||||||||||
2012 | 2013 | ||||||||||||||
10% increase of US dollar versus euro | 4,564 | 4,938 | |||||||||||||
10% decrease of US dollar versus euro | (4,564 | ) | (4,938 | ) | |||||||||||
10% increase of Singapore dollar versus euro | 5,868 | 6,088 | |||||||||||||
10% decrease of Singapore dollar versus euro | (5,868 | ) | (6,088 | ) | |||||||||||
10% increase of Hong Kong dollar versus euro | 56,693 | 94,396 | |||||||||||||
10% decrease of Hong Kong dollar versus euro | (56,693 | ) | (94,396 | ) | |||||||||||
10% increase of Korean won versus euro | 3,969 | 5,840 | |||||||||||||
10% decrease of Korean won versus euro | (3,969 | ) | (5,840 | ) | |||||||||||
10% increase of Japanese yen versus euro | 5,294 | 4,561 | |||||||||||||
10% decrease of Japanese yen versus euro | (5,294 | ) | (4,561 | ) | |||||||||||
Schedule of Company's Price Sensitivity Impact on Net Earnings | ' | ||||||||||||||
The following table analyzes the Company’s sensitivity to a hypothetical 10% strengthening and 10% weakening of the US dollar, Singapore dollar, Hong Kong dollar, Korean won or Japanese yen against the euro at average exchange rates for the years 2012 and 2013. A positive amount indicates an increase in net earnings. | |||||||||||||||
Impact on net earnings | |||||||||||||||
2012 | 2013 | ||||||||||||||
10% increase of US dollar versus euro | 915 | 601 | |||||||||||||
10% decrease of US dollar versus euro | (915 | ) | (601 | ) | |||||||||||
10% increase of Singapore dollar versus euro | 644 | 671 | |||||||||||||
10% decrease of Singapore dollar versus euro | (644 | ) | (671 | ) | |||||||||||
10% increase of Hong Kong dollar versus euro | 3,630 | 100,072 | |||||||||||||
10% decrease of Hong Kong dollar versus euro | (3,630 | ) | (100,072 | ) | |||||||||||
10% increase of Korean won versus euro | 1,400 | 1,962 | |||||||||||||
10% decrease of Korean won versus euro | (1,400 | ) | (1,962 | ) | |||||||||||
10% increase of Japanese yen versus euro | 923 | 485 | |||||||||||||
10% decrease of Japanese yen versus euro | (923 | ) | (485 | ) | |||||||||||
Summary of Company's Contractual Obligations | ' | ||||||||||||||
The following table summarizes the Company’s contractual obligations as at December 31, 2013 aggregated by type of contractual obligation: | |||||||||||||||
Total | Less than | 3-Jan | 5-Mar | More than | |||||||||||
1 year | years | years | 5 years | ||||||||||||
Operating leases | 20,727 | 4,857 | 7,080 | 5,130 | 3,660 | ||||||||||
Pension liabilities | 4,777 | 209 | 650 | 1,122 | 2,796 | ||||||||||
Purchase obligations: | |||||||||||||||
Purchase commitments to suppliers | 48,982 | 48,982 | — | — | — | ||||||||||
Capital expenditure commitments | 458 | 458 | — | — | — | ||||||||||
Unrecognized tax benefits (ASC 740) | — | — | — | — | — | ||||||||||
Total contractual obligations | 74,944 | 54,506 | 7,730 | 6,252 | 6,456 | ||||||||||
Research_and_development_Table
Research and development (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Research and Development Expense [Abstract] | ' | ||||||||
Schedule of Research and Development | ' | ||||||||
Research and Development consists of the following: | |||||||||
Year ended December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Research and development expenses | 130,153 | 150,118 | 76,427 | ||||||
Research and development grants and credits | (753 | ) | (899 | ) | (1,036 | ) | |||
Total research and development expenses | 129,400 | 149,219 | 75,391 | ||||||
Income_taxes_Tables
Income taxes (Tables) | 12 Months Ended | ||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||
Income Tax Disclosure [Abstract] | ' | ||||||||||||||||||||
Components Of Earnings (Loss) Before Income Taxes And Non-Controlling Interest | ' | ||||||||||||||||||||
The components of earnings (loss) before income taxes and non-controlling interest consist of: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
The Netherlands | (3,450 | ) | (70,263 | ) | 1,018,554 | ||||||||||||||||
Other countries | 356,305 | 136,994 | 41,867 | ||||||||||||||||||
Earnings before income taxes and Non-controlling interest | 352,855 | 66,731 | 1,060,421 | ||||||||||||||||||
Schedule Of Income Tax Expense | ' | ||||||||||||||||||||
The income tax expense consists of: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
Current: | |||||||||||||||||||||
The Netherlands | (494 | ) | (110 | ) | (1,938 | ) | |||||||||||||||
Other countries | (64,684 | ) | (26,337 | ) | (9,479 | ) | |||||||||||||||
(65,178 | ) | (26,447 | ) | (11,417 | ) | ||||||||||||||||
Deferred: | |||||||||||||||||||||
The Netherlands | — | — | — | ||||||||||||||||||
Other countries | 28,486 | 147 | 296 | ||||||||||||||||||
Income tax expense | (36,692 | ) | (26,300 | ) | (11,121 | ) | |||||||||||||||
Schedule Of Reconciliation Of The Provisions For Income Taxes And The Amounts That Would Be Computed Using Statutory Income Tax Rates | ' | ||||||||||||||||||||
A reconciliation of the provisions for income taxes and the amounts that would be computed using the Dutch statutory income tax rates is set forth as follows: | |||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||
Earnings before income taxes and Non-controlling interest | 352,855 | 66,731 | 1,060,421 | ||||||||||||||||||
Dutch statutory income tax rate | 25 | % | 25 | % | 25 | % | |||||||||||||||
Income tax provision at statutory rate | (88,214 | ) | (16,683 | ) | (265,105 | ) | |||||||||||||||
Non-deductible expenses | (8,228 | ) | (6,508 | ) | (1,957 | ) | |||||||||||||||
Foreign taxes at a rate other than the Dutch statutory rate | 12,983 | (2,699 | ) | (556 | ) | ||||||||||||||||
Valuation allowance | 17,991 | (14,876 | ) | (3,960 | ) | ||||||||||||||||
Non-taxable income -1- | 30,156 | 4,887 | 260,425 | ||||||||||||||||||
Other -2- | (1,380 | ) | 9,579 | 32 | |||||||||||||||||
Income tax expense | (36,692 | ) | (26,300 | ) | (11,121 | ) | |||||||||||||||
1) | Non-taxable income for 2013 mainly consist of revenues deriving from the disposal of the 12% shareholding in ASMPT in March which are exempt under the Dutch participation exemption. | ||||||||||||||||||||
2) | Other in 2013 mainly consists of tax credits, adjustments to prior years, changes in (enacted) tax laws and revaluation of certain assets. | ||||||||||||||||||||
Schedule Of Deferred Income Taxes | ' | ||||||||||||||||||||
Deferred income taxes developed as follows: | |||||||||||||||||||||
1-Jan-12 | Acquisitions | Reclassifications | Consolidated statement of operations | Equity | Exchange differences | 31-Dec-12 | |||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Reserves and allowances | 10,415 | — | 3,985 | 4,928 | 1,730 | (736 | ) | 20,322 | |||||||||||||
Net operating losses | 86,720 | — | — | (2,303 | ) | — | (939 | ) | 83,478 | ||||||||||||
Depreciation | 363 | — | 508 | 1,478 | — | (89 | ) | 2,260 | |||||||||||||
Other | 6,391 | — | (6,525 | ) | 1,345 | 28 | (127 | ) | 1,112 | ||||||||||||
Gross deferred tax assets | 103,889 | — | (2,032 | ) | 5,448 | 1,758 | (1,891 | ) | 107,172 | ||||||||||||
Less: valuation allowance | (76,467 | ) | — | (180 | ) | (6,442 | ) | — | (161 | ) | (83,250 | ) | |||||||||
Net deferred tax assets | 27,422 | — | (2,212 | ) | (994 | ) | 1,758 | (2,052 | ) | 23,922 | |||||||||||
Deferred tax liabilities | (4,381 | ) | — | 2,212 | 1,142 | — | 39 | (988 | ) | ||||||||||||
Net deferred income taxes | 23,041 | — | — | 148 | 1,758 | (2,013 | ) | 22,934 | |||||||||||||
1-Jan-13 | Deconsolidation ASMPT | Change income tax rate | Consolidated statement of operations | Equity | Exchange differences | 31-Dec-13 | |||||||||||||||
Deferred tax assets: | |||||||||||||||||||||
Reserves and allowances | 20,322 | (15,199 | ) | (258 | ) | (814 | ) | 255 | (1,152 | ) | 3,154 | ||||||||||
Net operating losses | 83,478 | (11,905 | ) | — | (1,664 | ) | — | 49 | 69,958 | ||||||||||||
Depreciation | 2,260 | (2,121 | ) | (88 | ) | 1,603 | — | (319 | ) | 1,335 | |||||||||||
Other | 1,112 | (194 | ) | (38 | ) | (146 | ) | — | (164 | ) | 570 | ||||||||||
Gross deferred tax assets | 107,172 | (29,419 | ) | (384 | ) | (1,021 | ) | 255 | (1,586 | ) | 75,017 | ||||||||||
Less: valuation allowance | (83,250 | ) | 11,675 | — | 1,664 | — | (47 | ) | (69,958 | ) | |||||||||||
Net deferred tax assets | 23,922 | (17,744 | ) | (384 | ) | 643 | 255 | (1,633 | ) | 5,059 | |||||||||||
Deferred tax liabilities | (988 | ) | 921 | — | 37 | — | (5 | ) | (35 | ) | |||||||||||
Net deferred income taxes | 22,934 | (16,823 | ) | (384 | ) | 680 | 255 | (1,638 | ) | 5,024 | |||||||||||
Schedule Of Deferred Tax Assets And Liabilities | ' | ||||||||||||||||||||
Deferred tax assets and liabilities are classified in the consolidated balance sheet as follows: | |||||||||||||||||||||
December 31, | |||||||||||||||||||||
2012 | 2013 | ||||||||||||||||||||
Deferred tax assets—current | 17,967 | 3,739 | |||||||||||||||||||
Deferred tax assets—non-current | 5,955 | 1,320 | |||||||||||||||||||
Deferred tax liabilities—current | (36 | ) | — | ||||||||||||||||||
Deferred tax liabilities—non-current | (952 | ) | (35 | ) | |||||||||||||||||
22,934 | 5,024 | ||||||||||||||||||||
Schedule Of Amounts And Expiration Dates Of Net Operating Losses For Tax Purposes | ' | ||||||||||||||||||||
The amounts and expiration dates of net operating losses for tax purposes are as follows: | |||||||||||||||||||||
Expiration year | Total of net operating losses for tax purposes | Net operating losses for which deferred tax assets are recognized | |||||||||||||||||||
2014 | 37,607 | — | |||||||||||||||||||
2015-2016 | — | — | |||||||||||||||||||
2017 | 47,429 | — | |||||||||||||||||||
2018 | 44,664 | — | |||||||||||||||||||
2019 | 35,905 | — | |||||||||||||||||||
2020 | 4 | — | |||||||||||||||||||
2021 | 60,198 | — | |||||||||||||||||||
2022 | 28,556 | — | |||||||||||||||||||
2023-2028 | — | — | |||||||||||||||||||
2029 | 14,343 | — | |||||||||||||||||||
2030 | 3,779 | — | |||||||||||||||||||
Unlimited | 125 | — | |||||||||||||||||||
Total | 272,610 | — | |||||||||||||||||||
Schedule Of Reconciliation Of The Beginning And Ending Balance Of The Liability For Unrecognized Tax Benefits | ' | ||||||||||||||||||||
A reconciliation of the beginning and ending balance of the liability for unrecognized tax benefits is as follows: | |||||||||||||||||||||
Balance January 1, 2011 | 20,057 | ||||||||||||||||||||
Gross increases - tax positions in current year | 950 | ||||||||||||||||||||
Foreign currency translation effect | 742 | ||||||||||||||||||||
Balance December 31, 2011 | 21,749 | ||||||||||||||||||||
Gross increases - tax positions in current year | 1,157 | ||||||||||||||||||||
Foreign currency translation effect | (395 | ) | |||||||||||||||||||
Balance December 31, 2012 | 22,511 | ||||||||||||||||||||
Deconsolidation ASMPT | (22,325 | ) | |||||||||||||||||||
Gross increases - tax positions in current year | — | ||||||||||||||||||||
Foreign currency translation effect | (186 | ) | |||||||||||||||||||
Balance December 31, 2013 | — | ||||||||||||||||||||
Summary Of Open Tax Years By Major Jurisdiction | ' | ||||||||||||||||||||
A summary of open tax years by major jurisdiction is as follows: | |||||||||||||||||||||
Jurisdiction | |||||||||||||||||||||
Japan | 2009-2013 | ||||||||||||||||||||
The Netherlands | 2009-2013 | ||||||||||||||||||||
Singapore | 2008-2013 | ||||||||||||||||||||
United States of America | 1997-2013 | ||||||||||||||||||||
South Korea | 2008-2013 |
Disclosures_about_segments_and1
Disclosures about segments and related information (Tables) | 12 Months Ended | |||||||||||||||||
Dec. 31, 2013 | ||||||||||||||||||
Segment Reporting [Abstract] | ' | |||||||||||||||||
Schedule of Segment Reporting Information by Segment | ' | |||||||||||||||||
Year ended December 31, 2013 | ||||||||||||||||||
Front-end | Back-end 100% | Elimination non consolidated | Total | |||||||||||||||
Net sales to unaffiliated customers | 451,992 | 1,051,376 | (891,091 | ) | 612,277 | |||||||||||||
Gross profit | 176,160 | 307,618 | (269,228 | ) | 214,550 | |||||||||||||
Result from operations | 44,704 | 66,352 | (70,638 | ) | 40,418 | |||||||||||||
Interest income | 904 | 272 | (204 | ) | 972 | |||||||||||||
Interest expense | (2,553 | ) | (2,082 | ) | 1,693 | (2,942 | ) | |||||||||||
Foreign currency exchange gains (losses), net | (9,005 | ) | 847 | — | (8,158 | ) | ||||||||||||
Result from investments | — | — | 1,030,132 | 1,030,132 | ||||||||||||||
Income tax expense | (9,484 | ) | (11,308 | ) | 9,671 | (11,121 | ) | |||||||||||
Net earnings (loss) | 24,565 | 54,081 | 970,654 | 1,049,300 | ||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 1,051,893 | |||||||||||||||||
Non-controlling interest | (2,593 | ) | ||||||||||||||||
Capital expenditures and purchase of intangible assets | 11,072 | 34,003 | (27,542 | ) | 17,533 | |||||||||||||
Depreciation and amortization | 19,415 | 41,066 | (32,015 | ) | 28,466 | |||||||||||||
Cash and cash equivalents | 312,437 | 149,313 | (149,313 | ) | 312,437 | |||||||||||||
Capitalized goodwill | 11,421 | — | — | 11,421 | ||||||||||||||
Other intangible assets | 5,637 | 902 | (902 | ) | 5,637 | |||||||||||||
Investments and associates | 278 | — | 943,676 | 943,954 | ||||||||||||||
Other identifiable assets | 277,800 | 599,709 | (599,709 | ) | 277,800 | |||||||||||||
Total assets | 607,573 | 749,924 | 193,752 | 1,551,249 | ||||||||||||||
Total debt | — | 65,105 | (65,105 | ) | — | |||||||||||||
Headcount in full-time equivalents -1- | 1,503 | 14,400 | (14,400 | ) | 1,503 | |||||||||||||
__________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
Year ended December 31, 2012 | ||||||||||||||||||
Front-end | Back-end | Total | ||||||||||||||||
Net sales to unaffiliated customers | 370,409 | 1,047,658 | 1,418,067 | |||||||||||||||
Gross profit | 124,531 | 315,898 | 440,429 | |||||||||||||||
Result from operations | 539 | 87,717 | 88,256 | |||||||||||||||
Interest income | 1,015 | 974 | 1,989 | |||||||||||||||
Interest expense | (11,381 | ) | (732 | ) | (12,113 | ) | ||||||||||||
Loss resulting from early extinguishment of debt | (2,209 | ) | — | (2,209 | ) | |||||||||||||
Accretion interest expense convertible notes | (4,329 | ) | (140 | ) | (4,469 | ) | ||||||||||||
Foreign currency exchange gains (losses), net | (3,050 | ) | (907 | ) | (3,957 | ) | ||||||||||||
Result on investments | (766 | ) | — | (766 | ) | |||||||||||||
Income tax expense | (8,965 | ) | (17,335 | ) | (26,300 | ) | ||||||||||||
Net earnings (loss) | (29,146 | ) | 69,577 | 40,431 | ||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 7,149 | |||||||||||||||||
Non-controlling interest | 33,282 | |||||||||||||||||
Capital expenditures | 21,973 | 46,189 | 68,162 | |||||||||||||||
Net purchase of other intangibles | 2,042 | 2,588 | 4,630 | |||||||||||||||
Depreciation and amortization | 18,838 | 39,622 | 58,460 | |||||||||||||||
Cash and cash equivalents | 145,061 | 145,414 | 290,475 | |||||||||||||||
Capitalized goodwill | 11,649 | 40,239 | 51,888 | |||||||||||||||
Other intangible assets | 9,049 | 4,866 | 13,915 | |||||||||||||||
Other identifiable assets | 334,399 | 808,829 | 1,143,228 | |||||||||||||||
Total assets | 500,158 | 999,348 | 1,499,506 | |||||||||||||||
Total debt | — | 80,623 | 80,623 | |||||||||||||||
Headcount in full-time equivalents -1- | 1,636 | 15,768 | 17,404 | |||||||||||||||
__________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
Year ended December 31, 2011 | ||||||||||||||||||
Front-end | Back-end | Total | ||||||||||||||||
Net sales to unaffiliated customers | 456,065 | 1,178,270 | 1,634,334 | |||||||||||||||
Gross profit | 172,318 | 398,308 | 570,626 | |||||||||||||||
Result from operations | 62,581 | 304,869 | 367,450 | |||||||||||||||
Interest income | 976 | 1,925 | 2,902 | |||||||||||||||
Interest expense | (13,142 | ) | (354 | ) | (13,497 | ) | ||||||||||||
Loss resulting from early extinguishment of debt | (824 | ) | — | (824 | ) | |||||||||||||
Accretion interest expense convertible notes | (4,401 | ) | — | (4,401 | ) | |||||||||||||
Revaluation conversion option | (4,378 | ) | — | (4,378 | ) | |||||||||||||
Foreign currency exchange gains (losses), net | 8,296 | (2,692 | ) | 5,604 | ||||||||||||||
Income tax expense | (4,581 | ) | (32,111 | ) | (36,692 | ) | ||||||||||||
Net earnings (loss) | 44,527 | 271,637 | 316,164 | |||||||||||||||
Allocation of net earnings (loss): | ||||||||||||||||||
Shareholders of the parent | 186,770 | |||||||||||||||||
Non-controlling interest | 129,394 | |||||||||||||||||
Capital expenditures | 16,369 | 72,849 | 89,218 | |||||||||||||||
Net purchase of other intangibles | 6,141 | 910 | 7,051 | |||||||||||||||
Depreciation and amortization | 14,335 | 32,638 | 46,973 | |||||||||||||||
Impairment of property, plant and equipment | — | (8,038 | ) | (8,038 | ) | |||||||||||||
Cash and cash equivalents | 228,114 | 162,136 | 390,250 | |||||||||||||||
Capitalized goodwill | 11,193 | 40,939 | 52,131 | |||||||||||||||
Other intangible assets | 9,643 | 5,133 | 14,776 | |||||||||||||||
Other identifiable assets | 336,090 | 788,973 | 1,125,063 | |||||||||||||||
Total assets | 585,040 | 997,181 | 1,582,221 | |||||||||||||||
Total debt | 162,464 | 32,946 | 195,409 | |||||||||||||||
Headcount in full-time equivalents -1- | 1,631 | 14,563 | 16,194 | |||||||||||||||
___________________ | ||||||||||||||||||
-1 | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. | |||||||||||||||||
Schedule of Geographical Information | ' | |||||||||||||||||
Geographical information is summarized as follows: | ||||||||||||||||||
Europe | United | Japan | Southeast | Corporate | Consolidated | |||||||||||||
States of | Asia | |||||||||||||||||
America | ||||||||||||||||||
Year ended December 31, 2011 | ||||||||||||||||||
Net sales to unaffiliated customers | 338,065 | 185,943 | 96,697 | 1,013,629 | — | 1,634,334 | ||||||||||||
Long-lived assets | 16,021 | 13,110 | 18,273 | 212,605 | 171 | 260,180 | ||||||||||||
Total assets | 406,586 | 131,498 | 120,717 | 733,571 | 189,849 | 1,582,221 | ||||||||||||
Capital expenditures | 7,425 | 8,429 | 1,559 | 71,720 | 85 | 89,218 | ||||||||||||
Purchase of intangible assets | 29 | 779 | 635 | 1,378 | 4,230 | 7,051 | ||||||||||||
Year ended December 31, 2012 | ||||||||||||||||||
Net sales to unaffiliated customers | 255,795 | 197,566 | 59,385 | 905,321 | — | 1,418,067 | ||||||||||||
Long-lived assets | 17,587 | 22,567 | 17,313 | 217,849 | 120 | 275,436 | ||||||||||||
Total assets | 473,561 | 128,484 | 71,838 | 717,986 | 107,637 | 1,499,506 | ||||||||||||
Capital expenditures | 7,098 | 12,837 | 4,947 | 43,280 | — | 68,162 | ||||||||||||
Purchase of intangible assets | 1,732 | 437 | 72 | 997 | 1,392 | 4,630 | ||||||||||||
Year ended December 31, 2013 | ||||||||||||||||||
Net sales to unaffiliated customers | 97,777 | 147,036 | 36,623 | 330,841 | — | 612,277 | ||||||||||||
Long-lived assets | 2,871 | 24,429 | 15,112 | 14,075 | 44 | 56,531 | ||||||||||||
Total assets | 60,709 | 105,952 | 62,252 | 1,112,919 | 209,417 | 1,551,249 | ||||||||||||
Capital expenditures | 3,693 | 8,179 | 1,128 | 4,063 | — | 17,063 | ||||||||||||
Purchase of intangible assets | 108 | — | — | 124 | 238 | 470 | ||||||||||||
Selected_operating_expenses_an1
Selected operating expenses and additional information (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Compensation Related Costs [Abstract] | ' | ||||||||
Schedule of Personnel Expenses for Employees | ' | ||||||||
Personnel expenses for employees were as follows: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Wages and salaries | 318,944 | 353,437 | 136,936 | ||||||
Social security | 42,622 | 47,124 | 16,049 | ||||||
Pension expenses | 18,945 | 21,151 | 7,539 | ||||||
380,511 | 421,712 | 160,524 | |||||||
Schedule of Average Number of Employees, Exclusive of Temporary Workers, by Geographic Area | ' | ||||||||
The average number of employees, exclusive of temporary workers, by geographic area during the year was as follows: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
The Netherlands | 167 | 178 | 156 | ||||||
Other European countries | 993 | 1,057 | 448 | ||||||
United States of America | 468 | 594 | 556 | ||||||
Southeast Asia | 15,716 | 15,300 | 5,050 | ||||||
Japan | 181 | 203 | 181 | ||||||
17,525 | 17,332 | 6,391 | |||||||
Earnings_per_share_Tables
Earnings per share (Tables) | 12 Months Ended | ||||||||
Dec. 31, 2013 | |||||||||
Earnings Per Share [Abstract] | ' | ||||||||
Reconciliation of Net Earnings (Loss) and Weighted Average Number of Shares Outstanding | ' | ||||||||
The following represents a reconciliation of net earnings and weighted average number of shares outstanding (in thousands) for purposes of calculating basic and diluted net earnings per share: | |||||||||
December 31, | |||||||||
2011 | 2012 | 2013 | |||||||
Net earnings used for purpose of computing basic earnings per common share | 186,770 | 7,149 | 1,049,300 | ||||||
After-tax equivalent of interest expense on convertible subordinated notes | 17,670 | — | — | ||||||
Net earnings used for purposes of computing diluted net earnings per common share | 204,440 | 7,149 | 1,049,300 | ||||||
Basic weighted average number of shares outstanding during the year used for purpose of computing basic earnings per share (thousands) | 55,210 | 56,108 | 63,202 | ||||||
Dilutive effect of stock options | 570 | 659 | 994 | ||||||
Dilutive effect of convertible subordinated notes | 8,902 | — | — | ||||||
Dilutive weighted average number of shares outstanding | 64,682 | 56,767 | 64,196 | ||||||
Net earnings per share: | |||||||||
Basic net earnings from continuing operations | 3.38 | 0.13 | 16.6 | ||||||
Diluted net earnings from continuing operations | 3.16 | 0.13 | 16.35 | ||||||
Board_remuneration_Tables
Board remuneration (Tables) | 12 Months Ended | ||||||||||||||||||||||
Dec. 31, 2013 | |||||||||||||||||||||||
Management Board [Member] | ' | ||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] | ' | ||||||||||||||||||||||
Schedule of Information Concerning All Remuneration From the Company For Services in All Capacities | ' | ||||||||||||||||||||||
The following table sets forth as to all current and former members of the Management Board of the Company, information concerning all remuneration from the Company (including its subsidiaries) for services in all capacities: | |||||||||||||||||||||||
Base | Bonuses | Pensions | Share based payment expenses -1- | Other | Total | ||||||||||||||||||
compensation | |||||||||||||||||||||||
Management Board: | |||||||||||||||||||||||
C.D. del Prado | |||||||||||||||||||||||
2013 2) | 520 | 527 | 92 | 506 | 60 | 1,705 | |||||||||||||||||
2012 2) | 510 | 177 | 76 | 398 | 59 | 1,220 | |||||||||||||||||
2011 | 500 | 339 | 69 | 182 | 56 | 1,146 | |||||||||||||||||
P.A.M. van Bommel | |||||||||||||||||||||||
2013 2) | 375 | 391 | 79 | 418 | 45 | 1,308 | |||||||||||||||||
2012 2) | 367 | 144 | 88 | 325 | 59 | 983 | |||||||||||||||||
2011 | 360 | 233 | 54 | 141 | 46 | 834 | |||||||||||||||||
1. | These amounts represent the vesting expenses related to the financial year. | ||||||||||||||||||||||
2. | A one-time crisis levy of 16% as imposed by the Dutch government amounts to €145 (2012: €175 ) in total. This crisis tax levy is payable by the employer and is charged over income of employees exceeding a €150 threshold for both years. These expenses do not form part of the remuneration costs mentioned. | ||||||||||||||||||||||
Schedule of Outstanding Options To Purchase ASM International N.V. Common Shares | ' | ||||||||||||||||||||||
Year | Outstanding January 1, 2013 | Granted | Exercised | Adjustments following the capital distribution -6- | Outstanding December 31, 2013 | Exercise | End date | ||||||||||||||||
of | in 2013 | in 2013 -7- | price | ||||||||||||||||||||
grant | |||||||||||||||||||||||
C.D. del Prado 1,5 | 2003 | 20,000 | — | (20,000 | ) | — | — | US$ | 11.35 | Feb 1, 2013 | |||||||||||||
C.D. del Prado 2 | 2007 | 19,645 | — | — | 3,523 | 23,168 | € | 16.51 | May 23, 2015 | ||||||||||||||
C.D. del Prado 2 | 2008 | 125,000 | — | — | 22,416 | 147,416 | € | 10.78 | Mar 31, 2016 | ||||||||||||||
C.D. del Prado 3 | 2009 | 50,000 | — | — | 8,967 | 58,967 | € | 12.79 | Dec 31, 2017 | ||||||||||||||
C.D. del Prado 4 | 2011 | 75,000 | — | — | 13,450 | 88,450 | € | 18.93 | Dec 31, 2018 | ||||||||||||||
C.D. del Prado 4 | 2012 | 60,000 | — | 10,760 | 70,760 | € | 22.93 | Dec 31, 2019 | |||||||||||||||
C.D. del Prado 4 | 2013 | — | 75,000 | — | 75,000 | € | 23.73 | Dec 31, 2020 | |||||||||||||||
P.A.M. van Bommel 3 | 2010 | 25,000 | — | — | 4,483 | 29,483 | € | 13.8 | Jun 7, 2018 | ||||||||||||||
P.A.M. van Bommel 4 | 2011 | 53,000 | — | — | 9,504 | 62,504 | € | 18.93 | Dec 31, 2018 | ||||||||||||||
P.A.M. van Bommel 4 | 2012 | 40,000 | — | — | 7,173 | 47,173 | € | 22.93 | Dec 31, 2019 | ||||||||||||||
P.A.M. van Bommel 4 | 2013 | — | 53,000 | — | 53,000 | € | 23.73 | Dec 31, 2020 | |||||||||||||||
467,645 | 128,000 | (20,000 | ) | 80,276 | 655,921 | ||||||||||||||||||
1 | These options are granted for a term of ten years, and became exercisable in equal parts over a five year period. | ||||||||||||||||||||||
2 | These options are conditional. A percentage, not exceeding 150%, of the options which have been granted conditionally will become unconditional after three years, based on the total return of the Company's shares for the three years after the options are granted compared to the average total return of the shares of a relevant number of companies which are similar to the Company during the same three-year period. The options are granted for a term of eight years | ||||||||||||||||||||||
3 | These options are granted for a term of eight years and become exercisable after a three years vesting period. | ||||||||||||||||||||||
4 | These options are granted for a term of seven years and become exercisable after a three years vesting period. | ||||||||||||||||||||||
5 | These options have been exercised on January 25, 2013 at a share price of €29.04. | ||||||||||||||||||||||
6 | Following the sale of a 12% share of ASMPT, a capital distribution of €4.25 per common share was effectuated on July 25, 2013. As a result of this capital distribution the underlying value of ASMI option holders was diluted. The Management Board of ASMI and the Supervisory Board of ASMI decided to apply a theoretical adjustment ratio of 0.84974 to the outstanding options granted to employees including members of the Management Board as determined based on the specific rules issued and applied by NYSE Liffe. These specific rules issued by NYSE Liffe are similar to the adjustment ratio as applied to traded securities that are also not entitled to receive the capital distribution. Under these rules a theoretical adjustment ratio was determined based on the value and the effective date of the capital distribution and this ratio was applied to adjust the original number of the options and the original exercise price of the outstanding options. | ||||||||||||||||||||||
Supervisory Board [Member] | ' | ||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] | ' | ||||||||||||||||||||||
Schedule of Company Information Concerning All Remuneration Excluding Bonuses or Pensions Paid From the Company | ' | ||||||||||||||||||||||
The following table sets forth as to all current and former members of the Supervisory Board of the Company information concerning all remuneration (base compensation, no bonuses or pensions were paid) from the Company (including its subsidiaries) for services in all capacities: | |||||||||||||||||||||||
Year ended December 31, | |||||||||||||||||||||||
2011 | 2012 | 2013 | |||||||||||||||||||||
Supervisory Board: | |||||||||||||||||||||||
J.C. Lobbezoo | 53 | 53 | 61 | ||||||||||||||||||||
G.J. Kramer -1- | 68 | 68 | 25 | ||||||||||||||||||||
J.M.R. Danneels | 50 | 50 | 50 | ||||||||||||||||||||
H.W. Kreutzer | 50 | 50 | 51 | ||||||||||||||||||||
M.C.J. van Pernis | 50 | 50 | 51 | ||||||||||||||||||||
U.H.R. Schumacher | 50 | 50 | 50 | ||||||||||||||||||||
321 | 321 | 288 | |||||||||||||||||||||
Share_ownership_and_related_pa1
Share ownership and related party transactions (Tables) | 12 Months Ended | |||||||||||
Dec. 31, 2013 | ||||||||||||
Related Party Transactions [Abstract] | ' | |||||||||||
Schedule of Ownership or Controlling Interest of Outstanding Common Shares | ' | |||||||||||
The ownership or controlling interest of outstanding common shares of ASM International NV by members of the Management Board and Supervisory Board or members of their immediate family are as follows: | ||||||||||||
31-Dec-12 | 31-Dec-13 | |||||||||||
Shares | Percentage of | Shares | Percentage of | |||||||||
owned | Common shares | owned | Common shares | |||||||||
outstanding | outstanding | |||||||||||
A.H. del Prado | 9,204,284 | 14.59 | % | 9,204,284 | 14.5 | % | ||||||
C.D. del Prado (member of the Management Board) | 132,945 | 0.21 | % | 132,945 | 0.21 | % | ||||||
Stichting Administratiekantoor ASMI | 2,142,039 | 3.39 | % | 2,142,039 | 3.37 | % | ||||||
General_information_Summary_of2
General information / Summary of significant accounting policies (Details) (EUR €) | 12 Months Ended | 12 Months Ended | ||||||||
In Millions, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | |
segment | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Minimum [Member] | Maximum [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ||||
country | ||||||||||
Accounting Policies [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of countries in which entity operates (in countries) | 14 | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of operating segments (in segments) | 2 | ' | ' | ' | ' | ' | ' | ' | ' | |
Non-consolidated ownership percentage | ' | ' | ' | ' | ' | ' | ' | 39.94% | 40.08% | [1] |
Evaluation tools useful lives in years | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | |
Sale period to qualify as asset held-for-sale | '1 year | ' | ' | ' | ' | ' | ' | ' | ' | |
Assets Held-for-sale, sale period if circumstances prevent sale within one year (beyond one year) | '1 year | ' | ' | ' | ' | ' | ' | ' | ' | |
Deferred revenues from installations | € 3.90 | € 3.50 | € 6.30 | ' | ' | ' | ' | ' | ' | |
Warranty period | ' | ' | ' | ' | ' | '1 year | '2 years | ' | ' | |
Percentage of stake sold | ' | ' | ' | 12.00% | 11.88% | ' | ' | ' | ' | |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
List_of_significant_subsidiari2
List of significant subsidiaries and associates (Details) | Mar. 15, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | |||||||||||||
Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Almere, The Netherlands [Member] | Montpellier, France [Member] | Montpellier, France [Member] | Leuven, Belgium [Member] | Leuven, Belgium [Member] | Agrate, Italy [Member] | Agrate, Italy [Member] | Helsinki, Finland [Member] | Helsinki, Finland [Member] | Dublin, Ireland [Member] | Dublin, Ireland [Member] | Tel Aviv, Israel [Member] | Tel Aviv, Israel [Member] | Phoenix, Arizona, United States of America [Member] | Phoenix, Arizona, United States of America [Member] | Tokyo, Japan [Member] | Tokyo, Japan [Member] | Quarry Bay, Hong Kong, People's Republic Of China [Member] | Quarry Bay, Hong Kong, People's Republic Of China [Member] | Shanghai, People's Republic Of China [Member] | Shanghai, People's Republic Of China [Member] | Singapore [Member] | Singapore [Member] | Singapore [Member] | Singapore [Member] | Hsin-Chu, Taiwan [Member] | Hsin-Chu, Taiwan [Member] | Kuala Lumpur, Malaysia [Member] | Kuala Lumpur, Malaysia [Member] | Cheonan, South Korea [Member] | Cheonan, South Korea [Member] | Kwai Chung Hong Kong Peoples Republic Of China [Member] | Kwai Chung Hong Kong Peoples Republic Of China [Member] | ||||||||||||||
ASM Europe B.V. [Member] | ASM Europe B.V. [Member] | ASM United Kingdom Sales B.V. [Member] | ASM United Kingdom Sales B.V. [Member] | ASM Germany Sales B.V. [Member] | ASM Germany Sales B.V. [Member] | ASM Pacific Holding B.V. [Member] | ASM Pacific Holding B.V. [Member] | ASM IP Holding BV [Member] | ASM IP Holding BV [Member] | ASM France SARL [Member] | ASM France SARL [Member] | ASM Belgium N.V. [Member] | ASM Belgium N.V. [Member] | ASM Italia S.r.l. [Member] | ASM Italia S.r.l. [Member] | ASM Microchemistry Oy [Member] | ASM Microchemistry Oy [Member] | ASM Services And Support Ireland Ltd. [Member] | ASM Services And Support Ireland Ltd. [Member] | ASM Services And Support Israel Ltd [Member] | ASM Services And Support Israel Ltd [Member] | ASM America, Inc. [Member] | ASM America, Inc. [Member] | ASM Japan K.K. [Member] | ASM Japan K.K. [Member] | ASM Wafer Process Equipment Ltd. [Member] | ASM Wafer Process Equipment Ltd. [Member] | ASM China Ltd. [Member] | ASM China Ltd. [Member] | ASM Wafer Process Equipment Singapore Pte Ltd. [Member] | ASM Wafer Process Equipment Singapore Pte Ltd. [Member] | ASM Front-End Manufacturing Singapore Pte Ltd. [Member] | ASM Front-End Manufacturing Singapore Pte Ltd. [Member] | ASM Front-End Sales & Services Taiwan Co., Ltd. [Member] | ASM Front-End Sales & Services Taiwan Co., Ltd. [Member] | ASM Services And Support Malaysia SDN. BDH. [Member] | ASM Services And Support Malaysia SDN. BDH. [Member] | ASM Genitech Korea Ltd [Member] | ASM Genitech Korea Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | |||||||||||||||||||
Subsidiary or Equity Method Investee [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||
Ownership Percentage | ' | ' | ' | ' | ' | 100.00% | [1] | 100.00% | [1] | 100.00% | [1] | 100.00% | [1] | 100.00% | [1] | 100.00% | [1] | 100.00% | [1],[2],[3] | 100.00% | [1],[2],[3] | 100.00% | [1] | 100.00% | [1] | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | ' | 51.96% | [2] | ||
Non-consolidated ownership percentage | ' | 39.94% | 40.08% | [2] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 39.94% | [2] | ' | |||||||||||
Percentage of stake sold | 11.88% | ' | ' | 12.00% | 11.88% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||
[1] | For these subsidiaries ASM International NV has filed statements at the Dutch Chamber of Commerce assuming joint and several liability in accordance with Article 403 of Book 2, Part 9 of the Netherlands Civil Code. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | Established in 2008, ASM Pacific Holding BV holds 39.94% of the shares in ASM Pacific Technology Ltd. |
Divestment_Details
Divestment (Details) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | Mar. 15, 2013 | Jul. 25, 2013 | |
EUR (€) | EUR (€) | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ||
EUR (€) | EUR (€) | EUR (€) | HKD | EUR (€) | EUR (€) | HKD | |||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of subsidiary shares sold (in shares) | ' | ' | ' | ' | ' | ' | ' | 47,424,500 | 47,424,500 | ' | |
Equity method investment, common stock, par value (in HK dollars per share) | ' | ' | ' | ' | ' | 0.1 | ' | ' | 90 | ' | |
Percentage of stake sold | ' | ' | ' | ' | ' | ' | ' | 11.88% | 11.88% | 12.00% | |
Cash proceeds | ' | ' | ' | ' | ' | ' | ' | € 413,196,000 | 4,191,980,000,000 | ' | |
Percent of subsidiary sold | ' | ' | ' | ' | ' | ' | ' | 51.96% | 51.96% | ' | |
Percent of associate purchased | ' | ' | ' | ' | ' | ' | ' | 40.08% | 40.08% | ' | |
Realized gain on sale 11.88% ASMPT shares | ' | ' | ' | ' | ' | ' | 242,838,000 | 243,000,000 | ' | ' | |
Non-consolidated ownership percentage | ' | ' | 39.94% | 40.08% | [1] | 39.94% | 39.94% | 39.94% | ' | ' | ' |
Unrealized re-measurement gain on retained interest | ' | ' | ' | 1,156,000,000 | ' | ' | 1,155,625,000 | ' | ' | ' | |
Equity method investment, share price | ' | ' | ' | ' | ' | 64.9 | ' | ' | ' | ' | |
Equity method investment, impairment charge | ' | ' | 335,000,000 | ' | ' | ' | 335,406,000 | ' | ' | ' | |
Equity method investment, common shares issued (in shares) | ' | ' | ' | ' | 1,389,200 | 1,389,200 | ' | ' | ' | ' | |
Equity method investment | 943,954,000 | 278,000 | 943,676,000 | ' | 943,676,000 | ' | 943,676,000 | ' | ' | ' | |
Historical cost basis of investment | ' | ' | 264,384,000 | ' | 264,384,000 | ' | 264,384,000 | ' | ' | ' | |
Basis difference | ' | ' | 680,000,000 | ' | 680,000,000 | ' | 680,000,000 | ' | ' | ' | |
Basis difference allocated to property, plant and equipment and intangible assets | ' | ' | 161,532,000 | ' | 161,532,000 | ' | 161,532,000 | ' | ' | ' | |
Basis difference, amount allocated to inventory, portion recognized as expense | ' | ' | ' | ' | ' | ' | 40,000,000 | ' | ' | ' | |
Basis difference, amortization, net of tax | ' | ' | ' | ' | ' | ' | 17,000,000 | ' | ' | ' | |
Market value of equity investment | ' | ' | € 971,130,000 | ' | € 971,130,000 | ' | € 971,130,000 | ' | ' | ' | |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
Divestment_Reconcile_Cash_Proc
Divestment - Reconcile Cash Proceeds (Details) | 12 Months Ended | 0 Months Ended | |||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Mar. 15, 2013 | Mar. 15, 2013 |
EUR (€) | EUR (€) | EUR (€) | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | |
EUR (€) | HKD | ||||
Disposition of Stock in Subsidiary [Abstract] | ' | ' | ' | ' | ' |
Gross proceeds | ' | ' | ' | € 420,409 | ' |
Paid fees, stamp duty and other expenses | ' | ' | ' | -7,213 | ' |
Net proceeds | ' | ' | ' | 413,196 | 4,191,980,000 |
Currency translation differences | ' | ' | ' | 1,232 | ' |
Cash balance ASMPT upon sale | ' | ' | ' | -116,174 | ' |
Net cash on disposal ASMPT | € 298,254 | € 0 | € 0 | € 298,254 | ' |
Divestment_Equity_Method_Inves
Divestment - Equity Method Investment in Consolidated Balance Sheet (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Mar. 15, 2013 | |
In Thousands, unless otherwise specified | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ||||
Associates: | ' | ' | ' | ' | ' | |
ASMI share (39.94%) in equity value ASMPT | ' | ' | ' | € 264,384 | ' | |
Recognized other intangible assets and fair value changes from PPA | ' | ' | ' | 188,985 | ' | |
Goodwill, net | 11,421 | 51,888 | 52,131 | 517,761 | ' | |
Total value investment in ASMPT | ' | ' | ' | 971,130 | ' | |
Deferred value related to the use of the trade name ASM | ' | ' | ' | -27,454 | ' | |
Total value reported on line investments and associates | € 943,954 | € 278 | ' | € 943,676 | ' | |
Non-consolidated ownership percentage | ' | ' | ' | 39.94% | 40.08% | [1] |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
Divestment_Equity_Method_Inves1
Divestment - Equity Method Investment in Consolidated Statement of Operations (Details) (EUR €) | 12 Months Ended | 0 Months Ended | 0 Months Ended | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Mar. 15, 2013 | Jul. 25, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | |
Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | |||||
Result investments and associates | ' | ' | ' | ' | ' | ' | ' | ' | |
ASMI share net earnings March 16 - December 31, 2013 | ' | ' | ' | ' | ' | ' | ' | € 23,727 | |
Realized gain on sale 11.88% ASMPT shares | ' | ' | ' | 243,000 | ' | ' | ' | 242,838 | |
Unrealized remeasurement gain on retained 40.08% ASMPT shares | ' | ' | ' | ' | ' | ' | 1,156,000 | 1,155,625 | |
Impairment loss | ' | ' | ' | ' | ' | -335,000 | ' | -335,406 | |
Amortization other intangible assets and fair value changes from PPA | ' | ' | ' | ' | ' | ' | ' | -56,652 | |
Reported on line result investments and associates | € 1,030,132 | -€ 766 | € 0 | ' | ' | ' | ' | € 1,030,132 | |
Percentage of stake sold | ' | ' | ' | 11.88% | 12.00% | ' | ' | ' | |
Non-consolidated ownership percentage | ' | ' | ' | ' | ' | 39.94% | 40.08% | [1] | 39.94% |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
Divestment_Equity_Method_Inves2
Divestment - Equity Method Investment Summarized Financial Information (Details) (Asm Pacific Technology Ltd [Member], EUR €) | 12 Months Ended |
In Thousands, unless otherwise specified | Dec. 31, 2013 |
Asm Pacific Technology Ltd [Member] | ' |
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract] | ' |
Percent of summarized earnings information of equity investment | 100.00% |
Net sales | € 1,051,376 |
Income before income tax | 65,269 |
Net earnings | 53,244 |
Percent of summarized balance sheet information of equity investment | 100.00% |
Current assets | 749,924 |
Non-current assets | 254,525 |
Current liabilities | 308,922 |
Non-current liabilities | 33,287 |
Equity | € 662,240 |
Cash_And_cash_equivalents_and_1
Cash And cash equivalents and pledged bank deposits (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
Cash and Cash Equivalents, at Carrying Value [Abstract] | ' | ' | ' | ' |
Cash and cash equivalents | € 312,437,000 | € 290,475,000 | € 390,250,000 | € 340,294,000 |
Restricted cash and cash equivalents | € 3,000,000 | ' | ' | ' |
Accounts_receivable_Schedule_o
Accounts receivable (Schedule of Carrying Amount Of Accounts Receivable) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
Accounts Receivable, Net, Current [Abstract] | ' | ' |
Current | € 54,614,000 | € 223,546,000 |
Overdue 30 days or less | 18,787,000 | 38,666,000 |
Overdue 31 – 60 days | 783,000 | 13,537,000 |
Overdue 61 – 120 days | 2,527,000 | 13,954,000 |
Overdue greater than 120 days | 6,305,000 | 15,137,000 |
Total | 83,016,000 | 304,840,000 |
Notes receivable included in total accounts receivable | € 0 | € 42,588,000 |
Accounts_receivable_Schedule_o1
Accounts receivable (Schedule of Changes In Allowance For Doubtful Accounts Receivable) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Allowance for Doubtful Accounts Receivable [Roll Forward] | ' | ' |
Balance at beginning of year | -€ 8,551 | -€ 7,601 |
Deconsolidation ASMPT | 6,191 | 0 |
Charged to selling, general and administrative expenses | 756 | -2,825 |
Utilization | 1,469 | 1,841 |
Foreign currency translation effect | 62 | 34 |
Balance at end of year | -€ 73 | -€ 8,551 |
Inventories_Schedule_Of_Invent
Inventories (Schedule Of Inventories) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Inventory Disclosure [Abstract] | ' | ' | ' |
Components and raw materials | € 78,579 | € 180,575 | ' |
Work in process | 31,442 | 196,313 | ' |
Finished goods | 20,073 | 91,799 | ' |
Total inventories, gross | 130,094 | 468,687 | ' |
Allowance for obsolescence | -25,627 | -65,287 | -58,989 |
Total inventories, net | € 104,467 | € 403,400 | ' |
Inventories_Schedule_Of_Change
Inventories (Schedule Of Changes In Allowance For Obsolescence) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Changes in Allowance for Obsolesence, Inventories [Roll Forward] | ' | ' |
Balance at beginning of year | -€ 65,287 | -€ 58,989 |
Deconsolidation ASMPT | 39,146 | 0 |
Charged to cost of sales | -8,648 | -10,858 |
Utilization | 6,464 | 3,569 |
Foreign currency translation effect | 2,698 | 991 |
Balance at end of year | -€ 25,627 | -€ 65,287 |
Other_intangible_assets_Schedu
Other intangible assets (Schedule of Change In The Amount of Intangible Assets) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
At cost: | ' | ' |
Beginning balance | € 34,739 | € 30,254 |
Deconsolidation ASMPT | -12,146 | ' |
Additions | 470 | 4,630 |
Disposals | -1 | -10 |
Foreign currency translation effect | -417 | -135 |
Ending balance | 22,645 | 34,739 |
Accumulated amortization: | ' | ' |
Beginning balance | 20,824 | 15,478 |
Deconsolidation ASMPT | -7,639 | ' |
Amortization for the year | 4,189 | 5,418 |
Disposals | -1 | -10 |
Foreign currency translation effect | -365 | -62 |
Ending balance | 17,008 | 20,824 |
Other intangible assets, net: | 5,637 | 13,915 |
Software [Member] | ' | ' |
At cost: | ' | ' |
Beginning balance | 20,346 | 18,042 |
Deconsolidation ASMPT | -4,931 | ' |
Additions | 437 | 2,447 |
Disposals | -1 | -10 |
Foreign currency translation effect | -248 | -133 |
Ending balance | 15,603 | 20,346 |
Accumulated amortization: | ' | ' |
Beginning balance | 13,446 | 10,785 |
Deconsolidation ASMPT | -3,744 | ' |
Amortization for the year | 2,118 | 2,784 |
Disposals | -1 | -10 |
Foreign currency translation effect | -211 | -113 |
Ending balance | 11,608 | 13,446 |
Other intangible assets, net: | 3,995 | 6,900 |
Purchased Technology And Other Intangible Assets [Member] | ' | ' |
At cost: | ' | ' |
Beginning balance | 14,393 | 12,212 |
Deconsolidation ASMPT | -7,215 | ' |
Additions | 33 | 2,183 |
Disposals | 0 | 0 |
Foreign currency translation effect | -169 | -2 |
Ending balance | 7,042 | 14,393 |
Accumulated amortization: | ' | ' |
Beginning balance | 7,378 | 4,693 |
Deconsolidation ASMPT | -3,895 | ' |
Amortization for the year | 2,071 | 2,634 |
Disposals | 0 | 0 |
Foreign currency translation effect | -154 | 51 |
Ending balance | 5,400 | 7,378 |
Other intangible assets, net: | € 1,642 | € 7,015 |
Minimum [Member] | ' | ' |
Accumulated amortization: | ' | ' |
Amortization period of other intangible assets | '3 years | ' |
Maximum [Member] | ' | ' |
Accumulated amortization: | ' | ' |
Amortization period of other intangible assets | '7 years | ' |
Other_intangible_assets_Schedu1
Other intangible assets (Schedule of Estimated Amortization Expenses) (Details) (EUR €) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | ' |
2014 | € 1,819 |
2015 | 1,255 |
2016 | 1,224 |
2017 | 547 |
2018 | 528 |
2019 | 264 |
Total | € 5,637 |
Goodwill_Schedule_of_Changes_I
Goodwill (Schedule of Changes In the Carrying Amount of Goodwill) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Goodwill [Roll Forward] | ' | ' |
Goodwill, Beginning balance | € 51,888 | € 52,131 |
Deconsolidation ASMPT | -38,482 | ' |
Foreign currency translation effect | -1,985 | -243 |
Goodwill, Ending balance | 11,421 | 51,888 |
Front-End Segment [Member] | ' | ' |
Goodwill [Roll Forward] | ' | ' |
Goodwill, Beginning balance | 11,649 | 11,193 |
Deconsolidation ASMPT | 0 | ' |
Foreign currency translation effect | -228 | 456 |
Goodwill, Ending balance | 11,421 | 11,649 |
Back-End Segment [Member] | ' | ' |
Goodwill [Roll Forward] | ' | ' |
Goodwill, Beginning balance | 40,239 | 40,938 |
Deconsolidation ASMPT | -38,482 | ' |
Foreign currency translation effect | -1,757 | -699 |
Goodwill, Ending balance | € 0 | € 40,239 |
Goodwill_Schedule_of_Allocatio
Goodwill (Schedule of Allocation of the Carrying Amount of Goodwill) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | € 11,421 | € 51,888 | € 52,131 |
Front-End Segment [Member] | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | 11,421 | 11,649 | 11,193 |
Front-End Segment [Member] | ASM Microchemistry Oy [Member] | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | 3,560 | 3,560 | ' |
Front-End Segment [Member] | ASM Genitech Korea Ltd [Member] | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | 7,861 | 8,089 | ' |
Back-End Segment [Member] | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | 0 | 40,239 | 40,938 |
Back-End Segment [Member] | Asm Pacific Technology Ltd [Member] | ' | ' | ' |
Goodwill [Line Items] | ' | ' | ' |
Goodwill, Total | € 0 | € 40,239 | ' |
Goodwill_Narrative_Details
Goodwill (Narrative) (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ' | ' |
Discount rate of pre-tax weighted average cost of capital | 16.00% | 22.70% |
Maximum term of cash flow calculations | '5 years | ' |
Percentage of perpetuity growth rates used | 1.00% | ' |
Enabling technology products rate used | 3.00% | ' |
Property_plant_and_equipment_S
Property, plant and equipment (Schedule of Changes in the Amount of Property, Plant And Equipment) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
At cost: | ' | ' | ' |
Beginning balance | € 663,509 | € 622,824 | ' |
Capital expenditures | 17,063 | 68,162 | ' |
Deconsolidation ASMPT | -467,688 | ' | ' |
Retirements and sales | -24,758 | -10,531 | ' |
Reclassification from held for sale | 3,393 | ' | ' |
Reclassification | -66 | -320 | ' |
Foreign currency translation effect | -20,647 | -16,626 | ' |
Ending balance | 170,806 | 663,509 | ' |
Accumulated depreciation: | ' | ' | ' |
Beginning balance | 388,073 | 362,644 | ' |
Depreciation for the year | 20,047 | 47,702 | ' |
Deconsolidation ASMPT | -257,280 | ' | ' |
Retirements and sales | -20,789 | -9,639 | ' |
Reclassification | -66 | -320 | ' |
Foreign currency translation effect | -15,710 | -12,314 | ' |
Ending balance | 114,275 | 388,073 | ' |
Property, plant and equipment, net | 56,531 | 275,436 | 260,180 |
Land, Buildings And Leasehold Improvements [Member] | ' | ' | ' |
At cost: | ' | ' | ' |
Beginning balance | 187,880 | 167,874 | ' |
Capital expenditures | 1,580 | 23,355 | ' |
Deconsolidation ASMPT | -145,290 | ' | ' |
Retirements and sales | -13,792 | -278 | ' |
Reclassification from held for sale | 3,393 | ' | ' |
Reclassification | 0 | 428 | ' |
Foreign currency translation effect | -4,824 | -3,499 | ' |
Ending balance | 28,947 | 187,880 | ' |
Accumulated depreciation: | ' | ' | ' |
Beginning balance | 87,377 | 77,096 | ' |
Depreciation for the year | 4,502 | 12,420 | ' |
Deconsolidation ASMPT | -64,699 | ' | ' |
Retirements and sales | -13,700 | -81 | ' |
Reclassification | 0 | 3 | ' |
Foreign currency translation effect | -2,751 | -2,061 | ' |
Ending balance | 10,729 | 87,377 | ' |
Property, plant and equipment, net | 18,218 | 100,503 | ' |
Machinery, Equipment, Furniture And Fixtures [Member] | ' | ' | ' |
At cost: | ' | ' | ' |
Beginning balance | 475,629 | 454,950 | ' |
Capital expenditures | 15,483 | 44,807 | ' |
Deconsolidation ASMPT | -322,398 | ' | ' |
Retirements and sales | -10,966 | -10,253 | ' |
Reclassification from held for sale | 0 | ' | ' |
Reclassification | -66 | -748 | ' |
Foreign currency translation effect | -15,823 | -13,127 | ' |
Ending balance | 141,859 | 475,629 | ' |
Accumulated depreciation: | ' | ' | ' |
Beginning balance | 300,696 | 285,548 | ' |
Depreciation for the year | 15,545 | 35,282 | ' |
Deconsolidation ASMPT | -192,581 | ' | ' |
Retirements and sales | -7,089 | -9,558 | ' |
Reclassification | -66 | -323 | ' |
Foreign currency translation effect | -12,959 | -10,253 | ' |
Ending balance | 103,546 | 300,696 | ' |
Property, plant and equipment, net | € 38,313 | € 174,933 | ' |
Property_plant_and_equipment_S1
Property, plant and equipment (Schedule of Useful Lives of Property, Plant And Equipment) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 |
Land, Buildings And Leasehold Improvements [Member] | Land, Buildings And Leasehold Improvements [Member] | Machinery, Equipment, Furniture And Fixtures [Member] | Machinery, Equipment, Furniture And Fixtures [Member] | Minimum [Member] | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | Maximum [Member] | |
Buildings And Leasehold Improvements [Member] | Machinery And Equipment [Member] | Furniture And Fixtures [Member] | Buildings And Leasehold Improvements [Member] | Machinery And Equipment [Member] | Furniture And Fixtures [Member] | |||||
Property, Plant and Equipment [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Useful lives in years | ' | ' | ' | ' | '10 years | '2 years | '2 years | '25 years | '10 years | '10 years |
Assets under construction | € 0 | € 2,962,000 | € 11,483,000 | € 12,963,000 | ' | ' | ' | ' | ' | ' |
Assets_held_for_sale_Schedule_
Assets held for sale (Schedule Of Changes In The Carrying Value Of Assets Held For Sale) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Assets Held For Sale [Roll Forward] | ' | ' |
Beginning balance | € 5,998 | € 6,862 |
Impairment | -796 | ' |
Reclassification to assets held in use | -3,393 | ' |
Foreign currency translation effect | -1,071 | -864 |
Ending balance | 738 | 5,998 |
Japan [Member] | ' | ' |
Assets Held For Sale [Roll Forward] | ' | ' |
Beginning balance | 5,721 | 6,585 |
Impairment | -796 | ' |
Reclassification to assets held in use | -3,393 | ' |
Foreign currency translation effect | -1,071 | -864 |
Ending balance | 461 | 5,721 |
The Netherlands [Member] | ' | ' |
Assets Held For Sale [Roll Forward] | ' | ' |
Beginning balance | 277 | 277 |
Impairment | 0 | ' |
Reclassification to assets held in use | 0 | ' |
Foreign currency translation effect | 0 | 0 |
Ending balance | € 277 | € 277 |
Assets_held_for_sale_Narrative
Assets held for sale (Narrative) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Long Lived Assets Held-for-sale [Line Items] | ' | ' | ' |
Assets held for sale | € 738 | € 5,998 | € 6,862 |
Impairment charge of building | 796 | ' | ' |
Japan Building [Member] | ' | ' | ' |
Long Lived Assets Held-for-sale [Line Items] | ' | ' | ' |
Impairment charge of building | 796 | ' | ' |
Japan Land [Member] | ' | ' | ' |
Long Lived Assets Held-for-sale [Line Items] | ' | ' | ' |
Assets held for sale | 461 | ' | ' |
The Netherlands [Member] | ' | ' | ' |
Long Lived Assets Held-for-sale [Line Items] | ' | ' | ' |
Assets held for sale | 277 | 277 | 277 |
Impairment charge of building | 0 | ' | ' |
Carrying value | € 277 | ' | ' |
Evaluation_tools_at_customers_1
Evaluation tools at customers (Schedule Of Changes In The Amount Of Evaluation Tools) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Evaluation Tools at Customers [Roll Forward] | ' | ' |
Beginning Balance | € 16,922 | € 13,987 |
Evaluation tools shipped | 8,329 | 11,120 |
Depreciation | -3,771 | -3,798 |
Evaluation tools sold | -6,221 | -3,277 |
Foreign currency translation effect | -1,927 | -1,110 |
Ending Balance | 13,332 | 16,922 |
Evaluation tools useful lives in years | '5 years | ' |
Gross carrying amount of evaluation tools at customers | 18,082 | 21,750 |
Accumulated depreciation of evaluation tools at customers | € 4,750 | € 4,828 |
Investments_and_associates_Det
Investments and associates (Details) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Mar. 15, 2013 | Mar. 15, 2013 | Jul. 25, 2013 | |
EUR (€) | EUR (€) | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Levitech B V [Member] | Levitech B V [Member] | Levitech B V [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ||
EUR (€) | EUR (€) | EUR (€) | HKD | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | HKD | |||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Equity method investment | € 943,954,000 | € 278,000 | € 943,676,000 | ' | € 943,676,000 | ' | € 943,676,000 | € 278,000 | € 278,000 | € 1,044,000 | ' | ' | ' | |
Non-consolidated ownership percentage | ' | ' | 39.94% | 40.08% | [1] | 39.94% | 39.94% | 39.94% | 20.00% | ' | ' | ' | ' | ' |
Number of subsidiary shares sold (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 47,424,500 | 47,424,500 | ' | |
Equity method investment, common stock, par value (in HK dollars per share) | ' | ' | ' | ' | ' | 0.1 | ' | ' | ' | ' | ' | 90 | ' | |
Percentage of stake sold | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 11.88% | 11.88% | 12.00% | |
Cash proceeds | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 413,196,000 | 4,191,980,000,000 | ' | |
Percent of subsidiary sold | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.96% | 51.96% | ' | |
Percent of associate purchased | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40.08% | 40.08% | ' | |
Realized gain on sale 11.88% ASMPT shares | ' | ' | ' | ' | ' | ' | 242,838,000 | ' | ' | ' | 243,000,000 | ' | ' | |
Unrealized re-measurement gain on retained interest | ' | ' | ' | 1,156,000,000 | ' | ' | 1,155,625,000 | ' | ' | ' | ' | ' | ' | |
Equity method investment, impairment charge | ' | ' | 335,000,000 | ' | ' | ' | 335,406,000 | ' | ' | ' | ' | ' | ' | |
Historical cost basis of investment | ' | ' | 264,384,000 | ' | 264,384,000 | ' | 264,384,000 | ' | ' | ' | ' | ' | ' | |
Basis difference | ' | ' | 680,000,000 | ' | 680,000,000 | ' | 680,000,000 | ' | ' | ' | ' | ' | ' | |
Basis difference allocated to property, plant and equipment and intangible assets | ' | ' | 161,532,000 | ' | 161,532,000 | ' | 161,532,000 | ' | ' | ' | ' | ' | ' | |
Basis difference, amount allocated to inventory, portion recognized as expense | ' | ' | ' | ' | ' | ' | 40,000,000 | ' | ' | ' | ' | ' | ' | |
Basis difference, amortization, net of tax | ' | ' | ' | ' | ' | ' | 17,000,000 | ' | ' | ' | ' | ' | ' | |
Market value of equity investment | ' | ' | € 971,130,000 | ' | € 971,130,000 | ' | € 971,130,000 | ' | ' | ' | ' | ' | ' | |
Equity method investment, common shares issued (in shares) | ' | ' | ' | ' | 1,389,200 | 1,389,200 | ' | ' | ' | ' | ' | ' | ' | |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
Investments_and_associates_Sch
Investments and associates (Schedule of Changes in Investment) (Details) (EUR €) | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | 12 Months Ended | |||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | |
Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Levitech B V [Member] | Levitech B V [Member] | Net Equity Share [Member] | Other Intangible Assets and Fair Value Changes [Member] | Goodwill [Member] | |||||
Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ||||||||||
Changes in Investment [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Beginning balance | € 278 | ' | ' | ' | ' | ' | € 1,044 | € 278 | ' | ' | ' | |
40.08% investment in ASMPT March 15, 2013 | ' | ' | ' | ' | 1,381,310 | ' | ' | ' | 255,701 | 227,010 | 898,599 | |
Share in income of investments and associates | ' | ' | ' | ' | 23,727 | ' | -766 | ' | 23,727 | ' | ' | |
Amortization recognized, intangible assets | -696 | -1,264 | -911 | ' | -16,848 | ' | ' | ' | ' | -16,848 | ' | |
Fair value changes related to inventories and tax losses | ' | ' | ' | ' | -39,807 | ' | ' | ' | ' | -39,807 | ' | |
Impairment | ' | ' | ' | -335,000 | -335,406 | ' | ' | ' | ' | ' | -335,406 | |
Dividends | ' | ' | ' | ' | -10,171 | ' | ' | ' | -10,171 | ' | ' | |
Dilution ASMPT share to 39.94% | ' | ' | ' | ' | 3,541 | ' | ' | ' | 3,541 | ' | ' | |
Other changes in equity | ' | ' | ' | ' | 480 | ' | ' | ' | 480 | ' | ' | |
Foreign currency translation effect | ' | ' | ' | ' | -63,150 | ' | ' | ' | -8,894 | -8,824 | -45,432 | |
Ending balance | € 943,954 | € 278 | ' | € 943,676 | € 943,676 | ' | € 278 | € 278 | € 264,384 | € 161,531 | € 517,761 | |
Non-consolidated ownership percentage | ' | ' | ' | 39.94% | 39.94% | 40.08% | [1] | ' | 20.00% | ' | ' | ' |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. |
Notes_payable_to_banks_Schedul
Notes payable to banks (Schedule of Information on Notes Payable) (Details) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | EUR (€) | EUR (€) | Hong Kong Dollar [Member] | Hong Kong Dollar [Member] | ASMPT [Member] | ASMPT [Member] |
HKD | HKD | EUR (€) | EUR (€) | |||
Short-term Debt [Line Items] | ' | ' | ' | ' | ' | ' |
Short-term debt outstanding | € 0 | € 61,675 | 0 | 630,686 | € 0 | € 61,675 |
Notes_payable_to_banks_Narrati
Notes payable to banks (Narrative) (Details) (EUR €) | 12 Months Ended | |||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | |
covenant | ||||
Short-term Debt [Line Items] | ' | ' | ' | ' |
Weighted average interest rate of outstanding notes payable | ' | 1.64% | ' | ' |
Short-term lines of credit, amount | € 150,000,000 | ' | ' | ' |
Short-term debt outstanding | 0 | 61,675,000 | ' | ' |
Undrawn portion of lines of credit | 150,000,000 | ' | ' | ' |
Undrawn portion includes revolving credit facility | 150,000,000 | ' | ' | ' |
Number of financial covenants in credit facility | 2 | ' | ' | ' |
Minimum level of long-term committed capital | 320,000,000 | ' | ' | ' |
Long-term committed capital | 1,447,000,000 | ' | ' | ' |
Net debt/equity ratio, maximum | 2 | ' | ' | ' |
Net cash | 312,437,000 | 290,475,000 | 390,250,000 | 340,294,000 |
Total equity | 1,447,249,000 | 1,049,988,000 | 957,714,000 | 647,227,000 |
ASMPT [Member] | ' | ' | ' | ' |
Short-term Debt [Line Items] | ' | ' | ' | ' |
Short-term debt outstanding | € 0 | € 61,675,000 | ' | ' |
Provision_for_warranty_Schedul
Provision for warranty (Schedule of Product Warranty Liability) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Movement in Standard Product Warranty Accrual [Roll Forward] | ' | ' |
Beginning balance | € 43,921 | € 49,512 |
Charged to cost of sales | 8,491 | 26,527 |
Deconsolidation ASMPT | -34,290 | 0 |
Deductions | -9,850 | -31,948 |
Foreign currency translation effect | -306 | -170 |
Ending balance | 7,966 | 43,921 |
Non-current portion | 0 | 5,298 |
Current portion | € 7,966 | € 38,623 |
Minimum [Member] | ' | ' |
Movement in Standard Product Warranty Accrual [Roll Forward] | ' | ' |
Warranty period | '1 year | ' |
Maximum [Member] | ' | ' |
Movement in Standard Product Warranty Accrual [Roll Forward] | ' | ' |
Warranty period | '2 years | ' |
Accrued_expenses_and_other_Sch
Accrued expenses and other (Schedule of Accrued Expenses and Other) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Payables and Accruals [Abstract] | ' | ' |
Advance payments from customers | € 213 | € 29,350 |
Deferred revenue | 7,346 | 5,938 |
Accrual for salaries, wages and related taxes and expenses | 20,967 | 60,246 |
Interest payable | 0 | 307 |
Payables arising from acquisition of property, plant and equipment | 0 | 14,027 |
Other | 10,134 | 22,192 |
Total accrued expenses and other | € 38,660 | € 132,060 |
Longterm_debt_Schedule_Of_Long
Long-term debt (Schedule Of Long-Term Debt) (Details) | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 |
In Thousands, unless otherwise specified | USD ($) | EUR (€) | USD ($) | EUR (€) | 2.5% [Member] | 2.5% [Member] | London Interbank Offered Rate (LIBOR) [Member] |
ASMPT [Member] | ASMPT [Member] | 2.5% [Member] | |||||
Term Loans [Member] | Term Loans [Member] | ASMPT [Member] | |||||
EUR (€) | EUR (€) | Term Loans [Member] | |||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Long-term debt | $0 | ' | $25,000 | ' | € 0 | € 18,948 | ' |
Basis spread on variable rate | ' | ' | ' | ' | ' | ' | 2.50% |
Current portion | ' | 0 | ' | 6,316 | ' | ' | ' |
Non-current portion | ' | € 0 | ' | € 12,632 | ' | ' | ' |
Recovered_Sheet1
Long-term debt (Schedule of Long-term Debt, Including Current Portion, in Local Currencies) (Details) (USD $) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Long-term Debt, Unclassified [Abstract] | ' | ' |
Long-term debt | $0 | $25,000 |
Convertible_subordinated_debt_1
Convertible subordinated debt (Narrative) (Details) | 12 Months Ended | 0 Months Ended | 1 Months Ended | 12 Months Ended | |||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Oct. 08, 2012 | Nov. 30, 2009 | Nov. 30, 2009 | Dec. 31, 2012 | Dec. 31, 2009 | Dec. 31, 2011 | |
EUR (€) | EUR (€) | EUR (€) | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | 6.50% Convertible Unsecured Notes, Due 2014 [Member] | |
USD ($) | EUR (€) | EUR (€) | EUR (€) | ||||||
Debt Conversion [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Accretion interest expense | ' | € 4,469,000 | € 4,401,000 | ' | ' | ' | ' | ' | ' |
Convertible subordinated notes, interest rate | ' | ' | ' | ' | 6.50% | 6.50% | ' | ' | ' |
Convertible subordinated notes, newly issued common shares (in shares) | 0 | 9,074,396 | 2,151,020 | 9,074,396 | ' | ' | ' | ' | ' |
Convertible subordinated notes | ' | ' | ' | ' | 150,000,000 | ' | ' | ' | ' |
Convertible subordinated notes, conversion rate | ' | ' | ' | ' | 0.0585851 | 0.0585851 | ' | ' | ' |
Convertible subordinated notes, conversion rate, base amount | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' |
Conversion price, per share | ' | ' | ' | ' | ' | € 17.09 | ' | ' | ' |
Convertible, conversion price adjusted | ' | ' | ' | ' | ' | ' | € 16.53 | ' | € 16.85 |
Percentage of redemption price equal to principal amount | ' | ' | ' | ' | ' | ' | ' | 100.00% | ' |
Percentage of common shares that exceeds conversion price | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' |
Term of common shares exceeds conversion price threshold of 30 consecutive trading days | ' | ' | ' | ' | '20 days | '20 days | ' | ' | ' |
Subordinated debt converted into number of shares (in shares) | 0 | 9,074,396 | 2,151,020 | 9,074,396 | ' | ' | ' | ' | ' |
Loss resulting from early extinguishment of debt | € 0 | € 2,209,000 | € 824,000 | ' | ' | ' | € 2,209,000 | ' | ' |
Convertible_subordinated_debt_2
Convertible subordinated debt (Schedule Of Changes In Outstanding Amounts Of Convertible Subordinated Debt) (Details) (6.50% Convertible Unsecured Notes, Due 2014 [Member], EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2012 | Dec. 31, 2013 |
6.50% Convertible Unsecured Notes, Due 2014 [Member] | ' | ' |
Debt Conversion [Line Items] | ' | ' |
Liability at redemption value at date of issuance | ' | € 150,000 |
Conversion component at date of issuance | ' | -23,601 |
Liability component at date of issuance | ' | 126,399 |
Convertible Subordinated Debt [Roll Forward] | ' | ' |
Beginning Balance | 135,078 | ' |
Conversion of notes | -139,407 | ' |
Accrual of interest | 4,329 | ' |
Ending Balance | € 0 | ' |
Shareholders_equity_Narrative_
Shareholders' equity (Narrative) (Details) | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | ||||||
16-May-13 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2009 | Sep. 15, 2008 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | |
EUR (€) | EUR (€) | EUR (€) | Lehman Brothers [Member] | Lehman Brothers [Member] | Lehman Brothers [Member] | Preferred Shares [Member] | Common Shares [Member] | Financing Preferred Shares [Member] | Financing Preferred Shares [Member] | ||
USD ($) | EUR (€) | EUR (€) | EUR (€) | ||||||||
Schedule of Capitalization [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, authorized (in shares) | ' | 110,000,000 | 110,000,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Common shares, par value (in euro per share) | ' | € 0.04 | € 0.04 | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred shares, authorized (in shares) | ' | 118,000 | 118,000 | ' | ' | ' | ' | ' | ' | 8,000 | 8,000 |
Preferred shares, par value (in euro per share) | ' | € 40 | € 40 | ' | ' | ' | ' | ' | ' | € 40 | € 40 |
Common shares, outstanding (in shares) | ' | 63,468,390 | 63,095,986 | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred shares, outstanding | ' | 0 | ' | ' | ' | ' | ' | ' | ' | 0 | ' |
Voting rights per share | ' | 'one vote per €0.04 par value | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of votes per share | ' | ' | ' | ' | ' | ' | ' | ' | 1 | ' | ' |
Period after denial of preferred share transfer to provide list of acceptable buyers | ' | ' | ' | ' | ' | ' | ' | '2 months | ' | '2 months | ' |
Period after approval of preferred share transfer for shareholder to complete transfer | ' | ' | ' | ' | ' | ' | ' | '3 months | ' | '3 months | ' |
Period after approval of preferred share transfer for management board to submit proposal to annul preferred shares | ' | '2 years | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Preferred dividend paid-up amount | ' | ' | ' | € 5 | ' | ' | ' | ' | ' | ' | ' |
Shares purchased and held which were accounted for as treasury shares (in shares) | ' | ' | ' | ' | 2,552,071 | ' | ' | ' | ' | ' | ' |
Shortfall in the number of shares held (in shares) | ' | ' | ' | ' | ' | 221,359 | ' | ' | ' | ' | ' |
Adjustment to paid in capital as result of settlement of the Lehman treasury shares | ' | 4,190,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash compensation received in lieu of treasury stock | ' | ' | ' | ' | ' | 6,251,000 | ' | ' | ' | ' | ' |
Cash compensation receivable for dividends paid on unaccounted treasury stock | ' | ' | ' | ' | ' | ' | 273,062 | ' | ' | ' | ' |
Percent of principal claims for compensation received of unallocated treasury stock | ' | ' | ' | ' | ' | 92.20% | ' | ' | ' | ' | ' |
Gain on dilution of investments in subsidiaries | ' | € 3,587,000 | € 6,937,000 | ' | ' | ' | ' | ' | ' | ' | ' |
Number of months to repurchase shares | '18 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum percentage of share's average closing price | 110.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shares bought back under the authorization (in shares) | ' | ' | ' | ' | ' | 2,305,069 | ' | ' | ' | ' | ' |
Treasury stock, shares to be retired (in shares) | ' | ' | ' | ' | ' | 25,643 | ' | ' | ' | ' | ' |
Purchased and held shares accounted as treasury shares (in shares) | ' | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Maximum percentage of common shares issued which the company can hold in treasury | ' | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Shareholders_equity_Schedule_O
Shareholders' equity (Schedule Of Changes In The Amount Of Accumulated Other Comprehensive Loss) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Changes In The Amount Of Accumulated Other Comprehensive Loss [Roll Forward] | ' | ' | ' |
Beginning Balance | -€ 28,942 | -€ 20,151 | ' |
Realization deferred accumulative translation result following the sale of the 12% share of ASMPT | 23,053 | 0 | 0 |
Deconsolidation ASMPT | 1,597 | ' | ' |
Foreign currency translation effect on translation of foreign operations | -83,606 | -6,994 | ' |
Actuarial loss | -224 | -1,797 | ' |
Ending Balance | -88,122 | -28,942 | -20,151 |
Equity Method Investments [Member] | ' | ' | ' |
Changes In The Amount Of Accumulated Other Comprehensive Loss [Roll Forward] | ' | ' | ' |
Foreign currency translation effect on translation of foreign operations | 480 | ' | ' |
Ending Balance | 480 | ' | ' |
Foreign Currency Translation Effects [Member] | ' | ' | ' |
Changes In The Amount Of Accumulated Other Comprehensive Loss [Roll Forward] | ' | ' | ' |
Beginning Balance | -27,324 | -20,330 | ' |
Realization deferred accumulative translation result following the sale of the 12% share of ASMPT | 23,053 | ' | ' |
Foreign currency translation effect on translation of foreign operations | -84,086 | -6,994 | ' |
Ending Balance | -88,357 | -27,324 | ' |
Unrecognized Pension Obligations Net Of Tax [Member] | ' | ' | ' |
Changes In The Amount Of Accumulated Other Comprehensive Loss [Roll Forward] | ' | ' | ' |
Beginning Balance | -1,618 | 179 | ' |
Deconsolidation ASMPT | 1,597 | ' | ' |
Actuarial loss | -224 | -1,797 | ' |
Ending Balance | -€ 245 | -€ 1,618 | ' |
Employee_benefits_Narrative_De
Employee benefits (Narrative) (Details) | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||||||||||||||||||
Mar. 28, 2012 | Mar. 21, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 15, 2012 | Apr. 24, 2009 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 1989 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2011 | ||
EUR (€) | HKD | EUR (€) | EUR (€) | ASM International N.V. [Member] | ASM International N.V. [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Employee Stock Option Plan [Member] | Employee Share Incentive Scheme ASMPT [Member] | Employee Share Incentive Scheme ASMPT [Member] | Employee Share Incentive Scheme ASMPT [Member] | Employee Share Incentive Scheme ASMPT [Member] | Employee Share Incentive Scheme ASMPT [Member] | MPF Scheme [Member] | New Share Issues [Member] | New Share Issues [Member] | New Share Issues [Member] | Minimum [Member] | Maximum [Member] | Employees And Existing Management Board Members [Member] | ||||
company | plan | employee | EUR (€) | HKD | EUR (€) | EUR (€) | ORSO Scheme [Member] | ORSO Scheme [Member] | Employee Share Incentive Scheme ASMPT [Member] | ||||||||||||||||
member | |||||||||||||||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of contributing members covered by multiemployer union plan | ' | ' | 147,000 | 147,000 | ' | ' | 140 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of companies covered by multiemployer union plan | ' | ' | 1,300 | 1,300 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Maximum percentage of total contribution by entity to multiemployer union plan (less than 5%) | ' | ' | 5.00% | 5.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage of minimum coverage ratio | ' | ' | 104.30% | 104.30% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage of coverage ratio of the multiemployer union plan | ' | ' | 103.40% | 103.40% | 93.90% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Pension premium percentage | ' | ' | 24.10% | 24.10% | 24.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Actual return on plan assets | ' | ' | € 501,000 | ' | € 196,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage of contributions of basic salary of employee | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | 5.00% | 12.50% | ' | |
Level of payroll costs per employee | ' | ' | ' | 25,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Liabilities for severance payments in Italy and Austria | ' | ' | ' | ' | 353,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Expected contribution to defined benefit plan | ' | ' | 1,105,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Compensation expenses for stock options | ' | ' | 4,440,000 | ' | 3,242,000 | 1,872,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Options vesting period | ' | ' | '3 years | '3 years | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Options exercise period | ' | ' | '4 years | '4 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of options granted (in shares) | ' | 1,950,300 | ' | ' | ' | ' | 128,000 | ' | ' | ' | ' | 2,172,455 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage of shares outstanding during Stock Option Plan | ' | ' | 3.40% | 3.40% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Options outstanding (in shares) | ' | ' | 3,308,502 | 3,308,502 | 2,325,088 | ' | 655,921 | 467,645 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage of stake sold | ' | ' | ' | ' | ' | ' | ' | ' | 12.00% | 11.88% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Capital distribution | ' | ' | ' | ' | ' | ' | ' | ' | € 4.25 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Theoretical adjustment ratio | ' | ' | ' | ' | ' | ' | ' | ' | 0.84974 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Weighted average fair values of employee stock options granted (in euro per share) | ' | ' | € 10.22 | ' | € 12.27 | € 10.43 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Options exercisable, contractual life | ' | ' | '7 years | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Total intrinsic value of options exercised | ' | ' | 1,651,000 | ' | 2,209,000 | 4,077,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Shares sold upon exercise of options by employees (in shares) | ' | ' | ' | ' | 328,000 | ' | 20,000 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 125,402 | 144,570 | 294,119 | ' | ' | ' |
Aggregate intrinsic value of all options outstanding | ' | ' | 17,702,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Aggregate intrinsic value of all options exercisable | ' | ' | 8,562,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Compensation expenses related to Employee Share Incentive Scheme | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | € 19,823,000 | € 11,580,000 | ' | ' | ' | ' | ' | ' | ' | ' | |
Maximum percentage of total issued shares to directors and employees | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | ' | ' | ' | ' | |
Extended period for scheme | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Maximum percentage of limited shares on issued ordinary share capital | ' | ' | 7.50% | 7.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Number of sub-plans included in stock option plan | ' | ' | ' | ' | ' | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Maximum percentage of issued share capital subscribed or purchased for extended period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3.50% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Share award scheme, expiration period | '8 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Common shares of ASMPT were issued (in shares) | ' | ' | 63,468,390 | 63,468,390 | 63,095,986 | ' | ' | ' | ' | ' | ' | ' | 1,607,400 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,518,100 | |
Cash at par value (in euro per share) | ' | ' | € 0.04 | ' | € 0.04 | ' | ' | ' | ' | ' | ' | ' | 0.1 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Forfeited in period (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,900 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Vested in period (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 328,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
Percentage dilution of ownership interest | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.21% | 0.19% | ' | ' | ' | ' | ' | ' | ' | ' | |
Diluted ASMI's ownership in ASMPT | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.96% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |
[1] | These options were exercised in January 2013 at a share price of US$38.87. |
Employee_benefits_Schedule_Of_
Employee benefits (Schedule Of The Funded Status Of The Plan) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Front-End [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Defined benefit obligations | -€ 7,604 | -€ 8,357 | -€ 9,485 |
Fair value of plan assets | 5,189 | 4,794 | 4,090 |
Funded status/(deficit) | -2,415 | -3,563 | ' |
Back-End [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Defined benefit obligations | 0 | -33,987 | -22,303 |
Fair value of plan assets | 0 | 27,035 | 21,364 |
Funded status/(deficit) | € 0 | -€ 6,952 | ' |
Employee_benefits_Schedule_Of_1
Employee benefits (Schedule Of Changes In Defined Benefit Obligations And Fair Value Of Plan Assets) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] | ' | ' | ' |
Current service cost | € 484 | € 1,736 | ' |
Interest on obligation | 274 | 1,164 | ' |
Past service costs | 0 | 104 | ' |
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ' | ' | ' |
Expected return | 0 | 853 | ' |
Front-End [Member] | ' | ' | ' |
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] | ' | ' | ' |
Balance January 1 | 8,357 | 9,485 | ' |
Current service cost | 529 | 731 | 664 |
Interest on obligation | 113 | 121 | 107 |
Actuarial losses (gains) | 660 | -436 | ' |
Benefits paid | -128 | -423 | ' |
Foreign currency translation effect | -1,927 | -1,121 | ' |
Balance December 31 | 7,604 | 8,357 | 9,485 |
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ' | ' | ' |
Balance January 1 | 4,794 | 4,090 | ' |
Expected return | 142 | 144 | 103 |
Actuarial (losses) gains | 359 | 52 | ' |
Company contribution | 1,233 | 1,544 | ' |
Benefits paid | -128 | -423 | ' |
Foreign currency translation effect | -1,211 | -613 | ' |
Balance December 31 | 5,189 | 4,794 | 4,090 |
Back-End [Member] | ' | ' | ' |
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] | ' | ' | ' |
Balance January 1 | 33,987 | 22,303 | ' |
Deconsolidation of ASMPT | -34,691 | 0 | ' |
Current service cost | 472 | 1,691 | ' |
Interest on obligation | 262 | 1,095 | ' |
Past service costs | 0 | 104 | ' |
Actuarial losses (gains) | 0 | 8,532 | ' |
Benefits paid | -30 | -55 | ' |
Transfers | 0 | 85 | ' |
Contribution participants | 0 | 222 | ' |
Foreign currency translation effect | 0 | 10 | ' |
Balance December 31 | 0 | 33,987 | ' |
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ' | ' | ' |
Balance January 1 | 27,035 | 21,364 | ' |
Deconsolidation ASMPT | -27,820 | 0 | ' |
Expected return | 423 | 853 | ' |
Actuarial (losses) gains | 0 | 2,981 | ' |
Contribution participants | 0 | 222 | ' |
Company contribution | 362 | 1,615 | ' |
Benefits paid | -30 | -55 | ' |
Balance December 31 | 0 | 27,035 | ' |
Other Post-Employment Benefit Plans ASMPT [Member] | ' | ' | ' |
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] | ' | ' | ' |
Balance January 1 | 1,634 | 1,414 | ' |
Deconsolidation of ASMPT | -1,646 | 0 | ' |
Current service cost | 12 | 45 | ' |
Interest on obligation | 12 | 69 | ' |
Past service costs | 0 | 0 | ' |
Actuarial losses (gains) | 0 | 372 | ' |
Benefits paid | -12 | -181 | ' |
Transfers | 0 | -85 | ' |
Balance December 31 | 0 | 1,634 | ' |
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] | ' | ' | ' |
Expected return | 0 | 0 | ' |
Benefits paid | -€ 12 | -€ 181 | ' |
Employee_benefits_Schedule_Of_2
Employee benefits (Schedule Of Net Periodic Benefit Cost) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Current service cost | € 484 | € 1,736 | ' |
Interest on obligation | 274 | 1,164 | ' |
Past service costs | 0 | -104 | ' |
Expected return on plan assets | 0 | -853 | ' |
Net periodic pension benefit cost | 758 | 2,151 | ' |
Front-End [Member] | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Current service cost | 529 | 731 | 664 |
Interest on obligation | 113 | 121 | 107 |
Expected return on plan assets | -142 | -144 | -103 |
Amortization deferred actuarial loss | 0 | 46 | 6 |
Amortization of past service cost | -44 | -55 | -12 |
Net periodic pension benefit cost | 456 | 699 | 662 |
Other Post-Employment Benefit Plans ASMPT [Member] | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Current service cost | 12 | 45 | ' |
Interest on obligation | 12 | 69 | ' |
Past service costs | 0 | 0 | ' |
Expected return on plan assets | 0 | 0 | ' |
Net periodic pension benefit cost | 24 | 114 | ' |
Principal Defined Benefit Plans [Member] | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Current service cost | 472 | 1,691 | ' |
Interest on obligation | 262 | 1,095 | ' |
Past service costs | 0 | -104 | ' |
Expected return on plan assets | 0 | -853 | ' |
Net periodic pension benefit cost | € 734 | € 2,037 | ' |
Employee_benefits_Schedule_Of_3
Employee benefits (Schedule Of Actuarial Present Value Of Benefit Obligations And Net Periodic Benefit Cost) (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Front-End [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Discount rate for net periodic benefit cost | 1.50% | 1.55% | 1.25% |
Expected return on plan assets for net periodic benefit cost | 3.00% | 3.00% | 3.00% |
Expected rate of compensation increase for net periodic benefit cost | 2.93% | 2.93% | 2.93% |
Discount rate for obligations | 1.50% | 1.55% | 1.25% |
Expected rate of compensation increase for obligations | 2.93% | 2.93% | 2.93% |
Back-End [Member] | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' |
Discount rate for net periodic benefit cost | 0.00% | 3.50% | ' |
Expected return on plan assets for net periodic benefit cost | 0.00% | 3.50% | ' |
Expected rate of compensation increase for net periodic benefit cost | 0.00% | 2.25% | ' |
Discount rate for obligations | 0.00% | 3.50% | ' |
Expected rate of compensation increase for obligations | 0.00% | 2.25% | ' |
Employee_benefits_Allocation_O
Employee benefits (Allocation Of Plan Assets) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Front-End [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | € 5,127 | € 4,794 |
Total allocation of plan assets, percentage | 100.00% | 100.00% |
Front-End [Member] | Equity [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 1,351 | 1,087 |
Total allocation of plan assets, percentage | 26.00% | 23.00% |
Front-End [Member] | Bonds [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 3,019 | 2,957 |
Total allocation of plan assets, percentage | 59.00% | 62.00% |
Front-End [Member] | Loans [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 453 | 463 |
Total allocation of plan assets, percentage | 9.00% | 10.00% |
Front-End [Member] | Real Estate [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 89 | 72 |
Total allocation of plan assets, percentage | 2.00% | 2.00% |
Front-End [Member] | Other [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 215 | 215 |
Total allocation of plan assets, percentage | 4.00% | 4.00% |
Back-End [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 0 | 27,035 |
Total allocation of plan assets, percentage | 0.00% | 100.00% |
Back-End [Member] | Equity [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 0 | 5,677 |
Total allocation of plan assets, percentage | 0.00% | 21.00% |
Back-End [Member] | Fixed Income And Corporate Bonds [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | 0 | 20,817 |
Total allocation of plan assets, percentage | 0.00% | 77.00% |
Back-End [Member] | Cash And Other Assets [Member] | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' |
Total allocation of plan assets | € 0 | € 541 |
Total allocation of plan assets, percentage | 0.00% | 2.00% |
Employee_benefits_Schedule_Of_4
Employee benefits (Schedule Of Expected To Pay Benefits For Subsequent Years) (Details) (Front-End [Member], EUR €) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Front-End [Member] | ' |
Defined Benefit Plan Disclosure [Line Items] | ' |
2014 | € 209 |
2015 | 313 |
2016 | 337 |
2017 | 493 |
2018 | 629 |
Aggregate for the years 2019-2023 | 2,796 |
Total | € 4,777 |
Employee_benefits_Schedule_Of_5
Employee benefits (Schedule Of Retirement Plan Costs) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Defined benefit plans | € 758 | € 2,151 | ' |
Retirement Plan [Member] | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' |
Defined contribution plans | 5,277 | 16,952 | 15,990 |
Multi-employer plans | 1,274 | 1,420 | 1,111 |
Defined benefit plans | 988 | 2,779 | 1,844 |
Total retirement plan costs | € 7,539 | € 21,151 | € 18,945 |
Employee_benefits_Schedule_Of_6
Employee benefits (Schedule Of Changes In Options Outstanding) (Details) | 0 Months Ended | 12 Months Ended | 5 Months Ended | 7 Months Ended | 12 Months Ended | 5 Months Ended | 7 Months Ended | 12 Months Ended | |||
Mar. 21, 2012 | Dec. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 25, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Jul. 25, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
US Dollar [Member] | US Dollar [Member] | US Dollar [Member] | US Dollar [Member] | Eurodollar [Member] | Eurodollar [Member] | Eurodollar [Member] | Eurodollar [Member] | ||||
USD ($) | USD ($) | USD ($) | USD ($) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of options outstanding, beginning balance (in shares) | ' | ' | 3,308,502 | 346,510 | 400,400 | 515,110 | 686,060 | 1,876,088 | 1,924,688 | 1,319,957 | 759,463 |
Adjustment following capital distribution (in shares) | ' | ' | ' | 62,145 | ' | ' | ' | 336,446 | ' | ' | ' |
Number of options granted (in shares) | 1,950,300 | ' | ' | 0 | ' | 0 | 0 | 776,450 | ' | 708,891 | 687,114 |
Options forfeited, Number of options (in shares) | ' | ' | ' | -2,830 | -1,220 | -29,400 | -1,080 | -39,271 | -25,050 | -44,500 | 0 |
Options exercised, Number of options (in shares) | ' | -328,000 | ' | -17,675 | -52,670 | -85,310 | -169,870 | -29,361 | -23,550 | -59,660 | -126,620 |
Number of options outstanding, ending balance (in shares) | ' | 2,325,088 | 3,308,502 | 388,150 | 346,510 | 400,400 | 515,110 | 2,920,352 | 1,876,088 | 1,924,688 | 1,319,957 |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Beginning balance, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $21.72 | $20.94 | $20.83 | $20.40 | € 22.26 | € 22.22 | € 19.08 | € 15.74 |
Adjustment following capital distribution, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $18.42 | ' | ' | ' | € 18.88 | ' | ' | ' |
Options granted, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $0 | ' | $0 | $0 | € 23.73 | ' | € 27.04 | € 22.33 |
Options forfeited, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $9.06 | $13.65 | $20.63 | $16.65 | € 20.93 | € 24.72 | € 15.49 | € 0 |
Options exercised, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $12.66 | $15.97 | $20.42 | $19.10 | € 10.70 | € 15.91 | € 15.08 | € 14.82 |
Ending balance, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | $18.75 | $21.72 | $20.94 | $20.83 | € 20.22 | € 22.26 | € 22.22 | € 19.08 |
Employee_benefits_Schedule_Of_7
Employee benefits (Schedule Of Options Outstanding And Options Exercisable Classified By Range Of Exercise Prices) (Details) | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Jul. 25, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2013 | Jul. 25, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | |
US Dollar [Member] | US Dollar [Member] | US Dollar [Member] | US Dollar [Member] | US Dollar [Member] | Eurodollar [Member] | Eurodollar [Member] | Eurodollar [Member] | Eurodollar [Member] | Eurodollar [Member] | 1.00-10.00 [Member] | 1.00-10.00 [Member] | 10.00-15.00 [Member] | 10.00-15.00 [Member] | 15.00-20.00 [Member] | 15.00-20.00 [Member] | 20.00-25.00 [Member] | 20.00-25.00 [Member] | 25.00-30.00 [Member] | 1.00-30.00 [Member] | 1.00-25.00 [Member] | |||
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | US Dollar [Member] | Eurodollar [Member] | US Dollar [Member] | Eurodollar [Member] | US Dollar [Member] | Eurodollar [Member] | US Dollar [Member] | Eurodollar [Member] | US Dollar [Member] | US Dollar [Member] | Eurodollar [Member] | |||
USD ($) | EUR (€) | USD ($) | EUR (€) | USD ($) | EUR (€) | USD ($) | EUR (€) | USD ($) | USD ($) | EUR (€) | |||||||||||||
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Range of exercise prices, Lower range (in dollar/euro per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1 | € 1 | $10 | € 10 | $15 | € 15 | $20 | € 20 | $25 | $1 | € 1 |
Range of exercise prices, Upper range (in dollar/euro per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $10 | € 10 | $15 | € 15 | $20 | € 20 | $25 | € 25 | $30 | $30 | € 25 |
Options outstanding (in shares) | 3,308,502 | 2,325,088 | 388,150 | 346,510 | 400,400 | 515,110 | 686,060 | 2,920,352 | 1,876,088 | 1,924,688 | 1,319,957 | 759,463 | 65,313 | 2,715 | 30,265 | 445,993 | 128,057 | 854,171 | 114,985 | 1,617,473 | 49,530 | 388,150 | 2,920,352 |
Options outstanding, contractual life | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years 1 month 6 days | '3 months 18 days | '3 years 7 months 6 days | '2 years 8 months 12 days | '2 years 2 months 12 days | '4 years 6 months | '4 years 4 months 24 days | '6 years 4 months 24 days | '3 years | '3 years 6 months | '5 years 3 months 18 days |
Options outstanding, Weighted average exercise price (in euro/dollar per share) | ' | ' | $18.75 | $21.72 | $20.94 | $20.83 | $20.40 | € 20.22 | € 22.26 | € 22.22 | € 19.08 | € 15.74 | $6.75 | € 8.32 | $11.57 | € 12.20 | $18.88 | € 18.61 | $22.59 | € 21.57 | $29.69 | $18.75 | € 19.26 |
Options exercisable, Number exercisable (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 46,443 | 803 | 21,513 | 390,318 | 88,194 | 112,016 | 114,985 | 20,875 | 29,719 | 300,853 | 524,012 |
Options exercisable, Weighted average exercise price (in euro/dollar per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $6.90 | € 8.62 | $11.83 | € 12.11 | $18.67 | € 16.51 | $22.59 | € 22.47 | $29.69 | $18.95 | € 13.46 |
Employee_benefits_Schedule_Of_8
Employee benefits (Schedule Of Black-Scholes Weighted Average Assumptions) (Details) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Employee Benefits and Share-based Compensation [Abstract] | ' | ' | ' |
Expected life (years) | '7 years | '7 years | '7 years |
Risk free interest rate | 2.93% | 3.28% | 3.51% |
Dividend yield | 0.90% | 0.64% | 0.32% |
Expected volatility | 41.52% | 41.98% | 40.90% |
Commitments_and_contingencies_1
Commitments and contingencies (Schedule of Capital Leases in Property, Plant And Equipment) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Capital Leased Assets [Line Items] | ' | ' |
Capital leased assets, gross | € 3,006 | € 3,829 |
Less accumulated depreciation | -3,006 | -3,829 |
Capital leased assets, net | 0 | 0 |
Machinery And Equipment [Member] | ' | ' |
Capital Leased Assets [Line Items] | ' | ' |
Capital leased assets, gross | 2,737 | 3,485 |
Furniture And Fixtures [Member] | ' | ' |
Capital Leased Assets [Line Items] | ' | ' |
Capital leased assets, gross | € 269 | € 344 |
Commitments_and_contingencies_2
Commitments and contingencies (Schedule of Minimum Rental Commitments under Operating Leases) (Details) (EUR €) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Commitments and Contingencies Disclosure [Abstract] | ' |
2014 | € 4,857 |
2015 | 3,801 |
2016 | 3,279 |
2017 | 2,707 |
2018 | 2,423 |
Years thereafter | 3,660 |
Total | € 20,727 |
Commitments_and_contingencies_3
Commitments and contingencies (Narrative) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Commitments and Contingencies Disclosure [Abstract] | ' | ' | ' |
Aggregate rental expense for operating leases | € 9,529 | € 24,661 | € 22,335 |
Purchase commitments with suppliers | 141,908 | ' | ' |
Purchase commitments with suppliers for purchases within the next 12 months | 139,221 | ' | ' |
Commitments for capital expenditures | € 10,552 | ' | ' |
Financial_instruments_and_risk2
Financial instruments and risk management (Schedule of Financial Instruments) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
In Thousands, unless otherwise specified | ||||
Financial assets: | ' | ' | ' | ' |
Cash and cash equivalents | € 312,437 | € 290,475 | € 390,250 | € 340,294 |
Pledged cash deposits | 0 | 20,000 | ' | ' |
Accounts receivable | 83,016 | 304,840 | ' | ' |
Derivative instruments designated in cash flow hedges | 0 | 145 | ' | ' |
Financial liabilities: | ' | ' | ' | ' |
Notes payable to banks | 0 | 61,675 | ' | ' |
Accounts payable | 44,837 | 151,761 | ' | ' |
Current portion of long-term debt | 0 | 6,316 | ' | ' |
Long-term debt | € 0 | € 12,632 | ' | ' |
Financial_instruments_and_risk3
Financial instruments and risk management (Schedule of Gains or Losses Related to Financial Instruments) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Summary of Derivative Instruments by Risk Exposure [Abstract] | ' | ' | ' |
Interest income | € 972 | € 1,989 | € 2,902 |
Interest expense | -2,943 | -12,113 | -13,497 |
Accretion interest expense convertible notes at amortized value | 0 | -4,469 | -4,401 |
Loss resulting from early extinguishment of debt | 0 | -2,209 | -824 |
Losses Foreign currency exchange, net | -8,158 | -3,957 | ' |
Addition to allowance for doubtful accounts receivable | -€ 377 | -€ 2,825 | ' |
Financial_instruments_and_risk4
Financial instruments and risk management (Schedule of Financial Assets and Financial Liabilities That are Measured At Fair Value on a Recurring Basis) (Details) (Recurring [Member], EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | |
In Thousands, unless otherwise specified | |||
At fair value Level 1 | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Derivative financial instruments | ' | € 0 | [1] |
Associates | 971,131 | ' | |
Total | 971,131 | 0 | |
Level 2 | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Derivative financial instruments | ' | 145 | [1] |
Associates | 0 | ' | |
Total | 0 | 145 | |
Level 3 | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Derivative financial instruments | ' | 0 | [1] |
Associates | 0 | ' | |
Total | 0 | 0 | |
Reported Value Measurement [Member] | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Derivative financial instruments | ' | 145 | [1] |
Associates | 971,131 | ' | |
Total | 971,131 | 145 | |
Fair Value [Member] | ' | ' | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' | |
Derivative financial instruments | ' | 145 | [1] |
Associates | 971,131 | ' | |
Total | € 971,131 | € 145 | |
[1] | Derivative financial instruments consist of forward foreign exchange contracts. |
Financial_instruments_and_risk5
Financial instruments and risk management (Schedule of Outstanding Forward Exchange Contracts) (Details) (Fair Value Hedge Contracts [Member], Short Position [Member], EUR €) | Dec. 31, 2012 |
In Thousands, unless otherwise specified | |
Fair Value Hedge Contracts [Member] | Short Position [Member] | ' |
Derivatives, Fair Value [Line Items] | ' |
Derivative Assets, Notional amount | -€ 27,100 |
Derivative Asset, Fair Value, Gross Asset | -145 |
Derivative Assets, Included in accumulated other comprehensive income (loss) | € 0 |
Financial_instruments_and_risk6
Financial instruments and risk management (Narrative) (Details) (EUR €) | 12 Months Ended | 12 Months Ended | ||||||||
Dec. 31, 2013 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | ASM [Member] | Single Customer [Member] | Single Customer [Member] | Single Customer [Member] | Ten Largest Customers [Member] | Ten Largest Customers [Member] | Ten Largest Customers [Member] | ||
Financial Instruments And Risk Management [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Hypothetical percentage of strengthening and weakening of currency | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Percentage of stake sold | ' | 12.00% | 11.88% | ' | ' | ' | ' | ' | ' | ' |
Percentage of revenue on net sales | ' | ' | ' | ' | 28.30% | 8.80% | 6.40% | 85.60% | 31.60% | 27.90% |
Percentage of outstanding balance in accounts receivable | ' | ' | ' | ' | 28.10% | 6.50% | 4.50% | ' | ' | ' |
Short-term lines of credit, amount | € 150,000,000 | ' | ' | € 150,000,000 | ' | ' | ' | ' | ' | ' |
Lines of credit amount outstanding | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Line of credit facility amount undrawn | € 150,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Financial_instruments_and_risk7
Financial instruments and risk management (Schedule of Company's Price Sensitivity Impact on Equity) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Percentage of increase in price | 10.00% | ' |
Percentage of decrease in price | 10.00% | ' |
10% Increase Of U.S. Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | € 4,938 | € 4,564 |
10% Decrease Of U.S. Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | -4,938 | -4,564 |
10% Increase Of Singapore Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | 6,088 | 5,868 |
10% Decrease Of Singapore Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | -6,088 | -5,868 |
10% Increase Of Hong Kong Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | 94,396 | 56,693 |
10% Decrease Of Hong Kong Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | -94,396 | -56,693 |
10% Increase of Korean Won Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | 5,840 | 3,969 |
10% Decrease Of Korean Won Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | -5,840 | -3,969 |
10% Increase Of Japanese Yen Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | 4,561 | 5,294 |
10% Decrease Of Japanese Yen Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Changes recognized in equity due to revaluation effect of foreign currency translation | -€ 4,561 | -€ 5,294 |
Financial_instruments_and_risk8
Financial instruments and risk management (Schedule of Company's Price Sensitivity Impact on Net Earnings) (Details) (EUR €) | 12 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Percentage of increase in price | 10.00% | ' |
Percentage of decrease in price | 10.00% | ' |
10% Increase Of U.S. Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | € 601 | € 915 |
10% Decrease Of U.S. Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | -601 | -915 |
10% Increase Of Singapore Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | 671 | 644 |
10% Decrease Of Singapore Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | -671 | -644 |
10% Increase Of Hong Kong Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | 100,072 | 3,630 |
10% Decrease Of Hong Kong Dollar Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | -100,072 | -3,630 |
10% Increase of Korean Won Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | 1,962 | 1,400 |
10% Decrease Of Korean Won Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | -1,962 | -1,400 |
10% Increase Of Japanese Yen Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | 485 | 923 |
10% Decrease Of Japanese Yen Versus Euro [Member] | ' | ' |
Financial Instruments And Risk Management [Line Items] | ' | ' |
Impact on net earnings due to changes in average exchange rates | -€ 485 | -€ 923 |
Financial_instruments_and_risk9
Financial instruments and risk management (Summary of Company's Contractual Obligations) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
In Thousands, unless otherwise specified | ||||
Summary of Derivative Instruments by Risk Exposure [Abstract] | ' | ' | ' | ' |
Total | € 20,727 | ' | ' | ' |
Operating leases, Less than 1 year | 4,857 | ' | ' | ' |
Operating leases, 1-3 years | 7,080 | ' | ' | ' |
Operating leases, 3-5 years | 5,130 | ' | ' | ' |
Operating leases, More than 5 years | 3,660 | ' | ' | ' |
Purchase obligations: | ' | ' | ' | ' |
Purchase commitments to suppliers | 48,982 | ' | ' | ' |
Purchase commitments to suppliers, Less than 1 year | 48,982 | ' | ' | ' |
Capital expenditure commitments | 458 | ' | ' | ' |
Capital expenditure commitments, Less than 1 year | 458 | ' | ' | ' |
Unrecognized tax benefits (ASC 740) | 0 | 22,511 | 21,749 | 20,057 |
Total contractual obligations | 74,944 | ' | ' | ' |
Total contractual obligations, Less than 1 year | 54,506 | ' | ' | ' |
Total contractual obligations, 1-3 years | 7,730 | ' | ' | ' |
Total contractual obligations, 3-5 years | 6,252 | ' | ' | ' |
Total contractual obligations, More than 5 years | 6,456 | ' | ' | ' |
Pension Plan, Defined Benefit [Member] | ' | ' | ' | ' |
Defined Benefit Plan Disclosure [Line Items] | ' | ' | ' | ' |
Total | 4,777 | ' | ' | ' |
Pension liabilities, Less than 1 year | 209 | ' | ' | ' |
Pension liabilities, 1-3 years | 650 | ' | ' | ' |
Pension liabilities, 3-5 years | 1,122 | ' | ' | ' |
Pension liabilities, More than 5 years | € 2,796 | ' | ' | ' |
Research_and_development_Sched
Research and development (Schedule of Research and Development) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Research and Development Expense [Abstract] | ' | ' | ' |
Research and development expenses | € 76,427 | € 150,118 | € 130,153 |
Research and development grants and credits | -1,036 | -899 | -753 |
Total research and development expenses | € 75,391 | € 149,219 | € 129,400 |
Restructuring_expenses_Narrati
Restructuring expenses (Narrative) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' |
Restructuring expenses | € 2,473 | € 891 | € 0 |
Cost Reduction Program [Member] | ' | ' | ' |
Restructuring Cost and Reserve [Line Items] | ' | ' | ' |
Number of positions eliminated (in employees) | 100 | ' | ' |
Restructuring expenses | € 2,500 | € 900 | ' |
Income_taxes_Components_Of_Ear
Income taxes (Components Of Earnings (Loss) Before Income Taxes And Non-Controlling Interest) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Income Tax Disclosure [Abstract] | ' | ' | ' |
The Netherlands | € 1,018,554 | -€ 70,263 | -€ 3,450 |
Other countries | 41,867 | 136,994 | 356,305 |
Earnings before income taxes | € 1,060,421 | € 66,731 | € 352,855 |
Income_taxes_Schedule_Of_Incom
Income taxes (Schedule Of Income Tax Expense) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Current: | ' | ' | ' |
The Netherlands | -€ 1,938 | -€ 110 | -€ 494 |
Other countries | -9,479 | -26,337 | -64,684 |
Current | -11,417 | -26,447 | -65,178 |
Deferred: | ' | ' | ' |
The Netherlands | 0 | 0 | 0 |
Other countries | 296 | 147 | 28,486 |
Income tax expense | -€ 11,121 | -€ 26,300 | -€ 36,692 |
Income_taxes_Schedule_Of_Recon
Income taxes (Schedule Of Reconciliation Of The Provisions For Income Taxes And The Amounts That Would Be Computed Using Statutory Income Tax Rates) (Details) (EUR €) | 3 Months Ended | 12 Months Ended | ||||||
In Thousands, unless otherwise specified | Mar. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | |||
Income Tax Disclosure [Abstract] | ' | ' | ' | ' | ' | |||
Earnings before income taxes and Non-controlling interest | ' | € 1,060,421 | € 66,731 | € 352,855 | ' | |||
Dutch statutory income tax rate | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | |||
Income tax provision at statutory rate | ' | -265,105 | -16,683 | -88,214 | ' | |||
Non-deductible expenses | ' | -1,957 | -6,508 | -8,228 | ' | |||
Foreign taxes at a rate other than the Dutch statutory rate | ' | -556 | -2,699 | 12,983 | ' | |||
Valuation allowance | ' | -3,960 | -14,876 | 17,991 | ' | |||
Non-taxable income | ' | 260,425 | [1] | 4,887 | [1] | 30,156 | [1] | ' |
Other | ' | 32 | [2] | 9,579 | [2] | -1,380 | [2] | ' |
Income tax expense | ' | -€ 11,121 | -€ 26,300 | -€ 36,692 | ' | |||
[1] | Non-taxable income for 2013 mainly consist of revenues deriving from the disposal of the 12% shareholding in ASMPT in March which are exempt under the Dutch participation exemption. | |||||||
[2] | Other in 2013 mainly consists of tax credits, adjustments to prior years, changes in (enacted) tax laws and revaluation of certain assets. |
Income_taxes_Narrative_Details
Income taxes (Narrative) (Details) | 3 Months Ended | 12 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | |||||||||||
Mar. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2013 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 12, 2012 | Dec. 31, 2013 | Dec. 31, 2013 | Jul. 12, 2012 | ||||
EUR (€) | EUR (€) | EUR (€) | USD ($) | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | International Headquarters [Member] | Singapore And Other Countries [Member] | Maximum [Member] | Maximum [Member] | Maximum [Member] | Minimum [Member] | ||||||
EUR (€) | ASM Front-End Manufacturing Singapore Pte Ltd. [Member] | ASM Front-End Manufacturing Singapore Pte Ltd. [Member] | ASM Technology Singapore Pte Ltd. [Member] | ASM Technology Singapore Pte Ltd. [Member] | |||||||||||||
Income Taxes [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Percentage of stake sold | ' | ' | ' | ' | ' | ' | 12.00% | 11.88% | ' | ' | ' | ' | ' | ' | |||
Non-taxable income | ' | € 260,425,000 | [1] | € 4,887,000 | [1] | € 30,156,000 | [1] | ' | ' | ' | ' | ' | € 3,244,000 | ' | ' | ' | ' |
Tax exemption period range, years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | '10 years | ' | ' | |||
Income Taxes, Tax Incentive Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '5 years | |||
Concessionary tax rate percent | ' | ' | ' | ' | ' | ' | ' | ' | 5.00% | ' | ' | ' | ' | 5.00% | |||
Income Taxes, Concessionary Tax Rate Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '10 years | '10 years | |||
Netherlands statutory tax rate | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Net operating losses | ' | 272,610,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Valuation allowance | ' | 69,958,000 | 83,250,000 | 76,467,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Undistributed earnings of subsidiaries, subject to withholding taxes | ' | 26,734,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Unrecognized tax benefits, tax credits | ' | ' | ' | ' | ' | 20,900,000 | ' | ' | ' | ' | ' | ' | ' | ' | |||
Unrecognized tax benefits that would impact effective tax rate | ' | € 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
[1] | Non-taxable income for 2013 mainly consist of revenues deriving from the disposal of the 12% shareholding in ASMPT in March which are exempt under the Dutch participation exemption. |
Income_taxes_Schedule_Of_Defer
Income taxes (Schedule Of Deferred Income Taxes) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | € 3,154 | € 20,322 | € 10,415 |
Net operating losses | 69,958 | 83,478 | 86,720 |
Depreciation | 1,335 | 2,260 | 363 |
Other | 570 | 1,112 | 6,391 |
Gross deferred tax assets | 75,017 | 107,172 | 103,889 |
Less: valuation allowance | -69,958 | -83,250 | -76,467 |
Net deferred tax assets | 5,059 | 23,922 | 27,422 |
Deferred tax liabilities | -35 | -988 | -4,381 |
Net deferred income taxes | 5,024 | 22,934 | 23,041 |
Acquisitions [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | ' | 0 | ' |
Net operating losses | ' | 0 | ' |
Depreciation | ' | 0 | ' |
Other | ' | 0 | ' |
Gross deferred tax assets | ' | 0 | ' |
Less: valuation allowance | ' | 0 | ' |
Net deferred tax assets | ' | 0 | ' |
Deferred tax liabilities | ' | 0 | ' |
Net deferred income taxes | ' | 0 | ' |
Reclassifications [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | ' | 3,985 | ' |
Net operating losses | ' | 0 | ' |
Depreciation | ' | 508 | ' |
Other | ' | -6,525 | ' |
Gross deferred tax assets | ' | -2,032 | ' |
Less: valuation allowance | ' | -180 | ' |
Net deferred tax assets | ' | -2,212 | ' |
Deferred tax liabilities | ' | 2,212 | ' |
Net deferred income taxes | ' | 0 | ' |
Deferred Income Tax Deconsolidation ASMPT [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | -15,199 | ' | ' |
Net operating losses | -11,905 | ' | ' |
Depreciation | -2,121 | ' | ' |
Other | -194 | ' | ' |
Gross deferred tax assets | -29,419 | ' | ' |
Less: valuation allowance | 11,675 | ' | ' |
Net deferred tax assets | -17,744 | ' | ' |
Deferred tax liabilities | 921 | ' | ' |
Net deferred income taxes | -16,823 | ' | ' |
Deferred Income Tax Change Income Tax Rate [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | -258 | ' | ' |
Net operating losses | 0 | ' | ' |
Depreciation | -88 | ' | ' |
Other | -38 | ' | ' |
Gross deferred tax assets | -384 | ' | ' |
Less: valuation allowance | 0 | ' | ' |
Net deferred tax assets | -384 | ' | ' |
Deferred tax liabilities | 0 | ' | ' |
Net deferred income taxes | -384 | ' | ' |
Consolidated Statement of Operations [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | -814 | 4,928 | ' |
Net operating losses | -1,664 | -2,303 | ' |
Depreciation | 1,603 | 1,478 | ' |
Other | -146 | 1,345 | ' |
Gross deferred tax assets | -1,021 | 5,448 | ' |
Less: valuation allowance | 1,664 | -6,442 | ' |
Net deferred tax assets | 643 | -994 | ' |
Deferred tax liabilities | 37 | 1,142 | ' |
Net deferred income taxes | 680 | 148 | ' |
Equity [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | 255 | 1,730 | ' |
Net operating losses | 0 | 0 | ' |
Depreciation | 0 | 0 | ' |
Other | 0 | 28 | ' |
Gross deferred tax assets | 255 | 1,758 | ' |
Less: valuation allowance | 0 | 0 | ' |
Net deferred tax assets | 255 | 1,758 | ' |
Deferred tax liabilities | 0 | 0 | ' |
Net deferred income taxes | 255 | 1,758 | ' |
Exchange Differences [Member] | ' | ' | ' |
Deferred tax assets: | ' | ' | ' |
Reserves and allowances | -1,152 | -736 | ' |
Net operating losses | 49 | -939 | ' |
Depreciation | -319 | -89 | ' |
Other | -164 | -127 | ' |
Gross deferred tax assets | -1,586 | -1,891 | ' |
Less: valuation allowance | -47 | -161 | ' |
Net deferred tax assets | -1,633 | -2,052 | ' |
Deferred tax liabilities | -5 | 39 | ' |
Net deferred income taxes | -€ 1,638 | -€ 2,013 | ' |
Income_taxes_Schedule_Of_Defer1
Income taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) (EUR €) | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
In Thousands, unless otherwise specified | |||
Income Tax Disclosure [Abstract] | ' | ' | ' |
Deferred tax assets—current | € 3,739 | € 17,967 | ' |
Deferred tax assets—non-current | 1,320 | 5,955 | ' |
Deferred tax liabilities—current | 0 | -36 | ' |
Deferred tax liabilities—non-current | -35 | -952 | ' |
Net deferred income taxes | € 5,024 | € 22,934 | € 23,041 |
Income_taxes_Schedule_Of_Amoun
Income taxes (Schedule Of Amounts And Expiration Dates Of Net Operating Losses For Tax Purposes) (Details) (EUR €) | Dec. 31, 2013 |
In Thousands, unless otherwise specified | |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | € 272,610 |
Expiration Year: 2014 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 37,607 |
Expiration Year: 2015-2016 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 0 |
Expiration Year: 2017 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 47,429 |
Expiration Year: 2018 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 44,664 |
Expiration Year: 2019 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 35,905 |
Expiration Year: 2020 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 4 |
Expiration Year: 2021 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 60,198 |
Expiration Year: 2022 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 28,556 |
Expiration Year: 2023-2028 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 0 |
Expiration Year: 2029 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 14,343 |
Expiration Year: 2030 [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | 3,779 |
Unlimited (No Expiration) [Member] | ' |
Operating Loss Carryforwards [Line Items] | ' |
Total of net operating losses for tax purposes | € 125 |
Income_taxes_Schedule_Of_Recon1
Income taxes (Schedule Of Reconciliation Of The Beginning And Ending Balance Of The Liability For Unrecognized Tax Benefits) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | ' | ' | ' |
Unrecognized tax benefits, beginning balance | € 22,511 | € 21,749 | € 20,057 |
Deconsolidation ASMPT | -22,325 | ' | ' |
Gross increases—tax positions in current year | 0 | 1,157 | 950 |
Foreign currency translation effect | -186 | -395 | 742 |
Unrecognized tax benefits, ending balance | € 0 | € 22,511 | € 21,749 |
Disclosures_about_segments_and2
Disclosures about segments and related information (Schedule of Segment Reporting Information by Segment) (Details) (EUR €) | 12 Months Ended | 12 Months Ended | |||||||||||||||||||||||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2013 | Dec. 31, 2013 | Mar. 15, 2013 | |||||||||||
segment | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | Front-End [Member] | Front-End [Member] | Front-End [Member] | Back-End [Member] | Back-End [Member] | Back-End [Member] | Elimination, Non-Consolidated [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | |||||||||||||||
employee | employee | employee | employee | employee | employee | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | employee | ||||||||||||||||||
employee | employee | employee | |||||||||||||||||||||||||
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Number of operating segments | 2 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Percentage of interest acquired in subsidiary | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 39.94% | 40.08% | [1] | ||||||||||
Net sales to unaffiliated customers | € 612,277 | € 1,418,067 | € 1,634,334 | ' | € 612,277 | € 1,418,067 | € 1,634,334 | € 451,992 | € 370,409 | € 456,065 | € 1,051,376 | € 1,047,658 | € 1,178,270 | -€ 891,091 | ' | ' | |||||||||||
Gross profit | 214,550 | 440,429 | 570,626 | ' | 214,550 | 440,429 | 570,626 | 176,160 | 124,531 | 172,318 | 307,618 | 315,898 | 398,308 | -269,228 | ' | ' | |||||||||||
Result from operations | 40,418 | 88,256 | 367,450 | ' | 40,418 | 88,256 | 367,450 | 44,704 | 539 | 62,581 | 66,352 | 87,717 | 304,869 | -70,638 | ' | ' | |||||||||||
Interest income | 972 | 1,989 | 2,902 | ' | 972 | 1,989 | 2,902 | 904 | 1,015 | 976 | 272 | 974 | 1,925 | -204 | ' | ' | |||||||||||
Interest expense | -2,943 | -12,113 | -13,497 | ' | -2,942 | -12,113 | -13,497 | -2,553 | -11,381 | -13,142 | -2,082 | -732 | -354 | 1,693 | ' | ' | |||||||||||
Loss resulting from early extinguishment of debt | 0 | -2,209 | -824 | ' | ' | -2,209 | -824 | ' | -2,209 | -824 | ' | 0 | 0 | ' | ' | ' | |||||||||||
Accretion interest expense convertible notes | 0 | -4,469 | -4,401 | ' | ' | -4,469 | -4,401 | ' | -4,329 | -4,401 | ' | -140 | 0 | ' | ' | ' | |||||||||||
Revaluation conversion option | 0 | 0 | -4,378 | ' | ' | ' | -4,378 | ' | ' | -4,378 | ' | ' | 0 | ' | ' | ' | |||||||||||
Foreign currency exchange gains (losses), net | -8,158 | -3,957 | 5,604 | ' | -8,158 | -3,957 | 5,604 | -9,005 | -3,050 | 8,296 | 847 | -907 | -2,692 | 0 | ' | ' | |||||||||||
Results on investments | 1,030,132 | -766 | 0 | ' | 1,030,132 | -766 | ' | 0 | -766 | ' | 0 | 0 | ' | 1,030,132 | 1,030,132 | ' | |||||||||||
Income tax expense | -11,121 | -26,300 | -36,692 | ' | -11,121 | -26,300 | -36,692 | -9,484 | -8,965 | -4,581 | -11,308 | -17,335 | -32,111 | 9,671 | ' | ' | |||||||||||
Net earnings | 1,049,300 | 40,431 | 316,164 | ' | 1,049,300 | 40,431 | 316,164 | 24,565 | -29,146 | 44,527 | 54,081 | 69,577 | 271,637 | 970,654 | ' | ' | |||||||||||
Allocation of net earnings (loss): | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Shareholders of the parent | 1,051,893 | 7,149 | 186,770 | ' | 1,051,893 | 7,149 | 186,770 | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Non-controlling interest | -2,593 | 33,282 | 129,394 | ' | -2,593 | 33,282 | 129,394 | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||
Capital expenditures | 17,063 | 68,162 | 89,218 | ' | ' | 68,162 | 89,218 | ' | 21,973 | 16,369 | ' | 46,189 | 72,849 | ' | ' | ' | |||||||||||
Net purchase of other intangibles | 470 | 4,630 | 7,051 | ' | ' | 4,630 | 7,051 | ' | 2,042 | 6,141 | ' | 2,588 | 910 | ' | ' | ' | |||||||||||
Capital expenditures and purchase of intangible assets | ' | ' | ' | ' | 17,533 | ' | ' | 11,072 | ' | ' | 34,003 | ' | ' | -27,542 | ' | ' | |||||||||||
Depreciation and amortization | 28,466 | 58,460 | 49,450 | ' | 28,466 | 58,460 | 46,973 | 19,415 | 18,838 | 14,335 | 41,066 | 39,622 | 32,638 | -32,015 | ' | ' | |||||||||||
Impairment of property, plant and equipment | -796 | 0 | -8,038 | ' | ' | ' | -8,038 | ' | ' | 0 | ' | ' | -8,038 | ' | ' | ' | |||||||||||
Cash and cash equivalents | 312,437 | 290,475 | 390,250 | 340,294 | 312,437 | 290,475 | 390,250 | 312,437 | 145,061 | 228,114 | 149,313 | 145,414 | 162,136 | -149,313 | ' | ' | |||||||||||
Capitalized goodwill | 11,421 | 51,888 | 52,131 | ' | 11,421 | 51,888 | 52,131 | 11,421 | 11,649 | 11,193 | 0 | 40,239 | 40,939 | 0 | 517,761 | ' | |||||||||||
Other intangible assets, net | 5,637 | 13,915 | ' | ' | 5,637 | 13,915 | 14,776 | 5,637 | 9,049 | 9,643 | 902 | 4,866 | 5,133 | -902 | ' | ' | |||||||||||
Investments and associates | 943,954 | 278 | ' | ' | 943,954 | ' | ' | 278 | ' | ' | 0 | ' | ' | 943,676 | 943,676 | ' | |||||||||||
Other identifiable assets | ' | ' | ' | ' | 277,800 | 1,143,228 | 1,125,063 | 277,800 | 334,399 | 336,090 | 599,709 | 808,829 | 788,973 | -599,709 | ' | ' | |||||||||||
Total assets | 1,551,249 | 1,499,506 | 1,582,221 | ' | 1,551,249 | 1,499,506 | 1,582,221 | 607,573 | 500,158 | 585,040 | 749,924 | 999,348 | 997,181 | 193,752 | ' | ' | |||||||||||
Total debt | ' | ' | ' | ' | € 0 | € 80,623 | € 195,409 | € 0 | € 0 | € 162,464 | € 65,105 | € 80,623 | € 32,946 | -€ 65,105 | ' | ' | |||||||||||
Headcount in full-time equivalents | ' | ' | ' | ' | 1,503 | [2] | 17,404 | [2] | 16,194 | [2] | 1,503 | [2] | 1,636 | [2] | 1,631 | [2] | 14,400 | [2] | 15,768 | [2] | 14,563 | [2] | -14,400 | [2] | ' | ' | |
[1] | The accounts of ASM Pacific Technology Ltd were consolidated till March 15, 2013. On that date ASM International sold a 11.88% share in ASM Pacific Technology Ltd resulting in a cease of its control and a subsequent deconsolidation of its 40.08% associate. This shareholding diluted in December 2013 as a result of the issuance of shares to 39.94%. | ||||||||||||||||||||||||||
[2] | Headcount includes those employees with a fixed contract, and is exclusive of temporary workers. |
Disclosures_about_segments_and3
Disclosures about segments and related information (Schedule of Geographical Information) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | € 612,277 | € 1,418,067 | € 1,634,334 |
Long-lived assets | 56,531 | 275,436 | 260,180 |
Total assets | 1,551,249 | 1,499,506 | 1,582,221 |
Capital expenditures | 17,063 | 68,162 | 89,218 |
Purchase of intangible assets | 470 | 4,630 | 7,051 |
Europe [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | 97,777 | 255,795 | 338,065 |
Long-lived assets | 2,871 | 17,587 | 16,021 |
Total assets | 60,709 | 473,561 | 406,586 |
Capital expenditures | 3,693 | 7,098 | 7,425 |
Purchase of intangible assets | 108 | 1,732 | 29 |
United States [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | 147,036 | 197,566 | 185,943 |
Long-lived assets | 24,429 | 22,567 | 13,110 |
Total assets | 105,952 | 128,484 | 131,498 |
Capital expenditures | 8,179 | 12,837 | 8,429 |
Purchase of intangible assets | 0 | 437 | 779 |
Japan [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | 36,623 | 59,385 | 96,697 |
Long-lived assets | 15,112 | 17,313 | 18,273 |
Total assets | 62,252 | 71,838 | 120,717 |
Capital expenditures | 1,128 | 4,947 | 1,559 |
Purchase of intangible assets | 0 | 72 | 635 |
Southeast Asia [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | 330,841 | 905,321 | 1,013,629 |
Long-lived assets | 14,075 | 217,849 | 212,605 |
Total assets | 1,112,919 | 717,986 | 733,571 |
Capital expenditures | 4,063 | 43,280 | 71,720 |
Purchase of intangible assets | 124 | 997 | 1,378 |
Corporate [Member] | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' |
Net sales to unaffiliated customers | 0 | 0 | 0 |
Long-lived assets | 44 | 120 | 171 |
Total assets | 209,417 | 107,637 | 189,849 |
Capital expenditures | 0 | 0 | 85 |
Purchase of intangible assets | € 238 | € 1,392 | € 4,230 |
Selected_operating_expenses_an2
Selected operating expenses and additional information (Schedule Of Personnel Expenses For Employees And Average Number Of Employees, Exclusive Of Temporary Workers, By Geographic Area) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
employee | employee | employee | |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Wages and salaries | € 136,936 | € 353,437 | € 318,944 |
Social security | 16,049 | 47,124 | 42,622 |
Pension expenses | 7,539 | 21,151 | 18,945 |
Personnel expenses | € 160,524 | € 421,712 | € 380,511 |
Number of employees (in employees) | 6,391 | 17,332 | 17,525 |
The Netherlands [Member] | ' | ' | ' |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Number of employees (in employees) | 156 | 178 | 167 |
Other European Countries [Member] | ' | ' | ' |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Number of employees (in employees) | 448 | 1,057 | 993 |
United States [Member] | ' | ' | ' |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Number of employees (in employees) | 556 | 594 | 468 |
Southeast Asia [Member] | ' | ' | ' |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Number of employees (in employees) | 5,050 | 15,300 | 15,716 |
Japan [Member] | ' | ' | ' |
Schedule Of Selected Operating Expenses And Additional Information [Line Items] | ' | ' | ' |
Number of employees (in employees) | 181 | 203 | 181 |
Earnings_per_share_Reconciliat
Earnings per share (Reconciliation of Net Earnings (Loss) and Weighted Average Number of Shares Outstanding) (Details) (EUR €) | 12 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 |
Earnings Per Share [Abstract] | ' | ' | ' |
Net earnings used for purpose of computing basic earnings per common share | € 1,049,300 | € 7,149 | € 186,770 |
After-tax equivalent of interest expense on convertible subordinated notes | 0 | 0 | 17,670 |
Net earnings used for purposes of computing diluted net earnings per common share | € 1,049,300 | € 7,149 | € 204,440 |
Basic weighted average number of shares outstanding during the year used for purpose of computing basic earnings per share (thousands) (in shares) | 63,202 | 56,108 | 55,210 |
Dilutive effect of stock options (in shares) | 994 | 659 | 570 |
Dilutive effect of convertible subordinated notes (in shares) | 0 | 0 | 8,902 |
Dilutive weighted average number of shares outstanding (in shares) | 64,196 | 56,767 | 64,682 |
Net earnings per share: | ' | ' | ' |
Basic net earnings from continuing operations (in euro per share) | € 16.60 | € 0.13 | € 3.38 |
Diluted net earnings from continuing operations (in euro per share) | € 16.35 | € 0.13 | € 3.16 |
Earnings_per_share_Narrative_D
Earnings per share (Narrative) (Details) | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Sep. 15, 2008 | Dec. 31, 2013 | Dec. 31, 2013 | |
EUR (€) | Conversion Rights [Member] | Option Rights [Member] | Lehman Brothers [Member] | Lehman Brothers [Member] | Lehman Brothers [Member] | |
USD ($) | EUR (€) | |||||
Earnings Per Share [Line Items] | ' | ' | ' | ' | ' | ' |
Anti-dilutive securities (in shares) | ' | 8,231,432 | 81,500 | ' | ' | ' |
Shares purchased and held which were accounted for as treasury shares (in shares) | ' | ' | ' | 2,552,071 | ' | ' |
Shares bought back under the authorization (in shares) | ' | ' | ' | ' | 2,305,069 | ' |
Treasury stock, shares to be retired (in shares) | ' | ' | ' | ' | 25,643 | ' |
Shortfall in the number of shares held (in shares) | ' | ' | ' | ' | 221,359 | ' |
Cash compensation received in lieu of treasury stock | ' | ' | ' | ' | $6,251,000 | ' |
Cash compensation receivable for dividends paid on unaccounted treasury stock | ' | ' | ' | ' | ' | 273,062 |
Percent of principal claims for compensation received of unallocated treasury stock | ' | ' | ' | ' | 92.20% | ' |
Adjustment to paid in capital as result of settlement of the Lehman treasury shares | € 4,190,000 | ' | ' | ' | ' | ' |
Board_remuneration_Schedule_Of
Board remuneration (Schedule Of Information Concerning All Remuneration From The Company For Services In All Capacities) (Details) (EUR €) | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Pensions | € 7,539 | € 21,151 | € 18,945 | |||
Share based payment expenses | 4,703 | 23,065 | 13,452 | |||
One-time crisis levy, percentage | 16.00% | ' | ' | |||
One-time crisis levy, amount | 145 | 175 | ' | |||
One-time crisis levy, threshold | 150 | 150 | ' | |||
Management Board [Member] | C.D. Del Prado [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Base compensation | 520 | [1] | 510 | [1] | 500 | |
Bonuses | 527 | [1] | 177 | [1] | 339 | |
Pensions | 92 | [1] | 76 | [1] | 69 | |
Share based payment expenses | 506 | [1],[2] | 398 | [1],[2] | 182 | [2] |
Other | 60 | [1] | 59 | [1] | 56 | |
Board remuneration, Total | 1,705 | [1] | 1,220 | [1] | 1,146 | |
Management Board [Member] | P.A.M. Van Bommel [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Base compensation | 375 | [1] | 367 | [1] | 360 | |
Bonuses | 391 | [1] | 144 | [1] | 233 | |
Pensions | 79 | [1] | 88 | [1] | 54 | |
Share based payment expenses | 418 | [1],[2] | 325 | [1],[2] | 141 | [2] |
Other | 45 | [1] | 59 | [1] | 46 | |
Board remuneration, Total | € 1,308 | [1] | € 983 | [1] | € 834 | |
[1] | A one-time crisis levy of 16% as imposed by the Dutch government amounts to €145 (2012: €175 ) in total. This crisis tax levy is payable by the employer and is charged over income of employees exceeding a €150 threshold for both years. These expenses do not form part of the remuneration costs mentioned. | |||||
[2] | These amounts represent the vesting expenses related to the financial year. |
Board_remuneration_Narrative_D
Board remuneration (Narrative) (Details) (EUR €) | 12 Months Ended | ||
Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' |
Bonus, financial target | 75.00% | ' | ' |
Bonus, non-financial target | 25.00% | ' | ' |
Bonus, maximum pay-out of base salary | 125.00% | ' | ' |
Options vesting period | '3 years | ' | ' |
Options outstanding, contractual life | '7 years | ' | ' |
Fair value per option of options granted (in euro per share) | € 10.22 | € 12.27 | € 10.43 |
Exercise stock options by issue of common shares (in shares) | ' | 328,000 | ' |
Management Board [Member] | ' | ' | ' |
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' |
Fair value per option of options granted (in euro per share) | € 10.22 | € 12.27 | € 10.43 |
Exercise stock options by issue of common shares (in shares) | 20,000 | ' | ' |
Shares issued for exercise of stock options (in shares) | 20,000 | ' | ' |
Board_remuneration_Schedule_Of1
Board remuneration (Schedule Of Outstanding Options To Purchase ASM International N.V. Common Shares) (Details) | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||||||||||||||||||||
Mar. 21, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2013 | Jul. 25, 2013 | Mar. 15, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Jan. 25, 2013 | Jan. 25, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2013 | |||||||||||||
ASM International N.V. [Member] | Asm Pacific Technology Ltd [Member] | Asm Pacific Technology Ltd [Member] | 2003 [Member] | 2003 [Member] | 2003 [Member] | 2003 [Member] | 2007 [Member] | 2008 [Member] | 2009 [Member] | 2010 [Member] | 2011 [Member] | 2011 [Member] | 2012 [Member] | 2012 [Member] | 2013 [Member] | 2013 [Member] | 2007 and 2008 [Member] | 2009 and 2010 [Member] | 2011 and 2012 [Member] | ||||||||||||||||
EUR (€) | C.D. Del Prado [Member] | C.D. Del Prado [Member] | C.D. Del Prado [Member] | C.D. Del Prado [Member] | C.D. Del Prado [Member] | C.D. Del Prado [Member] | P.A.M. Van Bommel [Member] | C.D. Del Prado [Member] | P.A.M. Van Bommel [Member] | C.D. Del Prado [Member] | P.A.M. Van Bommel [Member] | C.D. Del Prado [Member] | P.A.M. Van Bommel [Member] | ||||||||||||||||||||||
ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | ASM International N.V. [Member] | |||||||||||||||||||||||
EUR (€) | USD ($) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |||||||||||||||||||||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Number of options outstanding, beginning balance (in shares) | ' | 2,325,088 | ' | 467,645 | ' | ' | ' | 20,000 | [1],[2] | ' | ' | 19,645 | [3] | 125,000 | [3] | 50,000 | [4] | 25,000 | [4] | 75,000 | [5] | 53,000 | [5] | 60,000 | [5] | 40,000 | [5] | 0 | [5] | 0 | [5] | ' | ' | ' | |
Number of options granted (in shares) | 1,950,300 | ' | ' | 128,000 | ' | ' | ' | 0 | [1],[2] | ' | ' | 0 | [3] | 0 | [3] | 0 | [4] | 0 | [4] | 0 | [5] | 0 | [5] | 0 | [5] | 0 | [5] | 75,000 | [5] | 53,000 | [5] | ' | ' | ' | |
Exercised (in shares) | ' | ' | -328,000 | -20,000 | [6] | ' | ' | ' | -20,000 | [1],[2],[6] | ' | ' | 0 | [3],[6] | 0 | [3],[6] | 0 | [4],[6] | 0 | [4],[6] | 0 | [5],[6] | 0 | [5],[6] | ' | 0 | [5],[6] | 0 | [5],[6] | 0 | [5],[6] | ' | ' | ' | |
Adjustments following the capital distribution (in shares) | ' | ' | ' | 80,276 | [7] | ' | ' | ' | 0 | [1],[2],[7] | ' | ' | 3,523 | [3],[7] | 22,416 | [3],[7] | 8,967 | [4],[7] | 4,483 | [4],[7] | 13,450 | [5],[7] | 9,504 | [5],[7] | 10,760 | [5],[7] | 7,173 | [5],[7] | ' | ' | ' | ' | ' | ||
Number of options outstanding, ending balance (in shares) | ' | 3,308,502 | 2,325,088 | 655,921 | ' | ' | ' | 0 | [1],[2] | ' | ' | 23,168 | [3] | 147,416 | [3] | 58,967 | [4] | 29,483 | [4] | 88,450 | [5] | 62,504 | [5] | 70,760 | [5] | 47,173 | [5] | 75,000 | [5] | 53,000 | [5] | ' | ' | ' | |
Exercise price (in euro/dollar per share) | ' | ' | ' | ' | ' | ' | ' | € 11.35 | [1],[2] | $38.87 | € 29.04 | € 16.51 | [3] | € 10.78 | [3] | € 12.79 | [4] | € 13.80 | [4] | € 18.93 | [5] | € 18.93 | € 22.93 | [5] | € 22.93 | € 23.73 | [5] | € 23.73 | ' | ' | ' | ||||
Options outstanding, contractual life | ' | '7 years | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '8 years | '8 years | '7 years | ||||||||||||
Options exercisable, contractual life | ' | '7 years | ' | ' | ' | ' | '5 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | ' | ' | ||||||||||||
Maximum percentage of options granted | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 150.00% | ' | ' | ||||||||||||
Options vesting period | ' | '3 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 years | '3 years | ||||||||||||
Percentage of stake sold | ' | ' | ' | ' | 12.00% | 11.88% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Capital distribution (in euro per share) | ' | ' | ' | ' | € 4.25 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Theoretical adjustment ratio | ' | ' | ' | ' | 0.84974 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
[1] | These options are granted for a term of ten years, and became exercisable in equal parts over a five year period. | ||||||||||||||||||||||||||||||||||
[2] | These options have been exercised on January 25, 2013 at a share price of €29.04. | ||||||||||||||||||||||||||||||||||
[3] | These options are conditional. A percentage, not exceeding 150%, of the options which have been granted conditionally will become unconditional after three years, based on the total return of the Company's shares for the three years after the options are granted compared to the average total return of the shares of a relevant number of companies which are similar to the Company during the same three-year period. The options are granted for a term of eight years | ||||||||||||||||||||||||||||||||||
[4] | These options are granted for a term of eight years and become exercisable after a three years vesting period. | ||||||||||||||||||||||||||||||||||
[5] | These options are granted for a term of seven years and become exercisable after a three years vesting period. | ||||||||||||||||||||||||||||||||||
[6] | These options were exercised in January 2013 at a share price of US$38.87. | ||||||||||||||||||||||||||||||||||
[7] | Following the sale of a 12% share of ASMPT, a capital distribution of €4.25 per common share was effectuated on July 25, 2013. As a result of this capital distribution the underlying value of ASMI option holders was diluted. The Management Board of ASMI and the Supervisory Board of ASMI decided to apply a theoretical adjustment ratio of 0.84974 to the outstanding options granted to employees including members of the Management Board as determined based on the specific rules issued and applied by NYSE Liffe. These specific rules issued by NYSE Liffe are similar to the adjustment ratio as applied to traded securities that are also not entitled to receive the capital distribution. Under these rules a theoretical adjustment ratio was determined based on the value and the effective date of the capital distribution and this ratio was applied to adjust the original number of the options and the original exercise price of the outstanding options. |
Board_remuneration_Schedule_Of2
Board remuneration (Schedule Of Company Information Concerning All Remuneration Excluding Bonuses Or Pensions Paid From The Company) (Details) (Supervisory Board [Member], EUR €) | 12 Months Ended | |||||
In Thousands, unless otherwise specified | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | € 288 | € 321 | € 321 | |||
J.C. Lobbezoo [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | 61 | 53 | 53 | |||
G.J. Kramer [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | 25 | [1] | 68 | [1] | 68 | [1] |
J.M.R. Danneels [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | 50 | 50 | 50 | |||
H.W. Kreutzer [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | 51 | 50 | 50 | |||
M.C.J. van Pernis [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | 51 | 50 | 50 | |||
U.H.R. Schumacher [Member] | ' | ' | ' | |||
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] | ' | ' | ' | |||
Supervisory board remuneration | € 50 | € 50 | € 50 | |||
[1] | Mr Kramer resigned from the Supervisory Board on May 16, 2013. |
Share_ownership_and_related_pa2
Share ownership and related party transactions (Schedule of Ownership or Controlling Interest of Outstanding Common Shares) (Details) | 12 Months Ended | |
Dec. 31, 2013 | Dec. 31, 2012 | |
Related Party Transaction [Line Items] | ' | ' |
Shares owned (in shares) | 63,468,390 | 63,095,986 |
A.H. Del Prado [Member] | ' | ' |
Related Party Transaction [Line Items] | ' | ' |
Shares owned (in shares) | 9,204,284 | 9,204,284 |
Percentage of common shares outstanding | 14.50% | 14.59% |
C.D. Del Prado [Member] | ' | ' |
Related Party Transaction [Line Items] | ' | ' |
Shares owned (in shares) | 132,945 | 132,945 |
Percentage of common shares outstanding | 0.21% | 0.21% |
Stichting Administratiekantoor ASMI [Member] | ' | ' |
Related Party Transaction [Line Items] | ' | ' |
Shares owned (in shares) | 2,142,039 | 2,142,039 |
Percentage of common shares outstanding | 3.37% | 3.39% |
Share_ownership_and_related_pa3
Share ownership and related party transactions (Narrative) (Details) | Dec. 31, 2013 |
Related Party Transactions [Abstract] | ' |
Number of shares owned beneficially by trust (in shares) | 713,000 |